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Abstract	  Antibiotic	  resistance	  is	   ‘as	  big	  a	  risk	  as	  terrorism’	  according	  to	  H.M.	  Government	  Chief	  Medical	  Officer	  in	  March	  2013.	  New	  insights	  into	  the	  ecology	  and	  evolution	  of	   resistance	   are,	   therefore,	   a	   research	   priority	   if	   we	   are	   to	   avert	   this	   crisis.	  Antibiotic	   resistance	   genes	   are	   often	   carried	   on	   plasmids,	   mobile	   genetic	  elements	   that	   allow	   rapid	   dissemination	   of	   resistance	   through	   bacterial	  populations.	   However,	   little	   is	   known	   about	   the	   ecology	   of	   plasmids	   and	  associated	   antibiotic	   resistance	   in	   natural	   bacterial	   communities.	   In	   addition,	  detoxifying	  antibiotic	  resistance	  is	  often	  cited	  as	  a	  social	  trait	  in	  bacteria.	  This	  is	  of	   particular	   interest	   because	   many	   virulence-­‐associated	   traits,	   including	  siderophore	   production	   and	   toxin	   secretion,	   are	   cooperative.	   This	   thesis	  examines	   the	   evolutionary	   ecology	   of	   both	   antibiotic	   resistance	   and	   resistance	  plasmids	  in	  E.	  coli	  in	  four	  related	  studies:	  i)	  an	  examination	  cooperative	  β-­‐lactam	  resistance	  using	   laboratory	  competition	  experiments,	  which	  demonstrated	   that	  cooperative	  resistance	  occurs	  only	  under	  very	  specific	  conditions:	  the	  presence	  of	   ‘persister’	  susceptible	  colonies,	  which	  are	  not	  resistant,	  but	  can	  tolerate	  high	  concentrations	  of	   antibiotic	   in	   the	  presence	  of	   resistant	   cells;	   ii)	   sequencing	  of	  non-­‐resistance	   plasmids,	   which	   demonstrated	   the	   wide	   variety	   of	   plasmids	  present	   in	  one	  bacterial	  community,	  and	  highlighted	  our	   limited	  understanding	  of	  plasmid	  gene	  function;	  iii)	  a	  population	  study	  of	  E.	  coli	  and	  its	  plasmids	  which	  found	  surprisingly	  low	  levels	  of	  antibiotic	  resistance,	  and	  interesting	  patterns	  of	  plasmid-­‐host	   diversity	   and	   population	   structuring;	   and	   iv)	   laboratory	   plasmid	  maintenance	  experiments	  which	  found	  a	  complex,	  frequency-­‐dependent	  pattern	  governing	  plasmid	  persistence.	  	  	  These	   results	   bring	   into	   question	   current	   assumptions	   about	   resistance	   as	   a	  cooperative	   trait,	   and	   suggest	   that	   frequency-­‐dependence	   could	   be	   key	   to	  explaining	   plasmid	   maintenance	   dynamics.	   They	   also	   provide	   insights	   into	  natural	   plasmid	   populations	   through	   sequencing	   and	   field	   study,	   which	  contribute	  to	  our	  understanding	  of	  the	  spread	  of	  antibiotic	  resistance	  genes.	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Chapter	  1: General	  Introduction	  
	  	  	  
1.1 Introductory	  statement	  Over	  twenty	  years	  ago	  Harold	  Neu	  published	   ‘The	  Crisis	  in	  Antibiotic	  Resistance’	  (Neu	   1992),	   which	   described	   the	   increasing	   prevalence	   of	   resistance	   across	  many	   bacterial	   genera	   and	   cited	   the	   overuse	   of	   antibiotics	   in	   hospitals,	   in	   the	  community	   and	   in	   animal	   husbandry	   as	   key	   contributory	   factors.	   Over	   the	  subsequent	   decades	   ‘superbugs’	   such	   as	   methicillin-­‐resistant	   Staphylococcus	  
aureus	  (MRSA)	  have	  continued	  to	  pose	  a	  huge	  challenge	  to	  medical	  professionals	  (Mulvey	   &	   Simor	   2009).	   The	   antibiotic	   resistance	   issue	   has	   even	   begun	   to	  permeate	   the	   national	   psyche,	   as	   demonstrated	   by	   recent	   statements	   from	  government	   (The	   Department	   of	   Health	   &	   The	   Prime	   Minister's	   Office,	   July	  2014),	  health	  officials	  (Davies	  2013)	  and	  the	  general	  public,	  who	  have	  voted	  to	  make	   ‘Antibiotics’	   the	   winning	   challenge	   for	   the	   Longitude	   Prize	   2014	   (see	  http://www.longitudeprize.org).	  	  	  Bacteria	  have	  so	  clearly	  demonstrated	  their	  capacity	  to	  evolve	  resistance	  to	  new	  drugs	   that	   alternative	   strategies	   for	   resistance	   management	   are	   desperately	  needed:	   a	   new	   drug	  will	   only	   remain	   effective	   if	   resistance	   can	   be	   controlled.	  Antibiotic	   resistance	   genes	   are	   often	   carried	   on	   plasmids,	   mobile	   genetic	  elements	   that	   allow	   rapid	   dissemination	   of	   resistance	   through	   bacterial	  populations.	   This	   thesis	   explores	   a	   novel	   strategy	   for	   exploiting	   plasmids	   and	  bacterial	   cooperation	   to	   limit	   the	   spread	   of	   resistance,	   and	   offers	   insights	   into	  the	   evolutionary	   ecology	   of	   plasmids	   and	   antibiotic	   resistance	   in	   natural	  bacterial	   communities.	   The	   introduction	   provides	   some	   background	   about	  antibiotic	   resistance	   and	   resistance	   plasmids,	   focusing	   on	   cooperative	   β-­‐lactamases	   and	   leading	   to	   the	   ‘cheat’	   plasmid	   hypothesis	   and	   its	   potential	   for	  resistance	   management.	   As	   well	   as	   exploring	   strategies	   for	   limiting	   antibiotic	  resistance,	  this	  thesis	  addresses	  more	  general	  questions	  of	  plasmid	  ecology	  and	  persistence	  which	  are	  outlined	  below,	  alongside	  an	  overview	  of	  the	  study	  system	  and	  the	  specific	  aims	  of	  this	  research.	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1.2 Antibiotic	  resistance	  and	  resistance	  plasmids	  
1.2.1 Mechanisms	  of	  resistance	  Antibiotics	   have	   many	   varied	   modes	   of	   action,	   so	   it	   follows	   that	   resistance	  mechanisms	   too	   are	   varied;	   resistance	   can	   be	   conferred	   by	   a	   single	   point	  mutation	  in	  the	  target	  gene,	  or	  it	  may	  require	  the	  acquisition	  of	  a	  whole	  new	  set	  of	   genes	   (Mazel	   2001;	   Hayes	   &	   Wolf	   1990).	   Figure	   1.1	   illustrates	   five	   key	  resistance	   strategies:	   i)	   reduced	   drug	   import	   due	   to	   alterations	   in	   the	   cell	  membrane	  or	  in	  active	  transporters	  such	  as	  omp	  proteins	  (Hayes	  &	  Wolf	  1990);	  ii)	  target	  site	  modification,	  such	  as	  rifampicin	  resistance	  due	  to	  mutations	  in	  the	  RNA	  polymerase	  β-­‐subunit	   (Spratt	  1994);	   iii)	   drug	  modification	  by	   cleavage	  of	  the	   drug	   (β-­‐lactams)	   or	   by	   enzymatic	   alterations	   such	   as	   	   acetylation	   or	  phosphorylation	  (kanamycin)	  (Walsh	  2000);	  iv)	  antibiotic	  sequestration,	  such	  as	  bleomycin	  binding	  proteins	  (Dumas	  et	  al.	  1994);	  and	  finally	  v)	  drug	  efflux,	   	   the	  active	  removal	  of	  antibiotics	  from	  the	  cell	  by	  general	  or	  specific	  pumps,	  which	  is	  often	  associated	  with	  multi-­‐drug	  resistance	  (Webber	  &	  Piddock	  2003).	  
	  
Figure	  1.1:	  Mechanisms	  of	  antibiotic	  resistance.	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1.2.2 β-­‐lactam	  action	  and	  resistance	  Antibiotics	  containing	  a	  β-­‐lactam	  ring,	  penicillins	  and	  cephalosporins,	  target	  the	  bacterial	  cell	  wall.	  Much	  of	  the	  mechanism	  behind	  this	  process	  remains	  unclear	  despite	  over	  seven	  decades	  of	  research.	  However,	  it	  is	  known	  that	  the	  drugs	  bind	  to	   penicillin-­‐binding	   proteins	   (PBPs,	   which	   are	   many	   and	   varied)	   preventing	  peptidoglycan	   synthesis	   and	   stimulating	   the	   release	  of	   autolysins	   (Blumberg	  &	  Strominger	   1974;	  Waxman	   &	   Strominger	   1983;	   Lewis	   2007).	   This	   produces	   a	  range	   of	   outcomes	   depending	   on	   the	   PBP	   affected,	   the	   strain	   and	   the	   growth	  conditions;	   cell	   lysis,	   production	   of	   distorted	   round-­‐form	   cells,	   production	   of	  filaments	  and	  combinations	  of	  the	  three	  are	  possible	  (Gould	  &	  MacKenzie	  1997).	  Lysis	   is	   clearly	   a	   critical	   factor	   for	   cell	   death.	   Penicillins	   are	   bactericidal	   to	  growing	   cells	  with	   the	   rate	  of	  killing	  proportional	   to	  growth	   rate	   (Hobby	  et	   al.	  1942;	  Rolinson	  et	  al.	  1977),	  but	  they	  are	  largely	  ineffective	  on	  non-­‐growing	  cells	  (with	  limited	  exceptions,	  see	  Tuomanen	  et	  al.	  1986).	  	  	  The	   first	   β-­‐lactam	   resistance	   enzyme	   was	   identified	   before	   the	   release	   of	  penicillin	   for	   medical	   use	   (Abraham	   &	   Chain	   1940;	   Bradford	   2001).	   These	  enzymes,	   the	   β-­‐lactamases,	   confer	   resistance	   by	   facilitating	   cleavage	   of	   the	   β-­‐lactam	   ring	   hydrolysing	   penicillins	   to	   penicilloic	   acids	   (Figure	   1.2).	   This	  hydrolysis	  inhibits	  antibiotic	  binding	  to	  PBPs,	  rendering	  the	  drug	  inactive	  (Walsh	  2000;	   Davies	   1994).	   Extended-­‐spectrum	   β-­‐lactamases	   (ESBLs),	   which	   confer	  cephalosporin	   as	   well	   as	   penicillin	   resistance,	   are	   now	   widespread	   across	  Europe,	  and	  pose	  an	  increasing	  risk	  to	  both	  human	  and	  animal	  health	  (Livermore	  et	  al.	  2008;	  Canton	  et	  al.	  2008;	  Bradford	  2001).	  	  
	  
	  
Figure	   1.2:	   Hydrolysis	   of	   penicillin	   to	   penicilloic	   acid,	   catalysed	   by	   β-­‐lactamase	  enzymes.	  Adapted	  from	  Sykes	  &	  Matthew	  (1976).	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1.2.3 Resistance	  plasmids	  and	  the	  spread	  of	  ESBLs	  Horizontal	  gene	  transfer,	  the	  lateral	  exchange	  of	  genes	  between	  individuals,	  both	  within	  and	  between	  species,	  has	  been	  identified	  as	  one	  of	  the	  major	  factors	  in	  the	  spread	  of	  antibiotic	  resistance	  genes	  through	  bacterial	  populations	  (de	  la	  Cruz	  &	  Davies	  2000).	  In	  particular,	  conjugation,	  plasmid	  transfer	  via	  cell	  to	  cell	  contact,	  is	  critical	  for	  the	  spread	  of	  resistance	  genes	  (Ochman	  et	  al.	  2000).	  Plasmids	  are	  major	  carriers	  of	  antibiotic	  resistance	  genes:	  they	  facilitate	  gene	  transfer	  across	  bacterial	   genera,	   and	   allow	   multiple	   resistance	   genes	   to	   accrue	   on	   one	  transmissible	  element	   (Taylor	  et	  al.	  2004;	  Davies	  1994).	  They	  are	  also	  diverse,	  encompassing	   large	   and	   small,	   high-­‐	   and	   low-­‐	   copy	   number	   and	   many	  incompatibility	   (Inc)	   groups:	   plasmids	   with	   closely	   related	   replication	   control	  genes	  cannot	  be	  maintained	   in	  the	  same	  host	  cell	  and	  are	  termed	  incompatible	  (Taylor	  et	  al.	  2004).	  	  The	  spread	  of	  ESBLs,	  in	  particular	  CTX-­‐M	  β-­‐lactamases,	  has	  been	  largely	  plasmid	  mediated	   (Canton	   et	   al.	   2008).	   Plasmid	   carried	   CTX-­‐M	   genes	   are	   known	   to	   be	  derived	   from	  chromosomal	  β-­‐lactamases	  of	  Kluyvera	  sp.	   via	   insertion	  sequence	  mobilization	   (Livermore	   et	   al.	   2006).	   The	   wide	   variety	   of	   plasmids,	   many	   of	  which	   carry	   additional	   resistance	   genes,	   may	   indicate	   multiple	   mobilization	  events:	  one	  IncF	  plasmid,	  pEK499,	  was	  found	  to	  carry	  a	  cluster	  of	  ten	  resistance	  genes,	   including	   CTX-­‐M-­‐15	   (Woodford	   et	   al.	   2009).	   	   Worryingly,	   these	   CTX-­‐M	  carrying	  plasmids	  have	  also	  been	  linked	  to	  virulent	  E.	  coli	  genotypes	  (Cantón	  &	  Coque	   2006;	   Rossolini	   et	   al.	   2008).	   The	   emergence	   of	   CTX-­‐M	   enzymes	   in	  
Enterbacteriaceae	  since	  the	  1980s	  has	  seen	  a	  rapid	  increase	  in	  the	  prevalence	  of	  resistance	   and	   changes	   in	  plasmid	   epidemiology	   in	  both	  humans	   and	   livestock	  (Dierikx	   et	   al.	   2010;	   Bou	   et	   al.	   2002;	   Diestra	   et	   al.	   2009).	   Moreover,	   there	   is	  evidence	   for	   ESBL	   plasmid	   transmission	   from	   animals	   to	   humans	   via	   the	   food	  chain,	  highlighting	  the	  importance	  of	  resistance	  management	  in	  livestock	  as	  well	  as	  humans	  (Leverstein-­‐van	  Hall	  et	  al.	  2011).	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1.3 Microbial	  cooperation	  and	  resistance	  
1.3.1 Microbial	  cooperation	  West	   et	   al.	   (2006)	   define	   cooperation	   as	   “A	   behaviour	   that	   benefits	   another	  individual	  (the	  recipient)	  and	  which	  is	  maintained	  (at	  least	  partially)	  because	  of	  its	   beneficial	   effect	   on	   the	   recipient”.	   From	   an	   evolutionary	   perspective,	   these	  behaviours	  are	  hard	  to	  justify,	  as	  they	  appear	  to	  be	  fundamentally	  at	  odds	  with	  Darwin’s	   concept	   of	   ‘survival	   of	   the	   fittest’.	   However,	   this	   paradigm	   has	   been	  largely	   explained	   by	   Hamilton’s	   rule,	   which	   states	   that	   altruistic	   (cooperative)	  acts	  are	   favoured	  when	  the	  cost	   to	  the	  altruist	  (c)	   is	   low	  and	  the	  benefit	   to	   the	  recipient	  (b)	  and	  relatedness	  (r)	  of	  the	  two	  is	  high:	  	  	   rb	  –	  c	  >	  0	  	  (Frank	   1998;	   Hamilton	   1964;	   West	   et	   al.	   2006).	   By	   directing	   altruistic	   acts	  towards	   relatives,	   individuals	   may	   still	   gain	   indirect	   fitness	   benefits,	   by	  improving	   the	   reproductive	   success	   of	   individuals	   who	   are	   likely	   to	   carry	   the	  same	  genes	   (West	   et	   al.	   2007).	   Indirect	   fitness	   is	   dependent	  on	   altruism	  being	  directed	  towards	   individuals	  with	  shared	  genes	  by	  the	  process	  of	  kin	  selection.	  Two	  mechanisms	   govern	   this:	   limited	   dispersal	   and	   kin	   discrimination	   (Smith	  1964).	  Kin	  discrimination	  requires	  recognition	  of	  relatives	  so	  that	  altruistic	  acts	  can	  be	  directed	  towards	  them,	  whereas	  limited	  dispersal	  involves	  indiscriminate	  altruism	  towards	  close	  neighbours,	  assuming	  that	  they	  are	  also	  likely	  to	  be	  close	  relatives	   (West	   et	   al.	   2007).	   Limited	   dispersal	   is	   particularly	   relevant	   in	  microbial	  communities,	  where	  cells	  reproduce	  clonally	  so	  that	  close	  neighbours	  are	  almost	  certainly	  close	  relatives.	  	  	  In	  bacteria,	  cooperative	  traits	  often	  come	  in	  the	  form	  of	   ‘public	  goods’	  released	  into	  the	  environment	  and	  available	  to	  all.	  These	  traits	  are	  open	  to	  exploitation	  by	  selfish	   individuals,	   social	   ‘cheats’,	   who	   benefit	   from	   public	   goods	   but	   do	   not	  contribute	   to	   their	   production	   (and	   therefore	   do	   not	   pay	   any	   fitness	   costs).	  Ultimately	   this	   can	   lead	   to	   a	   collapse	   of	   cooperation	   and	   the	   ‘tragedy	   of	   the	  commons’	  where	  each	  individual	  acts	  selfishly	  to	  the	  detriment	  of	  the	  population	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as	   a	   whole	   (Hardin	   1968).	   	   Many	   virulence-­‐associated	   traits	   such	   as	   quorum	  sensing,	   siderophore	   production	   and	   toxin	   secretion	   are	   cooperative	   (Crespi	  2001;	  Raymond	  &	  Bonsall	  2013;	  Griffin	  et	  al.	  2004),	  and	   it	  has	  been	  suggested	  that	   these	   traits	   could	   be	   a	   target	   for	   antimicrobial	   therapy	   (André	   &	   Godelle	  2005)	  .	  	  
1.3.2 Cooperative	  resistance	  &	  ‘cheat’	  plasmids	  β-­‐lactamase	  enzymes	  can	  be	  considered	   to	  be	  public	  goods,	  as	   they	  benefit	   the	  whole	   bacterial	   population	   by	   detoxifying	   the	   environment.	   This	   cooperative	  resistance	   is	   open	   to	   exploitation	   by	   social	   cheats;	   cells	   that	   benefit	   from	   the	  enzyme	   produced	   by	   cooperators,	   but	   which	   do	   not	   themselves	   produce	   the	  public	  good.	  It	  has	  been	  shown	  that	  antibiotic	  sensitive	  bacteria	  can	  survive	  high	  concentrations	  of	  antibiotic	   in	   the	  presence	  of	   resistant	  strains	  (Dugatkin	  et	  al.	  2005;	  Perlin	  et	  al.	  2009;	  Clark	  et	  al.	  2009).	  	  	  Antibiotic	  resistance	  genes	  are	  often	  carried	  on	  plasmids.	  Horizontal	  transfer	  of	  plasmids	   to	   plasmid-­‐free	   cells	   would	   ensure	   that	   all	   cells	   carry	   the	   resistance	  gene	   and	   share	   the	   cost	   of	   public	   good	   production,	   thereby	   preventing	   the	  evolution	   of	   social	   cheats.	   However,	   plasmid	   spread	   is	   affected	   by	   plasmid	  incompatibility:	  cells	  cannot	  maintain	  two	  plasmids	  of	  the	  same	  incompatibility	  group	  (Taylor	  et	  al.	  2004).	  The	  ‘cheat’	  plasmid	  hypothesis	  predicts	  the	  existence	  of	   plasmids	   with	   similar	   cost	   to	   the	   resistance	   plasmid	   in	   the	   same	  incompatibility	   group	   but	   lacking	   the	   resistance	   gene.	   Carriage	   of	   a	   ‘cheat’	  plasmid	   would	   prevent	   cells	   from	   acquiring	   the	   resistance	   plasmid,	   thus	  maintaining	  susceptible	  cheats	  in	  the	  population	  despite	  horizontal	  gene	  transfer	  (HGT).	  It	  has	  been	  proposed	  that	  ‘Trojan	  horse’	  susceptible	  cheats	  could	  invade	  and	   displace	   resistant	   populations,	   facilitating	   clearance	   of	   an	   infection	   with	  antibiotics	   (Brown	   et	   al.	   2009).	   ‘Cheat’	   plasmids	   could	   block	   the	   spread	   of	  resistance	  genes	  by	  horizontal	  transfer,	  and	  thus	  invade	  resistant	  populations.	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1.4 Plasmid	  populations	  and	  persistence	  
1.4.1 Plasmid	  populations	  It	  is	  often	  stated	  that	  plasmids	  act	  as	  selfish	  genetic	  elements,	  existing	  purely	  for	  their	   own	   replication	   and	   proliferation	   (Werren	   2011).	   The	   existence	   of	   post-­‐segregational	   killing	   systems	   (toxin-­‐antitoxin	   systems),	   where	   a	   plasmid-­‐encoded	   toxin	   kills	   segregant	   daughter	   cells	   that	   have	   lost	   the	   corresponding	  antitoxin,	   is	  often	  cited	   to	  support	   the	   idea	  of	  selfish	  plasmids.	  However,	   it	  has	  also	   been	   proposed	   that	   these	   toxin-­‐antitoxin	   systems	  may	   have	   evolved	   as	   a	  mechanism	  for	  plasmid-­‐plasmid	  competition	  (Van	  Melderen	  &	  Saavedra	  De	  Bast	  2009;	   Kobayashi	   2004).	   These	   conflicting	   theories	   highlight	   our	   limited	  understanding	   of	   plasmid	   ecology	   and	   the	   selective	   forces	   driving	   plasmid	  evolution:	  plasmids	  exist	  not	  as	  individual	  entities,	  but	  as	  parts	  of	  communities	  interacting	  with	  each	  other	  and	  with	  bacterial	  hosts.	  Few	  studies	  have	  examined	  plasmid	  communities	  as	  a	  whole,	  and	  those	  which	  have	  often	  focus	  on	  plasmids	  associated	   with	   virulence	   and	   disease,	   in	   particular	   antibiotic	   resistance	  (Carattoli	  2011;	  Johnson	  &	  Nolan	  2009).	  This	  not	  only	  presents	  a	  biased	  view	  of	  plasmid	  populations	  and	  their	  dynamics	  but	  also	  fails	  to	  explain	  the	  existence	  of	  ‘cryptic’	   plasmids,	   which	   appear	   to	   have	   no	   functional	   genes	   at	   all.	   A	   broader	  understanding	   of	   plasmid	   communities	   could	   inform	   strategies	   for	   virulence	  management,	  such	  as	  ‘cheat’	  plasmids,	  and	  the	  ‘Trojan	  horse’	  approach	  proposed	  by	  Brown	  et	  al.	  (2009),	  as	  discussed	  in	  Section	  1.3.2	  above.	  	  
1.4.2 Plasmid	  persistence	  	  Plasmid	   carriage	   is	   widely	   assumed	   to	   be	   costly	   to	   the	   host.	   This	   can	   be	   a	  metabolic	  cost	  due	  to	  increased	  DNA	  replication	  and	  maintenance	  (especially	  for	  large	  or	  high	  copy	  number	  plasmids)	  or	  due	   to	  expression	  of	  plasmid	  genes.	   It	  can	  also	  be	  a	  phenotypic	  cost	   such	  as	   the	  expression	  of	   conjugation	  apparatus,	  which	  prevents	  replication	  and	  can	  be	  a	  target	  for	  bacteriophage	  (Thomas	  2004;	  Eberhard	   1990).	   Moreover,	   costly	   plasmids	   may	   be	   lost	   through	   segregation;	  uneven	  distribution	  during	  cell	  division.	  Given	  the	  cost	  of	  plasmid	  carriage	  and	  the	  rate	  of	  segregation,	  it	  is	  easy	  to	  imagine	  that	  plasmids	  would	  be	  lost	  from	  the	  population	  via	  segregation	  and	  competition	  with	   fitter	  plasmid-­‐free	  cells	   in	   the	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absence	  of	   selection	   in	   their	   favour.	  Conjugation	  may	  mitigate	   these	   factors	  by	  transferring	   plasmids	   to	   new	   hosts,	   and	   theory	   predicts	   that	   plasmids	   can	   be	  maintained	  parasitically	  (without	  conferring	  a	  benefit	  to	  the	  host)	  if	  these	  three	  key	  parameters	  can	  be	  balanced	  appropriately,	  i.e.	  high	  conjugation,	  low	  cost	  and	  low	  segregation	  rate,	  summarised	  by	  the	  equation	  (Stewart	  &	  Levin	  1977;	  Levin	  &	  Stewart	  1980):	  	   Transfer	  Rate	  >	  Cost	  of	  Carriage	  +	  Segregation	  Rate	  	  The	   rise	   of	   multi-­‐resistance	   plasmids,	   and	   the	   fact	   that	   many	   virulence	  associated	   genes	   are	   plasmid	   associated,	   heightens	   the	   importance	   of	  understanding	  plasmid	  maintenance	   if	  we	  are	   to	   limit	   their	  spread.	  The	  debate	  as	   to	   whether	   virulence	   or	   antibiotic	   resistance	   plasmids	   can	   survive	   in	   the	  absence	   of	   selection	   is	   also	   be	   key	   in	   the	   development	   of	   containment	   and	  management	  strategies	  in	  healthcare.	  	  	  
1.5 Aims	  of	  this	  thesis	  
1.5.1 Introduction	  to	  the	  study	  system	  This	   thesis	   uses	   E.	   coli	   and	   E.	   coli	   plasmids,	   isolated	   from	   cattle,	   to	   address	  evolutionary	   ecology	   questions	   for	   both	   antibiotic	   resistance	   and	   resistance	  plasmids.	   Antibiotic	   resistance	   is	   as	   pressing	   an	   issue	   for	   veterinarians	   as	   for	  clinicians;	   moreover,	   there	   is	   evidence	   of	   plasmid	   and	   bacterial	   transmission	  from	   animals	   to	   humans,	   which	   highlights	   the	   importance	   of	   resistance	  management	   in	   livestock	   (Leverstein-­‐van	   Hall	   et	   al.	   2011;	   Aslam	   et	   al.	   2003;	  Liebana	  et	  al.	  2004).	  Chapters	  2,	  3	  and	  5	  use	  the	  resistance	  plasmid	  pCT,	  isolated	  by	  Liebana	  et	  al.	  (2006)	  from	  the	  site	  of	  the	  first	  veterinary	  ESBL	  CTX-­‐M	  E.	  coli	  outbreak	   in	   the	   UK.	   pCT	   is	   a	   large,	   ~93Kbp	   plasmid,	   carrying	   the	   extended	  spectrum	   β-­‐lactamase,	   CTX-­‐M-­‐14.	   Extended-­‐spectrum	   β-­‐lactamases	   (ESBLs),	  which	  confer	  cephalosporin	  as	  well	  as	  penicillin	  resistance,	  are	  now	  widespread,	  with	   CTX-­‐M-­‐type	   ESBLs	   becoming	   the	   dominant	   type	   in	   Europe	   over	   the	   last	  decade	  (see	  Section	  1.2.3	  above),	  however	  their	  spread	  in	  livestock	  has	  not	  been	  as	   rapid	  as	   that	   seen	   in	  humans	   (Liebana	  et	   al.	   2006).	   In	  addition	   to	  pCT,	   four	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other	  plasmids	  from	  the	  same	  study	  site	  are	  investigated,	  alongside	  a	  field	  study	  that	  collected	  new	  E.	  coli	  and	  plasmids	  from	  cattle.	  	  
1.5.2 Aims	  and	  thesis	  outline	  	  The	   original	   aims	   of	   this	   thesis	   were	   as	   follows:	   i)	   to	   examine	   the	   conditions	  under	   which	   β-­‐lactam	   resistance	   is	   cooperative;	   ii)	   to	   identify	   and	   sequence	  ‘cheat’	   plasmids	   from	  natural	   zoonotic	   bacterial	   populations;	   iii)	   to	   investigate	  the	   manipulation	   of	   cooperative	   resistance	   population	   dynamics	   using	   ‘cheat’	  plasmids.	   Chapter	   2	   provides	   details	   of	  mutant	   strains	   and	  plasmids	   produced	  for	   this	   thesis,	   as	  well	   as	   generic	  methodologies.	   The	   first	   aim	   is	   addressed	   in	  Chapter	   3,	   which	   demonstrates	   the	   very	   particular	   conditions	   required	   for	  cooperative	   resistance.	   The	   second	   aim,	   to	   identify	   and	   sequence	   potential	  ‘cheat’	  plasmids,	  is	  addressed	  in	  Chapters	  4	  and	  5.	  Chapter	  5	  also	  includes	  a	  non-­‐selective	  field	  study	  of	  a	  zoonotic	  plasmid	  population.	  The	  work	  in	  Chapters	  2	  to	  5	   led	   to	  a	   further	  aim;	   iv)	   to	   investigate	  mechanisms	  of	  plasmid	  persistence,	   in	  particular	  the	  role	  of	  conjugation	  in	  the	  maintenance	  of	  large	  naturally	  occurring	  plasmids.	  This	  is	  addressed	  in	  Chapter	  6.	  	  	  Plasmids	   are	   major	   carriers	   of	   antibiotic	   resistance	   genes.	   A	   better	  understanding	  of	  their	  persistence,	  population	  dynamics	  and	  spread	  is	  critical	  if	  we	  are	   to	   limit	   the	   resistance	  crisis.	  Furthermore,	  bacteria	  are	  always	  going	   to	  evolve	  resistance	  to	  new	  drugs,	  so	  it	  is	  therefore	  vital	  to	  explore	  alternative	  ways	  of	  tackling	  infections,	  such	  as	  exploiting	  their	  own	  population	  dynamics	  (Brown	  et	  al.	  2009),	  or	  targeting	  plasmids	  themselves	  (Williams	  &	  Hergenrother	  2008).	  In	   addition	   to	   the	   resistance	   issue,	  plasmids	   are	   interesting	   in	   their	  own	   right:	  most	   studies	   have	   focused	   on	   plasmids	   carrying	   resistance	   or	   other	   virulence	  factors,	   and	   although	   this	   is	   important,	   it	   gives	   a	   skewed	   view	   of	   plasmid	  populations.	   To	   truly	   understand	   plasmid	   persistence,	   non-­‐selective	   strategies	  must	  be	  employed.	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2.1 Introduction	  The	   plasmid	   used	   throughout	   this	   thesis,	   pCT,	   is	   a	   large,	   ~93	   kb	   plasmid,	  carrying	  the	  extended	  spectrum	  β-­‐lactamase	  CTX-­‐M-­‐14,	  that	  was	  identified	  in	  E.	  
coli	  strain	  C159/11	  by	  Teale	  et	  al.	   (2005,	  as	  cited	  by	  Liebana	  et	  al.,	  2006),	  and	  sequenced	  by	  Cottell	  et	  al.	  (2011a,	  2011b).	  pCT	  is	  an	  IncK	  plasmid	  and	  a	  member	  of	  the	  IncI	  complex,	  which	  includes	  incompatibility	  groups	  I1,	   I2,	   Iγ,	  B,	  O	  and	  K	  (Cottell	  2011b,	  Praszkier	  et	  al.	  1991).	  It	  carries	  two	  conjugation	  operons,	  tra	  and	  
pil,	   and	   a	   shufflon	   recombinase,	   which	   are	   characteristic	   of	   IncI	   complex	  plasmids	   (Cottell	   2011b)	   and	   make	   pCT	   highly	   transmissible.	   In	   order	   to	  examine	   the	   effects	   of	   conjugation	   on	  plasmid	  maintenance	   (Chapter	   6)	   it	  was	  necessary	   to	   construct	  a	   conjugation-­‐null	  pCT	  mutant.	   In	  addition	   to	   this,	   a	   lac	  operon	  knockout	  of	  the	  host	  strain,	  Escherichia	  coli	  MG1655	  (Coli	  Genetic	  Stock	  Center	   #7740,	   Yale	   University,	   Connecticut,	   USA),	   was	   constructed	   for	   use	   in	  Chapters	  3	  and	  6.	  This	  second	  mutant	  provided	  a	  near-­‐isogenic	  background	  for	  competition	   experiments,	   and	   facilitated	   differentiation	   between	   resistant	   and	  susceptible	  strains	  using	  blue/white	  screening	   in	   the	  presence	  of	  X-­‐Gal	  &	   IPTG	  (5-­‐bromo-­‐4-­‐chloro-­‐3-­‐indolyl-­‐beta-­‐D-­‐galacto-­‐pyranoside	   &	   isopropyl-­‐beta-­‐D-­‐thiogalactopyranoside).	  	  Cottell	  et	  al.	  (2011a)	  identify	  two	  sets	  of	  conjugation	  genes	  on	  pCT;	  the	  tra	  and	  
pil	  loci,	  which	  show	  very	  high	  identity	  (99%)	  with	  the	  IncI	  plasmid	  R64.	  R64	  has	  23	   genes	   essential	   for	   conjugation,	   including	   several	   tra	   and	   trb	   genes	   with	  homologues	  in	  pCT	  (Cottell	  et	  al.	  2011a;	  Komano	  et	  al.	  2000).	  In	  R64	  the	  pil	  locus	  is	   not	   thought	   to	   be	   essential	   for	   all	   conjugation,	   but	   rather	   is	   just	   for	   liquid	  mating,	  so	  pil	  genes	  were	  discounted	  for	  deletion,	  as	  they	  would	  not	  fully	  inhibit	  conjugation.	   The	   trbA	   gene,	   which	   encodes	   a	   putative	   regulation	   protein,	   at	  position	  38848-­‐40110	  on	  pCT,	  was	   selected	   for	  deletion,	   as	   it	   is	   “indispensible	  for	  R64	  transfer”	  (Komano	  et	  al.	  2000).	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2.2 Methods	  
2.2.1 	  Generic	  methodology	  
Culture	  media	  Liquid	  cultures	  were	  grown	  in	  5ml	  Luria	  Bertani	  (LB)	  broth	  (Fisher	  Scientific	  UK	  Ltd.,	   Loughborough,	   UK).	   Plates	   were	   LB	   broth	   with	   2%	   (w/v)	   agar	   (Agar	  Bacteriological	   No.	   1,	   Oxoid,	   Basingstoke,	   UK).	   Broth	   and	   plates	   were	  supplemented	  with	   antibiotics	   as	   required;	   pCT	   plasmid	   carrying	   strains	  were	  maintained	  on	  plates	  containing	  either	  ampicillin	  or	  cefotaxime.	  See	  Table	  2.1	  for	  standard	  antibiotic	  doses	  used	  throughout	  this	  work.	  
	  
Antibiotic	   Supplier	   Dose	  (µg	  ml-­‐1)	  Ampicillin	  sodium	  salt	  	   Sigma-­‐Aldrich	  Company	  Ltd.,	  Gillingham,	  UK	   100	  	  Cefotaxime	  sodium	  salt	   Melford	  Laboratories	  Ltd.,	  Ipswich,	  UK	   8	  	  Chloramphenicol	  	   Sigma-­‐Aldrich	   20	  	  Tetracycline	  hydrochloride	  	   Sigma-­‐Aldrich	   12	  	  Rifampicin	   Sigma-­‐Aldrich	   100	  	  Nalidixic	  acid	   Sigma-­‐Aldrich	   15	  	  	  
Table	  2.1:	  Antibiotics	  used	  including	  standard	  doses	  and	  suppliers.	  	  
Overnight	  culture	  Overnight	   (o/n)	   cultures	   were	   initiated	   from	   single	   colonies	   on	   fresh	   LB	   agar	  plates.	  Colonies	  were	  inoculated	  into	  5ml	  LB	  broth	  and	  incubated,	  shaken	  at	  200	  rpm,	  at	  37°C	  for	  approximately	  16	  hours.	  
	  
Plating/dilutions	  To	   obtain	   accurate	   colony	   counts	   of	   cultures,	   serial	   dilution	   and	   plating	   were	  used.	  Serial	  dilutions	  were	  10-­‐fold,	  and	  used	  0.85%	  (w/v)	  sterile	  saline	  (NaCl).	  Two	   methods	   of	   plating	   were	   used:	   [1]	   spread-­‐plates,	   where	   50	   or	   100	   μl	  dilutions	  were	  spread	  onto	  LB	  agar	  with	  an	  L-­‐shaped	  spreader;	  [2]	  20	  μl	  droplets	  were	  used	  and	  were	  allowed	  to	  dry	  before	  incubation	  (Miles	  et	  al.	  1938).	  In	  both	  cases	  plates	  were	  incubated	  at	  37°C	  overnight.	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Optical	  density	  readings	  Optical	   density	   (OD)	   readings	   were	   taken	   in	   two	   ways:	   using	   a	   Nanodrop	  spectrophotometer	   (Thermo	   Scientific,	   USA),	   or	   using	   a	   plate	   reader	  (SpectraMax	   190,	   Molecular	   Devices	   UK	   Ltd.,	  Wokingham,	   UK).	   	   In	   both	   cases	  OD600	  of	  o/n	  cultures	  was	  measured.	  Nanodrop	  readings	  used	  1.5	  μl	  culture,	  the	  plate	  reader	  used	  100	  μl.	  	  
Long	  term	  strain	  storage	  Fresh	  o/n	  cultures	  were	  added	   to	  80%	  glycerol	   in	  a	  1:4	  ratio	  and	   immediately	  frozen	   in	  dry	   ice.	  Stock	  cultures	  were	  stored	   long	   term	  at	   -­‐80°C.	  Cultures	  were	  revived	   by	   plating	   from	   glycerol	   stocks	   onto	   LB	   agar	   (with	   appropriate	  antibiotics	  if	  required)	  and	  incubating	  o/n.	  	  
PCR	  Two	  PCR	   enzymes	  were	   used	   in	   this	   thesis:	   Taq	   (Qiagen	   Ltd,	  Manchester,	   UK)	  and	   Easy-­‐A	   cloning	   enzyme	   (Agilent	   Technologies,	   Wokingham,	   UK).	   Here	  standard	   PCR	   conditions	   are	   given	   for	   both	   enzymes.	   Specific	   annealing	  temperatures	  for	  each	  primer	  set	  are	  given	  in	  the	  appropriate	  methods	  sections.	  Easy-­‐A	   standard	   reagent	   concentrations:	   dNTPs	   10mM,	   Taq	   2.5	   units	   and	  primers	  0.2	  pmol	  μl-­‐1.	  Cycling	   conditions:	   initial	  denaturation,	  95°C,	  2	  minutes,	  followed	  by	  30	  cycles	  of	  denaturation	  (95°C,	  40	  seconds),	  annealing	  (30	  seconds)	  and	   extension	   (72°C,	   60	   seconds)	   and	   a	   final	   extension	   step	   of	   72°C	   for	   7	  minutes.	   Taq	   standard	   reagent	   concentrations:	   dNTPs	   0.4mM,	   Taq	   0.625	   units	  and	   primers	   0.2	   μM.	   Cycling	   conditions:	   initial	   denaturation,	   95°C,	   3	   minutes,	  followed	  by	  30	  cycles	  of	  denaturation	  (95°C,	  30	  seconds),	  annealing	  (30	  seconds)	  and	   extension	   (72°C,	   60	   seconds)	   and	   a	   final	   extension,	   step	   of	   72°C	   for	   3	  minutes.	  
	  
Colony	  PCR	  PCR	  reactions	  were	  prepared	  as	  described	  above	  except	  that	  cells	  from	  a	  single	  o/n	  colony	  were	  used	  as	  the	  DNA	  template.	  A	  sterile	  toothpick	  was	  used	  to	  touch	  the	  edge	  of	  a	  single	  colony	  from	  a	  fresh	  o/n	  plate.	  The	  cells	  were	  transferred	  to	  the	  reaction	  tube	  and	  the	  stick	  rapidly	  swirled	  for	  a	   few	  seconds	  to	  release	  the	  
	   30	  
cells.	  	  The	  cycling	  conditions	  were	  as	  described	  above,	  except	  for	  the	  addition	  of	  a	  long	  initial	  denaturation	  step	  of	  95°C	  for	  5	  minutes	  (Woodman	  2008).	  	  	  
2.2.2 	  Production	  of	  mutants	  	  The	  pCT	  plasmid	  was	   isolated	   from	  E.	  coli	  DH10B	  using	   a	  High-­‐speed	  Midi	  Kit	  (Qiagen).	   The	   extraction	   was	   run	   on	   an	   agarose	   gel	   to	   check	   the	   purity,	   as	  described	  by	  Gonzalez	  et	  al.	  (1982).	  	  Electrocompetant	  DH10B	  and	  MG1655	  cells	  were	   prepared	   according	   to	   the	   Bio-­‐Rad	   protocol	   (Bio-­‐Rad	   Laboratories,	   UK):	  300ml	   LB	   broth	   was	   inoculated	   1:100	   with	   an	   8-­‐hour	   starter	   culture	   of	   the	  appropriate	   E.	   coli,	   and	   was	   then	   incubated	   at	   37°C,	   and	   shaken	   at	   220	   rpm,	  overnight.	  This	  culture	  was	  then	  chilled	  on	  ice	  for	  20	  minutes	  before	  harvesting	  cells	  by	  centrifugation	  at	  4000	  x	  g	   for	  15	  minutes	  at	  4°C.	  The	  supernatant	  was	  poured	   off	   and	   the	   pellet	   resuspended	   in	   300	  ml	   ice-­‐cold	   10%	   (w/v)	   glycerol,	  and	  re-­‐centrifuged	  at	  4000	  x	  g	  for	  15	  minutes	  at	  4°C.	  This	  process	  was	  repeated	  twice	  more,	  resuspending	  first	  in	  150	  ml	  and	  then	  in	  12	  ml	  ice-­‐cold	  10%	  glycerol.	  After	  the	  final	  centrifugation	  step,	  cells	  were	  resuspended	  into	  2	  ml	  ice-­‐cold	  10%	  glycerol,	   and	   stored	   in	   200	   μl	   aliquots	   at	   -­‐80°C.	   Electrocompetant	   cells	   were	  transformed	  with	   the	   helper	   pLGBE	  plasmid	   (Bloor	  &	  Cranenburgh	   2006)	   and	  extracted	  pCT	  (DH10B	  only)	  using	  the	  MicroPulserTM	  electroporation	  apparatus	  (Bio-­‐Rad,	  Hemel	  Hempstead,	  UK).	  Here	  electrocompetant	  cells	  were	   thawed	  on	  ice	  and	  40	  μl	  cell	  suspension	  was	  mixed	  with	  1	  μl	  DNA	  (approximately	  100	  ng	  μl-­‐1)	  in	  a	  chilled	  microcentrifuge	  tube	  and	  chilled	  on	  ice	  for	  1	  minute.	  The	  DNA/cell	  mixture	   was	   added	   to	   an	   ice-­‐cold	   0.1	   cm	   cuvette	   and	   electroporated	   at	  approximately	  1.8	  kV	  for	  5	  ms.	  Immediately	  afterwards	  1	  ml	  of	  SOC	  media	  (2%	  Bacto-­‐tryptone,	   0.5%	   Bacto	   yeast	   extract,	   10	   mM	   NaCl,	   2.5	   mM	   KCl,	   10	   mM	  MgSO4	  and	  20	  mM	  glucose)	  was	  added	  and	  cells	  were	   transferred	   to	  universal	  tube	  and	  incubated	  at	  37°C	  for	  1	  hour,	  before	  plating	  on	  onto	  LB	  Agar	  containing	  ampicillin	  and	  incubating	  overnight.	  	  Mutants	  were	   produced	   using	   the	   Xercise	   protocol,	   as	   described	   by	   Bloor	   and	  Cranenburgh	  (2006).	  This	   involved	  PCR	  amplification	  of	  dif-­‐CAT-­‐dif	  motif	   from	  plasmid	   pTOPO-­‐DifCAT	   using	   primers	  with	   5’	   homology	   to	   the	   deletion	   target	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site	  (Table	  2.2)	  and	  Easy-­‐A	  cloning	  enzyme	  (Agilent	  Technologies,	  Wokingham,	  UK)	  (annealing	  temperature	  65°C).	  PCR	  products	  were	  then	  purified	  (QIAquick	  gel	  extraction	  kit,	  Qiagen).	  Host	   cells	   (DH10B	  or	  MG1655)	  carrying	  pLGBE	  and	  induced	   with	   1%	   arabinose	   were	   electrotransformed	   with	   the	   purified	   PCR	  products	   and	   selected	   with	   chloramphenicol.	   The	   PCR	   product	   carrying	   a	  chloramphenicol	   resistance	   gene	   homologously	   recombines	   at	   the	   target	  deletion	   site,	   displacing	   the	   unwanted	   region	   (see	   Figure	   2.1).	   Transformant	  colonies	   were	   then	   transferred	   to	   non-­‐selective	   LB	   broth	   culture,	   and	   replica	  plated	   onto	   tetracycline,	   chloramphenicol	   and	   LB	   plates.	   The	   helper	   pLGBE	  plasmid	   facilitates	   site-­‐specific	   recombination	   at	   dif	   sites,	   excising	   the	  chloramphenicol	   resistance	   gene.	   Transformants	  with	   successful	   deletions	   and	  subsequent	   recombination	   are	   chlorampenicol	   sensitive;	   and	   the	   loss	   of	   the	  helper	  pLGBE	  plasmid	  restores	  tetracycline	  susceptibility.	  A	  second	  Δlac	  mutant	  that	   retained	   the	  CAT	   (chloramphenicol	  acetyltransferase)	   resistance	  gene	  was	  produced	  by	  excluding	  the	  dif	  sites	  from	  the	  PCR	  construct.	  
	  
	  
Figure	  2.1:	  Xercise	  gene	  deletion	  method.	  	  The	  dif-­‐CAT-­‐dif	  motif	  of	  the	  pTOPO-­‐DifCAT	  plasmid	   is	   amplified	   using	   primers	   with	   homology	   to	   the	   target	   deletion	   site.	   This	  construct	   then	   homologously	   recombines	   at	   the	   target	   site	   to	   excise	   the	   desired	   gene	  (Step	  1).	  The	  dif	  sites	  then	  recombine	  to	  excise	  the	  selective	  chloramphenicol	  resistance	  marker	  (Step	  2).	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  Diagnostic	  PCR	  was	  used	  to	  assess	  the	  insertion	  and	  subsequent	  deletion	  of	  the	  dif-­‐CAT-­‐dif	  fragment	  into	  pCT	  and	  MG1655.	  Diagnostic	  PCR	  was	  conducted	  using	  Taq	   (Qiagen)	   with	   an	   annealing	   temperature	   of	   55°C.	   Deletion	   primers	   for	  MG1655	   Δlac	   +/-­‐	   CAT	  were	   taken	   from	  Datsenko	  &	  Wanner	   (2000).	   All	   other	  primers	   were	   designed	   using	   Primer3	   (Rozen	   &	   Skaletsky	   2000)	   and	   Serial	  Cloner	  2.5	  (Perez	  2013)	  (Table	  2.2).	  	  	  Electrocompetant	   MG1655,	   MG1655	   Δlac	   and	   MG1655	   Δlac	   CAT+	   cells	   were	  prepared	  according	  to	  the	  Bio-­‐Rad	  protocol,	  and	  transformed	  with	  both	  pCT	  and	  pCTΔtrbA	   plasmids	   using	   MicroPulser	   electroporation	   apparatus	   (Bio-­‐Rad)	   as	  described	  above.	  	  	  	  	  	  
Name	   Sequence	  (5’-­‐3’)	   Size	  (nt)	  F	  trbA	  del	   TTCTGCATCAACGGTATCAACAAGCACCGTTTCAGTTATTTCAGTGTGCTGGAATTCGCCCT	   62	  R	  trbA	  del	   ATTGTTCGCATTAATTCCACTCAGCCTCATCCCGAAATTTATCTATTTATCTGCAGAATTCGCCCTTCCT	   70	  F	  trbA	  diag	   CGGCATCCAGGCAGGCATCA	   20	  R	  trbA	  diag	   TTCAGCCCTGCCCGGTCATT	   20	  F	  lac	  del	   ATTGCGGCCTATATGGATGTTGGAACCGTAAGAGAAAGTGTGCTGGAATTCGCCCT	   56	  R	  lac	  del	   GCGGGCAGTGAGCGCAACGCAATTAATGTGAGTTAGCTGCAGAATTCGCCCTTCCT	   56	  	  F	  Lac	  del	  CAT+	  	   ATTGCGGCCTATATGGATGTTGGAACCGTAAGAGAACAGGCGTAGCACCAGGCGTT	   56	  R	  Lac	  del	  CAT+	  	   GCGGGCAGTGAGCGCAACGCAATTAATGTGAGTTAGGGGAAGCCCTGGGCCAACTT	   56	  F	  Lac	  diag	  	   ACGGAAAGAGTAACGTTGGGTGC	   23	  R	  Lac	  diag	  	  	   GCGCCATTACCGAGTCCGGG	   20	  
	  
Table	  2.2:	  trbA	   and	   lacZYA	  deletion	  &	  diagnostic	  primers.	  Primers	  designated	  ‘del’	  produced	   the	  homologous	  recombination	  construct.	  Bold:	  homology	   to	  pTOPO-­‐DifCAT	  plasmid;	   Standard:	   homology	   to	   target	   gene.	   Primers	   designated	   ‘diag’	   were	   used	   to	  diagnose	  successful	  insertions/deletions.	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2.2.3 	  Confirmation	  of	  mutant	  genotypes	  	  Diagnostic	   PCR	   using	   primers	   trbA	   diag	   or	   lac	   diag	   (Table	   2.2),	   identified	  potentially	   successful	   mutants	   by	   comparing	   product	   sizes	   on	   an	   agarose	   gel	  (Voytas	  2000).	  To	  confirm	  genotypes	  of	  mutant	  strains	  these	  PCR	  products	  were	  sequenced.	   PCR	   products	   were	   cleaned	   up	   using	   Exo1	   (Fisher	   Scientific)	   and	  TSAP	   (Promega	  UK,	   Southampton)	   both	   at	   final	   concentration	   0.045	   units	   μl-­‐1.	  Clean	  up	  mixes	  were	  incubated	  at	  37°C	  for	  30	  minutes,	  followed	  by	  80°C	  for	  15	  minutes.	   Sequencing	   reactions	  were	   conducted	   using	   BigDye®	   terminator	   v3.1	  cycle	  sequencing	  kit	   (Life	  Technologies	  Ltd.	  Paisley,	  UK)	  and	  both	   forward	  and	  reverse	   diagnostic	   primers.	   Cycling	   conditions	   were	   as	   follows:	   96°C	   for	  1minute,	  followed	  by	  25	  cycles	  of:	  96°C	  for	  10	  seconds,	  50°C	  for	  5	  seconds,	  60°C	  or	   4	   minutes.	   Sequencing	   reactions	   were	   cleaned	   up	   using	   ethanol/sodium	  acetate	   precipitation.	   The	   sequencing	   run	   was	   conducted	   by	   AHVLA	   Scientific	  (AHVLA,	  Weybridge,	   UK).	   Sequences	   were	   aligned	   using	   Geneious	   version	   5.2	  (Biomatters	  2012)	  and	  compared	  to	  the	  wild	  type	  sequence.	  	  
2.2.4 Confirmation	  of	  mutant	  phenotypes	  For	  the	  Δlac	  strain	  first	  screening	  was	  done	  on	  LB	  plates	  containing	  X-­‐Gal	  (0.02	  mg	  ml-­‐1)	  and	  IPTG	  (0.1	  mM)	  (Fisher	  Scientific),	  to	  assess	  for	  blue/white	  colour.	  White	   strains	   were	   confirmed	   by	   sequencing.	   For	   the	   CAT+	   strain,	  chloramphenicol	  was	  also	  added	  to	  selective	  plates.	  	  
Mating	  experiments	  To	   confirm	   the	   conjugation	   null	   phenotype	   of	   the	   pCTΔtrbA	   plasmid	   mating	  experiments	   were	   conducted	   with	   both	   wild	   type	   and	   mutant	   pCT.	   Mating	  experiments	   protocols	   were	   adapted	   from	   Liebana	   et	   al.	   (2004):	   OD600	   of	   o/n	  cultures	  of	  donor	  (MG1655+	  pCT/pCTΔtrbA)	  and	  recipient	  (MG1655	  Δlac	  CAT+)	  strains	  were	  measured,	  and	  crosses	  set	  up	  from	  independent	  cultures.	  Mixtures	  were	  made	  with	  a	  1:5	  ratio	  of	  donors	  to	  recipients	  and	  a	  1	  in	  5	  dilution	  into	  fresh	  LB	  broth,	  with	  a	  final	  volume	  of	  3ml.	  Mixes	  were	  incubated	  at	  37°C,	  220rpm	  for	  48	   hours.	   Single	   strain	   control	   cultures	   were	   also	   incubated.	   	   Initial	   mixtures	  were	   serially	   diluted	   and	   plated	   onto	   LB	   +	   cefotaxime	   or	   chloramphenicol	   to	  
	   34	  
assess	  initial	  ratios.	  After	  48	  hours,	  mixes	  and	  single	  strain	  cultures	  were	  plated	  onto	   cefotaxime	   and	   mixed	   antibiotic	   plates	   to	   determine	   final	   ratios	   and	  numbers	  of	  transconjugants,	  as	  shown	  in	  the	  formula:	  	  	  
Transconjugants	  per	  donor	  =	  Total	  transconjugants	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Total	  donors	  
	  Single	  strain	  cultures	  were	  used	  to	  determine	  the	  rate	  of	  spontaneous	  mutation	  to	   cefotaxime/chloramphenicol	   resistance.	   Two	   replicates	   of	   this	   experiment	  were	   run,	   with	   n	   =	   3	   and	   n	   =	   6	   for	   each	  mix.	   These	   data	   were	   compiled	   and	  analysed	  together.	  	  Mating	   experiments	   were	   also	   conducted	   using	   a	   rifampicin	   resistant	  
Enterobacter	   strain,	   jjbc,	   as	   the	   recipient.	   Donors	   and	   recipients	   were	   again	  mixed	   in	  a	  ratio	  of	  1:5	  and	  diluted	  1:5	   in	  LB	  broth,	  with	  a	   final	  volume	  of	  3ml.	  Cultures	  were	   incubated	  either	   shaken	  at	  220rpm,	  or	  unshaken,	   for	  5	  hours	  at	  37°C.	   Dilutions	   were	   then	   plated	   onto	   cefotaxime	   only	   and	   cefotaxime	   +	  rifampicin	  plates;	  these	  were	  incubated	  at	  37°C	  overnight,	  and	  colonies	  counted.	  	  	  
Competition	  experiments	  	  The	   fitness	   cost	   of	   the	   lacZYA	   knockout	   was	   assessed	   by	   competition	  experiments	   between	   blue	   and	   white	   strains	   (MG1655	   and	   MG1655Δlac).	  Competitions	  were	  conducted	  in	  LB	  broth	  and	  on	  LB	  agar	  plates,	  both	  containing	  X-­‐Gal	   &	   IPTG.	   OD600	   of	   o/n	   cultures	   of	   competing	   strains	   were	  measured	   and	  cultures	  diluted	  to	  approximately	  equal	  cell	  density	  with	  0.85%	  saline.	  For	  plate	  competitions,	  cultures	  were	  then	  mixed	  50:50	  and	  diluted	  with	  saline	  to	  give	  an	  approximate	   cell	   density	   of	   1	   colony	   forming	   unit	   (CFU)	   per	  µl	   	   (CFU	  µl-­‐1).	   To	  confirm	  the	  initial	  ratio	  of	  cells,	  mixed	  cultures	  were	  plated	  onto	  LB	  agar	  +	  X-­‐Gal	  &	  IPTG	  and	  incubated	  o/n	  at	  37°C,	  and	  blue	  and	  white	  colonies	  counted.	  For	  the	  competitions,	   100	  µl	  mixed	   cultures	  were	   spread	  onto	  plates	   and	   incubated	   at	  37°C	   for	   72	   hours,	   after	  which	   colonies	  were	   harvested	   by	   adding	   5ml	   0.85%	  saline	  to	  the	  plate,	  loosening	  colonies	  with	  a	  sterile	  spreader	  and	  homogenizing	  with	  a	  pipette.	  Harvested	  colonies	  were	  serially	  diluted	  and	  plated	  onto	  LB	  agar	  +	   X-­‐Gal	   &	   IPTG,	   with	   and	   without	   ampicillin.	   	   Plates	   were	   incubated	   at	   37°C	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overnight,	  and	  colonies	  counted	  to	  determine	  final	  ratios,	  and	  relative	  fitness	  of	  the	  blue	  (MG1655)	  strain.	  	  	  Broth	  competitions	  were	  conducted	   in	  1ml	  LB	  broth	  +	  X-­‐Gal	  &	   IPTG	   in	  24	  well	  plates	  (Costar®	  Corning®,	  Sigma-­‐Aldrich),	  inoculated	  1:5	  with	  diluted	  strains.	  20	  μl	  was	  immediately	  taken	  and	  diluted	  to	  obtain	  the	  starting	  ratio.	  Broth	  cultures	  were	   incubated	   at	   120	   rpm,	   37°C	   for	   24	   hours,	   and	   then	   serially	   diluted	   and	  plated	   out	   onto	   LB	   agar	   +	   X-­‐Gal	   &	   IPTG	   +/-­‐	   cefotaxime	   to	   get	   final	   ratios	   and	  calculate	   relative	   fitness	   of	   the	   blue	   strain	   (MG1655).	   Relative	  MG1655	   fitness	  was	  calculated	  as	  described	  by	  Lenski	  (1988),	  and	  is	  given	  by	  the	  equation:	  	   !!" = !"#!  !! 1 /  !!(0)!"#!  !!(1)/!!(0) 	  	  Where	  Wij	  is	   the	  fitness	  of	  strain	   i	   (MG1655)	  relative	  to	  strain	   j	   (MG1655	  Δlac),	  and	  N	  is	  the	  cell	  density	  at	  the	  start	  (0)	  and	  end	  (1)	  of	  the	  experiment.	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2.3 Results	  
2.3.1 	  Sequencing	  confirms	  mutant	  genotypes	  Diagnostic	   PCR	   using	   primers	   trbA	   diag	   or	   lac	   diag	   (Table	   2.2),	   identified	  mutants	   with	   successful	   insertions	   and	   subsequent	   deletion	   of	   the	   dif-­‐CAT-­‐dif	  motif	  (dCd)	  in	  the	  trbA	  and	  lacZYA	  target	  sites	  respectively.	  Figure	  2.2	  shows	  an	  agarose	  gel	  of	  this	  diagnostic	  PCR	  for	  the	  trbA	  site.	  Lane	  5	  shows	  wild	  type	  pCT,	  lanes	  3	  &	  4	  show	  insertion	  of	  the	  dCd	  motif,	  and	  lanes	  1	  &	  2	  show	  deletion	  of	  dCd	  by	   Xer	   recombinase	   following	   removal	   of	   chloramphenicol	   selection.	   The	  predicted	  fragment	  sizes	  are:	  wild	  type	  pCT	  1579bp;	  insertion	  1182bp;	  deletion	  269bp.	   For	   the	   lacZYA	  mutant,	   predicted	   product	   sizes	   are:	  wild	   type	  MG1655	  5222bp;	   insertion	   1563bp;	   deletion	   537bp.	   lacZYA	   CAT+	   mutant:	   wild	   type	  MG1655	  5222bp;	  insertion	  1323bp.	  Mutants	  with	  appropriate	  PCR	  product	  sizes	  were	  sequenced	  to	  confirm	  the	  deletion.	  Alignments	  of	  sequences	  from	  forward	  and	   reverse	   primers	   and	   from	  different	  mutants	  were	   carried	   out	   in	   Geneious	  version	  5.2	  (Biomatters	  2012).	  The	  alignments	  confirmed	  that	  the	  deletions	  had	  occurred	  in	  the	  correct	  genes	  (Figure	  2.3	  shows	  the	  alignment	  for	  pCT).	  	  
	  
Figure	   2.2:	   Gels	   showing	   PCR	   products	   of	   diagnostic	   PCR	   for	   pCTΔtrbA	   (A)	   and	  
MG1555	   mutants	   (B).	   A	   Lane	   5:	  wild	   type	   pCT;	   lanes	   3	   &	   4:	   insertion;	   lanes	   1	   &	   2:	  deletion	   of	   dCd;	   Lane	   6:	   2-­‐log	   ladder	   (NEB).	   Predicted	   fragment	   sizes:	   wild	   type:	  1579bp;	   insertion:	  1182bp;	  deletion:	  526bp.	  B	  Lanes	  1-­‐3:	  ΔlacZYA	  CAT+	  insertion;	   lane	  4:	  wild	   type	  pCT;	   lane	   5:	  ΔlacZYA	  dCd	  deletion;	   Lane	  6:	   2-­‐log	   ladder	   (NEB).	   Predicted	  fragment	  sizes:	  wild	  type	  MG1655	  5222bp;	  lacZYA	  CAT+	  insertion	  1323bp;	  ΔlacZYA	  dCd	  deletion	  537bp.	  
A B 















Figure	  2.3:	  Alignment	  of	  original	  pCT	  plasmid	  trbA	  region	  with	  dif-­‐CAT-­‐dif	  insertion	  and	  dif-­‐recombined	  deletion	  sequencing	  products.	  The	  top	  line	  shows	  the	  %	  identity	  between	  the	  sequences	  (n	  100%	  identity).	  Sequences	  are	  annotated	  with	  the	  dif-­‐CAT-­‐dif	  sites	  (n)	  and	  the	  homology	  region	  primer	  sites	  (n).	  Large	  gaps	  (___)	  were	  inserted	  into	  the	  insertion	  and	  deletion	  sequences	  to	  allow	  alignment	  of	  the	  primer	  sites.	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2.3.2 	  ΔtrbA	  mutants	  are	  non-­‐conjugative	  Mating	  experiments	  with	  the	  MG1655	  Δlac	  CAT+	  recipient	  demonstrated	  almost	  no	   conjugation	   in	   the	   ΔtrbA	  mutant	   compared	   to	   the	   wild	   type	   pCT.	   Rates	   of	  conjugation	  per	   donor	  were	   significantly	   lower	   for	   the	  mutant	   plasmid:	   4.43	   x	  10-­‐4	  for	  pCT	  and	  1.10	  x	  10-­‐6	  for	  ΔtrbA	  (p	  =	  6.1	  x	  10-­‐8)	  (Figure	  2.4).	  In	  fact,	  in	  6	  out	  of	  9	  ΔtrbA	  crosses	  no	  transconjugants	  were	  detected	  at	  all.	  	  Mating	   experiment	  with	   rifampicin	   resistant	  Enterobacter	   as	   the	   recipient	   also	  showed	  significantly	  less	  conjugation	  in	  the	  ΔtrbA	  mutant.	  The	  mean	  number	  of	  transconjugants	   per	   donor	   with	   pCT	   was	   2.13	   x	   10-­‐6,	   whereas	   for	   the	   ΔtrbA	  mutant	  it	  was	  3.31	  x	  10-­‐7	  (p	  =	  0.047).	  However,	  rates	  of	  conjugation	  were	  lower	  with	  the	  Enterobacter	  recipient,	  and	  rates	  of	  spontaneous	  mutation	  were	  higher	  (data	   not	   shown),	   therefore	   Enterobacter	   was	   determined	   to	   be	   a	   less	   useful	  recipient	  than	  the	  CAT+	  marked	  MG1655.	  	  
	  
Figure	  2.4:	  Mating	  experiments	  with	  wild	  type	  and	  ΔtrbA	  pCT.	  The	  mutant	  plasmid	  has	  a	  significantly	  lower	  conjugation	  rate	  than	  the	  wild	  type	  (p=	  6.1	  x	  10-­‐8).	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2.3.3 	  ΔlacZYA	  mutants	  do	  not	  metabolise	  X-­‐Gal	  &	  IPTG	  Screening	   on	   X-­‐Gal	  &	   IPTG	   plates	   showed	   that	  ΔlacZYA	  mutants	   did	   not	   break	  down	  X-­‐Gal,	  and	  colonies	  remained	  white.	  Figure	  2.5	  shows	  the	  relative	   fitness	  (W)	  of	  the	  blue	  MG1655	  strain	  in	  competition	  with	  the	  white	  ΔlacZYA	  knockout	  on	  LB	  agar	  plates	  and	  in	  LB	  broth.	  	  In	  plate	  competition,	  mean	  relative	  MG1655	  fitness	   is	   0.978	   (95%	   confidence	   limits:	   0.96	   –	   0.99),	   indicating	   that	   the	   blue	  strain	  does	  very	  slightly	  less	  well	  than	  if	  both	  strains	  were	  of	  equal	  fitness,	  that	  is	  
W	  =	  1	  (p	  =	  2.50	  x	  10-­‐6).	  Although	  this	  difference	  is	  significant,	  it	  is	  very	  small	  and	  unlikely	  to	  have	  a	  huge	  impact	  on	  further	  competition	  experiments.	  In	  contrast,	  despite	  the	  relative	  fitness	  of	  MG1655	  being	  higher	  in	  broth	  (mean	  =	  1.02,	  95%	  confidence	   limits:	   0.72	   –	   1.31),	   this	   is	   not	   a	   significant	   difference	   from	   equal	  fitness	  (p	  =	  0.47).	  Exclusion	  of	  the	  outlier,	  W	  =	  1.92,	  increases	  the	  mean	  to	  1.37	  (95%	   confidence	   limits:	   1.22	   –	   1.51).	   Although	   this	   difference	   is	   still	   not	  significant,	   p	   =	   0.13,	   this	   may	   be	   due	   to	   low	   replication	   in	   this	   test	   (n	   =	   5	  excluding	  the	  outlier).	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2.4 Discussion	  	  The	  Xercise	  gene	  deletion	  method	  (Bloor	  &	  Cranenburgh	  2006)	  was	  successful	  in	  producing	  both	  the	  non-­‐conjugative	  pCTΔtrbA	  mutants	  (CAT	  +/-­‐)	  and	  the	  white	  MG1655	   ΔlacZYA	  mutant,	   as	   demonstrated	   by	   both	   genotypic	   and	   phenotypic	  assays.	   Sequencing	   of	   the	   target	   regions	   showed	   correct	   insertion	   and	  subsequent	   recombination	   at	   the	   dif	   sites	   for	   all	   mutants.	   Phenotypic	   assays	  demonstrated	   that	   the	   deletions	   had	   the	   desired	   effects.	   Mating	   experiments	  with	  pCTΔtrbA	  showed	  significantly	  lower	  conjugation	  rates	  than	  wild	  type	  pCT	  with	   two	   different	   recipient	   strains,	   E.	   coli	   MG1655	   and	   Enterobacter.	  
Enterobacter	  was	  determined	  to	  be	  a	  less	  useful	  recipient	  as	  rates	  of	  conjugation	  where	  considerably	   lower,	  even	  with	   the	  wild	   type	  plasmid,	   therefore	  MG1655	  pairs	  are	  used	  in	  all	  subsequent	  experiments.	  	  The	  MG1655	  Δlac	  mutant	  does	  not	  break	  down	  X-­‐Gal	  and	  colonies	  remain	  white,	  whereas	   standard	   MG1655	   colonies	   are	   blue.	   Fitness	   assays	   suggest	   that	  although	   there	  are	  differences	  between	   the	   two	  strains	  on	  plates	  and	   in	  broth,	  these	   differences	   are	   small	   and	   unlikely	   to	   affect	   the	   outcome	   of	   further	  experiments.	   However,	   these	   results	   were	   taken	   into	   consideration	   in	   the	  analysis	  of	  subsequent	  competition	  experiments	  with	  these	  strains.	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Chapter	  3: Cooperative	  β-­‐lactam	  resistance	  	  	  	  
3.1 Introduction	  
3.1.1 Antibiotic	  resistance	  as	  a	  cooperative	  trait	  A	   cooperative	   trait	   is	   a	   behaviour	   by	   one	   individual	   that	   can	   benefit	   another	  (West	   et	   al.	   2006).	   In	   bacteria,	   cooperative	   traits	   often	   come	   in	   the	   form	   of	  ‘public	  goods’	  released	  into	  the	  environment	  and	  available	  to	  all.	  Many	  virulence	  factors,	  including	  siderophore	  production	  and	  biofilm	  formation	  are	  cooperative	  traits.	   Antibiotic	   resistance	   conferred	   by	   the	   enzymatic	   breakdown	   of	   drugs	   is	  potentially	  a	  cooperative	  trait	  as	  it	  can	  detoxify	  the	  environment	  for	  all	  cells,	  and	  the	  production	  of	  β-­‐lactamases,	  which	  cleave	  and	  deactivate	  penicillins,	   is	  often	  cited	  as	  a	  social	  trait	  in	  bacteria	  (West	  et	  al.	  2007;	  West	  et	  al.	  2006;	  Brown	  et	  al.	  2009).	  The	  phenomenon	  of	  protective	  clearance	  of	  antibiotics	  by	  resistant	  cells	  is	  commonly	   seen	   by	   microbiologists	   in	   the	   presence	   of	   ‘satellite’	   colonies	   on	  transformation	  plates	  (Figure	  3.1).	  These	  non-­‐resistant	  colonies	  are	  able	  to	  grow	  on	   ampicillin	   plates	  where	   resistant	   colonies	   are	   already	   established.	   It	   seems	  likely	   that	   resistant	   transformants	   clear	   the	   antibiotic	   from	   their	   immediate	  vicinity,	   creating	   an	   antibiotic-­‐free	   space	   where	   susceptible	   ‘satellite’	   colonies	  can	   then	   grow.	   Previous	   studies	   have	   demonstrated	   the	   survival	   of	   antibiotic	  sensitive	  Escherichia	  coli	  and	  Salmonella	  sp.	  in	  the	  presence	  of	  resistant	  strains	  at	  high	  concentrations	  of	  antibiotic	  in	  vitro	  (Dugatkin	  et	  al.	  2005;	  Perlin	  et	  al.	  2009;	  Clark	  et	  al.	  2009)	  Cross-­‐species	  protection	  of	  susceptible	  bacteria	  by	  β-­‐lactamase	  producers	  has	  also	  been	  seen	  in	  vivo	  (Brook	  et	  al.	  1983;	  Tacking	  1954;	  Hackman	  &	  Wilkins	  1975).	  	  	  Clinical	   studies	   have	   suggested	   that	   protective	   clearance	   is	   mediated	   by	   the	  release	  of	  β-­‐lactamase	  enzymes	  into	  the	  environment	  by	  producing	  cells	  (Brook	  2004),	   and	   packaging	   of	   β-­‐lactamases	   into	   extracellular	   vesicles	   has	   been	  demonstrated	   in	   Pseudomonas	   aeruginosa	   (Ciofu	   et	   al.	   2000).	   Secretion	   of	  enzymes	   could	   increase	   the	   area	   of	   antibiotic	   clearance,	   benefitting	   all	   cells	   in	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Figure	   3.1:	   Satellite	   colonies	   around	   a	   successful	   pUC19	   transformant	   on	  
ampicillin	   agar.	   Transformation	   of	   E.	   coli	   DH10B	   with	   pUC19	   confers	   resistance	   to	  ampicillin	  and	  also	  restores	  the	  lac	  operon,	  resulting	  in	  a	  blue	  colony	  on	  agar	  containing	  X-­‐Gal	   &	   IPTG.	   White	   susceptible	   colonies	   can	   be	   seen	   growing	   around	   the	   resistant	  transformant,	   these	   appeared	   after	   >24	   hours	   incubation,	   whereas	   successful	  transformants	  appeared	  after	  ~16	  hours.	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3.1.2 Persistence	  and	  antibiotic	  tolerance	  This	   chapter	   initially	   set	   out	   to	   examine	   the	   cooperation	   in	   plasmid	  mediated	  antibiotic	   resistance	  using	  a	  naturally	  occurring	  resistance	  plasmid,	   in	  order	   to	  explore	  the	  possibility	  of	  ‘cheat’	  plasmids	  occurring	  in	  wild	  bacterial	  populations	  (Chapter	   1,	   Section	   1.3.2).	   However,	   the	   results	   of	   the	   initial	   competition	  experiments	  showed	  no	  cooperative	  resistance,	  which	  was	  directly	  at	  odds	  with	  the	  results	  of	  previous	  work	  (Dugatkin	  et	  al.	  2005;	  Perlin	  et	  al.	  2009;	  Yurtsev	  et	  al.	  2013),	  my	  own	  bioassay	  data,	  and	  the	  observation	  of	  satellite	  colonies	  (Figure	  3.1).	   	   I	   therefore	   turned	   to	   the	   investigation	   of	   persisters	   as	   an	   alternative	  explanation	  for	  these	  results.	  	  	  Persister	  cells	  were	  identified	  early	  in	  the	  clinical	  life	  of	  penicillin	  (Bigger	  1944),	  but	  a	  recent	  resurgence	   in	   interest	  has	  been	   fuelled	  by	  a	  wider	  appreciation	  of	  their	   clinical	   importance,	   especially	   in	   the	   light	   of	   the	   current	   antibiotic	  resistance	  crisis	  (Lewis	  2007).	  Persister	  cells	  are	  natural	  variants	  present	  at	  low	  frequency	   in	   the	   bacterial	   population,	   which	   can	   survive	   high	   antibiotic	  concentrations	   by	   dormancy	   (Lewis	   2010).	   The	   phenotypic	   switch	   between	  persistence	  and	  active	  growth	  appears	  to	  occur	  at	  random,	  although	  it	  is	  affected	  by	   growth	   phase	   (Balaban	   2004).	   The	   presence	   of	   persisters	   in	   biofilms	   is	  thought	  to	  contribute	  to	  increased	  antimicrobial	  tolerance	  and	  the	  maintenance	  of	  chronic	  infections	  (Brooun	  et	  al.	  2000;	  Lewis	  2001;	  Harrison	  et	  al.	  2005).	  The	  second	   part	   of	   this	   chapter	   examines	   the	   exploitation	   of	   resistant	  β-­‐lactamase	  producers	  by	  persister	  ‘cheats’.	  The	  clinical	  importance	  of	  persisters	  makes	  their	  potential	  evolvement	  in	  social	  cheating	  all	  the	  more	  interesting.	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3.1.3 Aims	  The	   primary	   aim	   of	   this	   chapter	   was	   to	   examine	   the	   cooperative	   β-­‐lactam	  resistance	   using	   a	   naturally	   occurring	   resistance	   plasmid,	   pCT,	   (Cottell	   et	   al.	  2011)	   and	   to	   investigate	   both	   the	   environmental	   and	   population	   conditions	  under	   which	   cooperative	   resistance	   occurs.	   To	   this	   end,	   competition	  experiments	  were	  conducted	  between	  the	  pCT-­‐carrying	  strain	  and	  an	  otherwise	  isogenic	  plasmid-­‐free	  E.	  coli	   under	   a	   variety	  of	   conditions.	  The	   results	   of	   these	  initial	  competition	  experiments	  showed	  no	  cooperative	  resistance,	  in	  contrast	  to	  previous	  work	  and	  personal	  observations	  using	  a	  bioassay.	  In	  the	  second	  part	  of	  this	  chapter	  the	  reason	  for	  this	  discrepancy	  is	  explored	  by	  testing	  the	  hypothesis	  that	  persister	  cells	  facilitate	  social	  cheating.	  This	  hypothesis	  is	  tested	  by	  further	  competition	   experiments	   under	   a	   variety	   of	   conditions,	   followed	   by	   end-­‐point	  assays	  to	  confirm	  potential	  persisters.	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3.2 Methods	  
3.2.1 Strains	  &	  culture	  techniques	  The	  resistant	  strain	  is	  E.	  coli	  K-­‐12	  MG1655	  +	  pCT.	  The	  plasmid,	  pCT,	  carries	  the	  ESBL	   resistance	   gene	   CTX-­‐M-­‐14	   (Cottell	   et	   al.	   2011).	   The	   susceptible	   strain	   is	  MG1655	  ΔlacZYA.	   The	   resistant	   strain	   is	   blue	   in	   the	   presence	   of	   X-­‐Gal	   &	   IPTG	  whereas	  the	  susceptible	  strain	  is	  white.	  The	  fitness	  cost	  of	  the	   lacZYA	  knockout	  was	  assessed	  with	  competition	  on	  plates	  and	  a	  negligible	  fitness	  difference	  was	  found	   (Chapter	   2,	   Section	   2.3.3).	   Generic	   culture	   techniques	   and	   antibiotic	  specifications	  can	  also	  be	  seen	  in	  Chapter	  2,	  Section	  2.2.1.	  The	  bioassay	  was	  also	  conducted	  with	  E.	  coli	  DH10B	  +	  pCT	  as	   the	   resistant	   strain,	   and	  DH10B	  as	   the	  susceptible	  strain.	  	  
	  
3.2.2 Bioassay	  A	  bioassay	  was	  used	  to	  assess	  clearance	  of	  antibiotic	  from	  solid	  media.	  A	  single	  resistant	  colony	  was	  streaked	  onto	  LB	  agar	  containing	  ampicillin	  and	  incubated	  at	  37°C	  for	  48	  hours	  (Figure	  3.2	  B,	  blue	  line).	  Single	  colonies	  of	  susceptible	  E.	  coli	  were	   then	   streaked	   from	   the	   central	   resistant	   colony	   to	   the	   edge	   of	   the	   plates	  and	   onto	   plates	   with	   no	   resistant	   colony	   (Figure	   3.2,	   grey	   lines).	   Plates	   were	  incubated	   at	   37	   °C	   overnight	   and	   growth	   measured	   from	   the	   central	   colony	  outwards.	   In	   a	   further	   assay	   the	   central	   resistant	   colony	   was	   killed	   using	   a	  chloroform	  soaked	   filter	  disk,	  applied	   to	   the	  central	   colony	   for	  10	  minutes	  and	  then	  removed	  and	  allowed	  to	  dry	  before	  addition	  of	  the	  susceptible	  strain.	  	  	  	  	  	  
	  
	  
Figure	   3.2:	   Antibiotic	   clearance	   bioassay.	   Ampicillin	   plates	   were	   incubated	   for	   48	  hours	   with	   (B)	   or	   without	   (A)	   resistant	   colonies	   (blue),	   before	   the	   addition	   of	  susceptible	   colonies	   (grey).	   Distance	   of	   susceptible	   growth	   from	   central	   colony	   was	  measured	  after	  overnight	  growth.	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3.2.3 Minimum	  inhibitory	  concentration	  (MIC)	  assays	  MIC	  assays	  were	  used	   to	  determine	  doses	  of	   antibiotics	   for	  use	   in	   competition	  experiments,	   and	   subsequently	   to	   assess	   changes	   in	   antibiotic	   tolerance	   in	  persisters	   (Andrews	   2001).	   Assays	  were	   conducted	   in	   96	  well	   plates	   (Costar®	  Corning®,	   Sigma-­‐Aldrich),	   excluding	   the	   outermost	   wells	   to	   eliminate	   edge	  effects	   cause	   by	   evaporation	   loss.	   200	   μl	   LB	   broth	  with	   appropriate	   antibiotic	  dose	   (Table	   3.1)	   was	   inoculated	   with	   10	   μl	   overnight	   culture	   of	   resistant	   or	  susceptible	  cells	  or	  E.	  coli	  DH10B	  as	  a	  susceptible	  control.	  Plates	  were	  incubated	  at	   37°C,	   shaken	   at	   220	   rpm,	   overnight,	   and	   the	   OD630	  measured	   with	   a	   plate	  reader	  (SpectraMax	  190).	  Figure	  3.3	  shows	  MIC	  data	  for	  cefotaxime.	  	  	  
Antibiotic	   Dose	  (μg	  ml-­‐1)	  
Ampicillin	   100	   20	   4	   0.8	   0.16	   0.032	   0.0064	   0	  
Cefotaxime	  
Nalidixic	  acid	  
8	  40	   1.6	   0.32	   0.064	   0.0128	   0.00256	   0.00512	   0	  15	   10	   5	   2.5	   1	   0	   -­‐	  	  
Table	  3.1:	  Antibiotic	  doses	  for	  MIC	  assays	  
	  
Figure	  3.3	  Cefotaxime	  MIC	  assay.	  Optical	  density	  (OD630)	  of	  resistant	  (MG1655	  +	  pCT,	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3.2.4 Competition	  experiments	  	  Competitions	  were	  conducted	  on	  LB	  agar	  plates	  containing	  X-­‐Gal	  (0.02	  mg	  ml-­‐1)	  and	  IPTG	  (0.1	  mM).	  OD600	  of	  o/n	  cultures	  of	  competing	  strains	  (susceptible	  and	  resistant)	   were	   measured	   and	   cultures	   diluted	   to	   approximately	   equal	   cell	  density	  with	   0.85%	   (w/v)	   saline.	   Cultures	  were	   then	  mixed	   50:50	   and	   diluted	  with	   saline	   to	   give	   an	   approximate	   cell	   density	  of	  1	   colony	   forming	  unit	   (CFU)	  per	  µl	  	  (CFU	  µl-­‐1).	  To	  confirm	  the	  initial	  ratio	  of	  cells,	  mixed	  cultures	  were	  plated	  onto	   LB	   agar	   +	   X-­‐Gal	   &	   IPTG	   and	   incubated	   o/n	   at	   37°C,	   and	   blue	   and	   white	  colonies	  counted.	  	  	  For	  the	  competitions,	  plates	  containing	  low,	  intermediate	  and	  high	  doses	  (Table	  3.2)	  were	  selected	  based	  on	  the	  MIC	  assay	  (Section	  3.2.3,	  above).	  100	  µl	  mixture	  or	  susceptible-­‐only	  control	  was	  spread	  onto	  plates	  and	  incubated	  at	  37°C	  for	  72	  hours.	  Colonies	  were	  then	  harvested	  by	  adding	  5	  ml	  saline	  to	  the	  plate,	  loosening	  colonies	   with	   a	   sterile	   spreader	   and	   homogenizing	   with	   a	   pipette.	   Harvested	  colonies	  were	  serially	  diluted	  and	  plated	  onto	  LB	  agar	  +	  X-­‐Gal	  &	  IPTG,	  with	  and	  without	   ampicillin.	   	   Plates	   were	   incubated	   at	   37°C	   overnight,	   and	   colonies	  counted	  to	  determine	  final	  ratios	  and	  relative	  fitness	  of	  the	  susceptible	  (MG1655	  ΔlacZYA)	  strain	  (see	  Section	  3.2.7	  below).	   	  Four	   variations	   of	   this	   competition	   were	   conducted,	   altering	   (i)	   the	   initial	  proportion	  of	  resistants	  (0.1,	  0.5,	  0.9);	  (ii)	  the	  density	  of	  colonies	  per	  plate	  (100,	  1000,	   10000	   CFU);	   (iii)	   the	   nutrient	   availability	   (M9	   minimal	   salts	   2%	   agar,	  Sigma	  Aldrich);	  (iv)	  the	  antibiotic	  (cefotaxime,	  Table	  3.2).	  	  	  
Antibiotic	   Control	   Low	   Intermediate	   High	  
Ampicillin	   0	   4	   32	   100	  
Cefotaxime	   0	   0.064	   0.32	   8	  	  
Table	  3.2:	  Antibiotic	  doses	  (μg	  ml-­‐1)	  for	  competition	  experiments.	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3.2.5 Persister	  competition	  experiments	  In	   order	   to	   increase	   persister	   numbers	   to	   detectable	   levels,	   a	   large	   volume	   of	  susceptible	  culture	  was	  used	  to	   inoculate	  competition	  plates.	  An	  8-­‐hour	  starter	  culture	  in	  5	  ml	  LB	  broth	  was	  used	  to	  initiate	  300	  ml	  overnight	  culture	  by	  1:1000	  dilution.	   The	   overnight	   culture	   was	   centrifuged	   at	   4000x	   g	   for	   10	   minutes,	  resuspended	  in	  6	  ml	  0.85%	  saline	  and	  diluted	  1:10	  (no	  dilution	  was	  used	  in	  the	  varying	  dose	  experiment).	  Mixtures	  were	  made	  50:50	  with	  an	  overnight	  culture	  of	  resistant	  cells.	  Initial	  counts	  and	  competition	  plates	  were	  set	  up	  as	  described	  above,	  using	  both	  mixtures	  and	  susceptible	  only	  cultures	  (Section	  3.2.4).	  After	  24	  hours,	   competition	   plates	   were	   moved	   to	   room	   temperature	   incubation	  (approximately	  21°C)	  for	  up	  to	  3	  weeks.	  Blue	  and	  white	  colonies	  were	  counted	  after	   24	   hours,	   and	   then	   periodically.	   After	   3	   weeks	   incubation	   plates	   were	  photographed	   and	   potential	   persister	   colonies	   screened.	   Variations	   were	  conducted	   altering	   (i)	   the	   initial	   number	   of	   resistant	   colonies	   per	   plate	   (2,	   10,	  100	  CFU);	  and	  (ii)	  the	  ampicillin	  dose	  (0,	  10,	  32,	  100	  µg	  ml-­‐1).	  	  	  
3.2.6 Persister	  confirmation	  	  
Ampicillin	  sensitivity	  A	   subset	   of	   potential	   persister	   colonies	   was	   picked	   onto	   LB	   agar	   with	   and	  without	   ampicillin,	   to	   check	   for	   resistance.	   Persisters	   were	   also	   screened	   for	  increased	  tolerance	  to	  ampicillin	  with	  an	  MIC	  assay	  (see	  Section	  3.2.3).	  Persister	  colonies,	   plus	   resistant	   and	   susceptible	   controls,	   were	   resuspended	   in	   500	   µl	  saline,	  and	  10	  µl	  of	  this	  used	  as	  the	  inoculant.	  	  	  A	   growth	   curve	   was	   conducted	   at	   a	   sub-­‐MIC	   dose	   of	   ampicillin,	   2	   µg	   ml-­‐1,	   to	  assess	   any	   change	   in	   tolerance.	   Again	   persister	   colonies,	   plus	   resistant	   and	  susceptible	  controls,	  were	  resuspended	  in	  500	  µl	  saline,	  and	  10	  µl	  of	  this	  used	  to	  inoculate	  200	  µl	  ampicillin	  broth	  in	  a	  96	  well	  plate.	  Plates	  were	  incubated	  in	  the	  plate	  reader	  at	  37°C,	  shaken,	  for	  10	  hours	  and	  OD595	  measured	  every	  15	  minutes.	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Presence	  of	  pCT	  To	   elimate	   transconjugation	   as	   the	   cause	   of	   susceptible	   survival,	   a	   number	   of	  persister	  colonies	  were	  PCR	  screened	  for	  the	  presence	  of	  pCT.	  	  The	  pCT	  specific	  trbA	  diag	   primers	   (Chapter	   2,	   Table	   2.2)	  were	   used.	   Colony	  PCR	  protocols	   are	  described	  in	  Chapter	  2,	  Section	  2.2.1.	  	  
	  
Antibiotic	  effect	  Low-­‐level	   ampicillin	   resistance	   selected	   for	   by	   continued	   antibiotic	   exposure,	  rather	   than	  persistence,	   could	   explain	   the	   susceptible	   cells	   apparent	   ampicillin	  tolerance.	  In	  order	  to	  eliminate	  this	  explanation,	  persister	  cells	  were	  selected	  by	  plating	  susceptible	  cells	  onto	  nalidixic	  acid.	  Susceptible	  cultures	  were	  prepared	  as	  previously	  (Section	  3.2.5)	  and	  then	  spread	  onto	  15	  µg	  ml-­‐1	  nalidixic	  acid	  plates	  and	   incubated	   at	   37°C	   o/n,	   followed	   by	   room	   temperature	   for	   6	   days.	   The	  susceptible	   strain	   (MG1655	   ΔlacZYA)	   is	   not	   resistant	   to	   nalidixic	   acid,	   and	  therefore	  should	  not	  grow.	  Any	  colonies	  that	  emerged	  on	  the	  nalidixic	  acid	  plates	  were	   taken	   to	   be	   either	   spontaneous	   resistance	   mutants	   or	   persisters.	  Spontaneous	   resistant	  mutants	   appeared	   after	   overnight	   incubation,	   and	  were	  confirmed	  by	  re-­‐plating.	  Colonies	  that	  emerged	  after	  this	  (from	  24	  hours)	  were	  taken	   to	   be	   persisters,	   which	   had	   survived	   the	   antibiotic	   dose	   by	   dormancy.	  These	  persister	  colonies	  were	  screened	  for	  any	  change	  in	  ampicillin	  or	  nalidixic	  acid	   tolerance	  by	  MIC	  assay	   (as	  described	   in	   Section	  3.2.3,	   for	  doses	   see	  Table	  3.1).	  	  	  
3.2.7 Data	  analysis	  Relative	   susceptible	   fitness	   in	   competition	   experiments	   was	   calculated	   as	  described	  by	  Lenski	  (1988;	  also	  see	  Dahlberg	  &	  Chao	  2003),	  and	  is	  given	  by	  the	  equation:	   !!" = !"#!  !! 1 /  !!(0)!"#!  !!(1)/!!(0) 	  	  Where	  Wij	  is	  the	  fitness	  of	  strain	  i	  (susceptible)	  relative	  to	  strain	  j	  (resistant)	  and	  
N	   is	   the	   cell	   density	   at	   the	   start	   (0)	   and	   end	   (1)	   of	   the	   experiment.	   Initial	   cell	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density	  (0)	  was	  derived	  from	  the	  mean	  susceptible	  and	  resistant	  counts	  (CFU	  ml-­‐1)	  in	  the	  0	  μg	  ml-­‐1	  dose	  for	  each	  experiment.	  It	  is	  not	  possible	  to	  calculate	  relative	  fitness	  when	   there	   is	  no	  detectable	   growth;	   therefore	  all	   final	   cell	   counts	  were	  transformed	   by	   addition	   of	   the	   minimal	   detectable	   value,	   calculated	   by	   the	  equation:	  !"#"$%&  !"#"$#%&'"  !"#$% = !"#"$%$  !"##$%&'  !"#  !"#$%!"#$%&%  !"##$%&'  !"#  !"#$% 	  Relative	   susceptible	   fitness	   across	   treatments	   was	   compared	   using	   ANOVA,	  conducted	   in	  R	  (R	  Core	  Team	  2013).	  Persister	  data	  was	  analysed	  using	  ANOVA	  and	  linear	  regression	  as	  appropriate.	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3.3 Results	  











Figure	   3.4:	   Antibiotic	   clearance	   bioassay.	   Susceptible	   colonies	   grow	   on	   ampicillin	  plates	   in	   the	   presence	   of	   resistant	   colonies	   (bottom	   row),	   but	   not	   alone	   (top	   row).	  Resistant	  colonies	  were	  incubated	  overnight	  on	  100	  µg	  ml-­‐1	  ampicillin	  plates	  before	  the	  addition	  of	  susceptible	  colonies.	  Susceptible	  strains	  can	  grow	  in	   the	  region	  around	  the	  resistant	   colony,	   but	   do	   not	   grow	   outside	   the	   central	   zone	   or	   in	   the	   absence	   of	   a	  resistant	  colony	  (top	  row).	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3.3.2 Susceptible	  and	  resistant	  cells	  have	  equal	  fitness	  at	  sub-­‐inhibitory	  doses	  At	  sub-­‐inhibitory	  ampicillin	  doses	  (0	  &	  4	  µg	  ml-­‐1)	  the	  relative	  susceptible	  fitness	  is	  close	  to	  1	  across	  all	  treatments.	  It	  is	  slightly	  greater	  than	  1	  at	  0	  µg	  ml-­‐1,	  which	  may	  indicate	  higher	  susceptible	  fitness	  in	  the	  absence	  of	  antibiotic,	  however	  the	  difference	  is	  very	  small.	  Previous	  work	  showed	  that	  MG1655	  has	  slightly	  lower	  fitness	   in	   plate	   competition	   than	   the	   mutant	   MG1655	   Δlac	   in	   the	   absence	   of	  antibiotic	   (mean	  relative	   fitness:	  0.978,	  95%	  confidence	   limits:	  0.96	  –	  0.99,	   see	  Chapter	  2,	  section	  2.3.3).	  The	  fact	  that	  the	  susceptible	  strain	  has	  slightly	  higher	  relative	   fitness	   in	   these	   competitions	   may	   suggest	   a	   fitness	   cost	   of	   plasmid	  carriage	  at	  sub-­‐inhibitory	  antibiotic	  doses	  (Figure	  3.5	  A).	  	  	  
3.3.3 Relative	  susceptible	  fitness	  declines	  at	  inhibitory	  ampicillin	  doses	  In	  all	  competition	  experiments	  relative	  susceptible	  fitness	  declines	  dramatically	  at	  inhibitory	  doses	  (32	  &	  100	  µg	  ml-­‐1),	  with	  close	  to	  zero	  detectable	  growth	  in	  all	  cases	   (Figure	   3.5).	   This	   result	   is	   consistent,	   regardless	   of	   the	   initial	   resistant	  proportion	  or	   the	  density	  of	  colonies	  per	  plate,	   indicating	  that	  susceptible	  cells	  do	   not	   benefit	   from	   the	   presence	   of	   resistant	   cells	   at	   inhibitory	   doses	   of	  antibiotic,	  contradicting	  the	  bioassay	  result	  (Figure	  3.4).	  In	  the	  susceptible-­‐only	  controls	  there	  was	  no	  growth	  in	  the	  presence	  of	  inhibitory	  ampicillin	  doses	  (data	  not	  shown).	  	  The	   initial	  resistant	  proportion	  does	  not	  significantly	  affect	  relative	  susceptible	  fitness	   (F	   (2,	  55)	   =	  0.267,	  p	   =	   0.767),	   but	   the	  dose	  does	  have	   a	  highly	   significant	  effect	   (F	   (1,	  55)	   =	  102.64,	  p	   =	  3.49	  x	  10-­‐14,	   Figure	  3.5	  A).	  This	   is	  due	   to	   the	  huge	  change	  in	  relative	  susceptible	  fitness	  at	  inhibitory	  doses:	  no	  susceptible	  growth	  was	   detectable	   in	   any	   replicate	   at	   either	   32	   or	   100	   µg	   ml-­‐1	   ampicillin,	   and	  moreover	   there	   is	   no	   significant	   difference	   in	   relative	   susceptible	   fitness	  between	  the	  0	  and	  4	  µg	  ml-­‐1	  doses	  (means	  1.057	  and	  1.019	  respectively,	  t	  (28)	  =	  1.241,	  p	  =	  0.225).	  	  	  The	  density	  of	  colonies	  per	  plate	  has	  no	  significant	  effect	  on	  relative	  susceptible	  fitness	  (F	  (2,	  54)	  =	  0.21,	  p	  =	  0.811,	  Figure	  3.5	  B),	  but	  this	  experiment	  again	  shows	  a	  highly	   significant	   effect	   of	   antibiotic	   dose	   (F	   (1,	   54)	   =	   62.23,	   p	   =	   1.49	   x	   10-­‐10).	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Relative	  susceptible	   fitness	  at	   inhibitory	  doses	  was	  higher	   than	   in	   the	  previous	  experiment	   and,	   interestingly,	   susceptible	   colonies	   were	   detected	   here.	  Susceptible	  colonies	  were	  detected	  in	  the	  100	  and	  1000	  CFU/plate	  treatments	  at	  32	  µg	  ml-­‐1,	  and	  in	  the	  1000	  and	  10000	  CFU/plate	  treatments	  at	  100	  µg	  ml-­‐1.	  The	  higher	  relative	  susceptible	  fitness	  in	  the	  100	  CFU/plate	  treatment	  at	  32	  µg	  ml-­‐1	  is	  likely	  to	  be	  skewed	  by	  the	  low	  number	  of	  replicates	  (n	  =	  3),	  two	  of	  which	  had	  no	  detectable	   susceptible	   growth.	   This	   variation	   is	   demonstrated	   by	   the	   95%	  confidence	   limits:	   -­‐0.3663	   -­‐	   1.6631	   (mean:	   0.6484).	   It	   seems	   likely	   that	   this	  higher	   relative	   fitness	   is	   an	   artefact	   of	   low	   replication,	   particularly	   as	   this	  treatment	  is	  identical	  to	  the	  0.5	  resistant	  proportion	  in	  the	  previous	  experiment,	  where	  relative	  susceptible	  fitness	  at	  32	  µg	  ml-­‐1	  was	  -­‐0.8623	  with	  95%	  confidence	  limits	  of	  -­‐0.8656	  and	  -­‐0.8591.	  	  	  More	  interesting	  results	  were	  obtained	  from	  the	  1000	  CFU/plate	  treatment	  at	  32	  
µg	  ml-­‐1	  and	  the	  1000	  and	  10000	  CFU/plate	  treatments	  at	  100	  µg	  ml-­‐1.	  In	  the	  1000	  CFU/plate	   treatment	   at	   32	  µg	  ml-­‐1,	   three	   out	   of	   five	   replicates	   had	   detectable	  susceptible	  colonies	  (mean	  relative	  susceptible	  fitness:	  0.6409,	  95%	  confidence	  limits:	  -­‐0.1212	  -­‐	  1.4030).	  At	  100	  µg	  ml-­‐1	  the	  1000	  CFU/plate	  treatment	  just	  one	  replicate	   had	   detectable	   susceptible	   growth	   (mean	   relative	   susceptible	   fitness:	  0.5596,	   95%	   confidence	   limits:	   -­‐0.0661	   -­‐	   1.185),	   and	   the	   10000	   CFU/plate	  treatment	   had	   2	   replicates	   with	   detectable	   susceptible	   growth	   (mean	   relative	  susceptible	   fitness:	  0.6300,	  95%	  confidence	   limits:	   -­‐0.1633	   -­‐	  1.4232).	  Although	  confidence	   intervals	   are	   large	   for	   these	   treatments,	   the	   fact	   that	   susceptible	  colonies	   were	   detected	   at	   all	   is	   noteworthy.	   Although	   colony	   density	   is	   not	   a	  significant	   predictor	   of	   susceptible	   fitness,	   these	   data	   appear	   to	   indicate	   that	  higher	   cell	   densities	   may	   facilitate	   some	   susceptible	   survival	   at	   inhibitory	  antibiotic	   doses,	   although	   these	   levels	   are	   still	   low.	   The	   addition	   of	   a	   selective	  marker,	   such	   as	   another	   antibiotic	   resistance	   gene,	   to	   susceptible	   cells	   would	  improve	  the	  detection	  rate	  when	  very	  low	  susceptible	  numbers	  are	  present.	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Figure	  3.5:	  Relative	   fitness	  of	   the	   susceptible	   strain	   (MG1655	  ΔlacZYA)	   in	  mixed	  
populations	  with	  the	  resistant	  strain	  (MG1655	  +	  pCT)	  at	  different	  antibiotic	  doses.	  (A)	  varying	  initial	  proportion	  of	  resistant	  bacteria	  (squares	  0.1,	  circles	  0.5,	  triangles	  0.9).	  (B)	  varying	  initial	  cell	  density	  	  (circles	  100,	  squares	  1000,	  triangles	  10000	  CFU/plate).	  n	  =	   5	   for	   each	   data	   point	   except	   (A)	   0.1	   resistant	   at	   32	   μg	   ml-­‐1	   (n	   =	   4),	   and	   (B)	   100	  CFU/plate	   at	   32	   μg	   ml-­‐1	   (n	   =	   3).	   	   Relative	   susceptible	   fitness	   (W)	   was	   calculated	   as	  described	   by	   Lenski	   (1988),	   a	   value	   >1	   indicates	   higher	   relative	   fitness	   than	   the	  competitor,	  and	  a	  value	  <1	  indicate	  lower	  relative	  fitness.	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3.3.4 Stress	  conditions	  may	  mitigate	  plasmid	  cost	  When	  nutrient	  availability	  was	  limited	  (M9	  minimal	  media),	  relative	  susceptible	  fitness	  was	  reduced	  at	  4	  µg	  ml-­‐1	  (mean	  0.5483,	  95%	  confidence	  limits	  -­‐0.0891	  -­‐	  0.8735)	  compared	  to	  0	  µg	  ml-­‐1	  	  (mean	  1.0004,	  confidence	  limits	  0.9867	  -­‐	  1.0213,	  Figure	   3.6).	   This	   is	   a	   curious	   result,	   which	   may	   suggest	   that	   a	   low	   nutrient	  environment	   reduces	   antibiotic	   tolerance,	   contradicting	   the	   generally	   accepted	  view	  that	  slow	  growing,	  nutrient	  depleted	  cells	  are	  more	  tolerant	  to	  antibiotics	  (Gilbert	  et	  al.	  1990;	  McKenney	  1997).	   It	   is	  also	  possible	   that	   the	   lower	  relative	  fitness	   of	   the	   susceptible	   cells	   at	   4	   µg	   ml-­‐1	   in	   M9	   minimal	   media	   is	   due	   to	  increased	   sensitivity	  of	   susceptibles	   to	   ampicillin	  or	   some	  additional	  benefit	   of	  the	  plasmid	  in	  nutrient	  limited	  conditions.	  An	  MIC	  assay	  could	  be	  used	  to	  assess	  any	   change	   in	   the	   antibiotic	   sensitivity	   of	   the	   susceptible	   strain	   in	   nutrient	  limited	   conditions	   (M9	   media).	   In	   addition,	   any	   possible	   increased	   benefit	   of	  plasmid	  carriage	  in	  minimal	  media	  could	  be	  assessed	  by	  comparing	  growth	  rates	  of	   plasmid	   carrying	   cells	   in	  M9	   and	   LB	   broths	   using	   growth	   curves	   at	   varying	  doses	  of	  ampicillin	  (as	  described	  in	  Section	  3.2.6	  above)	  However,	  as	  susceptible	  growth	   was	   observed	   in	   just	   one	   of	   five	   replicates,	   and	   the	   95%	   confidence	  interval	   is	   large,	   further	  replication	   is	  also	  needed	  to	  confirm	  this	  result.	  When	  cefotaxime	   replaced	   ampicillin	   as	   the	   antibiotic,	   no	   susceptible	   growth	   was	  detected	  at	  all	  in	  the	  sub-­‐inhibitory	  dose	  (0.064	  µg	  ml-­‐1).	  Collectively,	  the	  M9	  and	  cefotaxime	  data	  indicate	  that	  in	  more	  stressed	  conditions	  the	  overall	  cost	  of	  the	  plasmid	   carriage	   may	   be	   reduced,	   which	   would	   increase	   the	   overall	   benefit	  associated	  with	  resistance	  even	  at	  low	  doses	  of	  antibiotic.	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Figure	   3.6:	   Relative	   fitness	   of	   susceptibles	   in	   mixed	   populations	   in	   nutrient	  
limited	   conditions	   and	   using	   cefotaxime.	   Nutrient	   limited	   competitions	   used	   M9	  media	   and	   ampicillin	   (grey	   diamonds).	   Cefotaxime	   experiments	   used	   LB	   media	   and	  cefotaxime	   instead	   of	   ampicillin	   (black	   squares).	   n	   =	   5	   for	   each	   data	   point.	   Relative	  susceptible	  fitness	  (W)	  was	  calculated	  as	  described	  by	  Lenski	  (1988).	  	  	  
3.3.5 β-­‐lactam	  resistant	  bacteria	  facilitate	  growth	  of	  persisters	  The	   contradiction	   between	   the	   results	   of	   the	   bioassay	   and	   the	   competition	  experiments	   can	   be	   explained	   by	   two	   factors:	   the	   bioassay	   had	   higher	   cell	  density	  and	   it	  also	  gave	   the	  resistants	  a	  head	  start	   in	  clearing	   the	  antibiotic.	   In	  addition,	   susceptible	  colonies	  were	  detected	  at	   inhibitory	  ampicillin	  doses	  only	  in	   the	   high	   density	   treatments.	   These	   factors	   led	   to	   the	   hypothesis	   that	  susceptible	   survival	   is	   facilitated	   by	   persister	   cells:	   natural	   variants	   present	   at	  low	   frequency	   in	   the	   susceptible	   population,	   which	   survive	   high	   antibiotic	  concentration	  by	  dormancy	  (Lewis	  2010).	  At	  high	  concentrations	  of	  susceptibles	  (3.5	   x	   108),	  white	   susceptible	   colonies	   can	   be	   observed	   close	   to	   blue	   resistant	  colonies	   even	   at	   the	   highest	   ampicillin	   dose,	   100	   µg	   ml-­‐1	   (Figure	   3.7).	   These	  susceptible	  colonies	  were	  not	  seen	  in	  the	  absence	  of	  resistant	  bacteria	  at	  100	  µg	  ml-­‐1,	  but	  were	  seen	  at	  32	  μg	  ml-­‐1	  when	  double	  the	  inoculum	  volume	  was	  used.	  It	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is	  likely	  that	  this	  susceptible	  growth	  is	  due	  to	  degradation	  of	  the	  antibiotic	  over	  time	  (5	  days	  at	  room	  temperature),	  facilitating	  the	  growth	  of	  persisters.	   	  At	  the	  higher	   dose,	   the	   antibiotic	   does	   not	   have	   sufficient	   time	   to	   degrade	   to	   a	   sub-­‐lethal	   level	  without	   the	   assistance	   of	   resistant	   colonies.	   This	   phenomenon	  was	  not	  seen	  when	  a	  lower	  density	  of	  persisters	  was	  used	  (Figure	  3.8	  B).	  	  	  	  	  	  	  	  	  	  
	  
Figure	   3.7:	   Persisters	   and	   resistant	   colonies.	   x3.0	   magnification	   image	   showing	  resistant	   colonies	   (blue)	   and	   persister	   colonies	   (white)	   on	   LB	   agar	   +	   100	   µg	   ml-­‐1	  ampicillin	   +	   X-­‐Gal	   &	   IPTG.	   Resistant	   colonies	   appeared	   after	   overnight	   incubation	   at	  37°C.	  Persister	  colonies	  appeared	  after	  further	  72	  hours	  incubation.	  
Photographer:	  Mr	  K	  de	  Souza,	  Dept.	  of	  Earth	  Sciences,	  Royal	  Holloway	  University	  of	  London	  	  	  
	   60	  
	  
Figure	   3.8:	   The	   number	   of	   persister	   colonies	   increases	   with	   the	   number	   of	  
resistant	   colonies.	   (A)	   Numbers	   of	   persister	   and	   resistant	   colonies	   per	   plate	   after	   8	  days	  incubation	  (sqrt	  transformed).	  Linear	  regression:	  Persisters	  =	  0.7801	  +	  resistants	  x	  1.5772.	  R2	  =	  0.8384.	  F	  (1,16)	  =	  87.907,	  p	  =	  6.682	  x10-­‐8.	  (B)	  Mean	  persister	  colonies	  with	  0	  (l),	   2	   (¿),	   10	   (¢)	   or	   100	   (p)	   resistant	   colonies	   per	   plate	   (n=6,	   sqrt	   transformed).	  There	  is	  a	  highly	  significant	  interaction	  between	  number	  of	  resistant	  colonies	  and	  time,	  
F	  (1,	  92)=	  17.85,	  p	  =	  5.62	  x	  10-­‐5.	  The	  number	  of	  these	  susceptible	  persister	  colonies	  increases	  with	  the	  number	  of	  resistant	  colonies	  present	  (Figure	  3.8	  A;	  R2	  =	  0.8384,	  F	  (1,16)	  =	  87.907,	  p	  =	  6.682	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x10-­‐8)	   and	   over	   time,	   as	   shown	   by	   the	   highly	   significant	   resistant	   colonies	   by	  time	  interaction	  term	  (Figure	  3.8	  B;	  F	  (1,	  92)=	  17.85,	  p	  =	  5.62	  x	  10-­‐5).	  No	  persisters	  were	   found	  at	  100	  µg	  ml-­‐1	   in	   the	   absence	  of	   resistant	   colonies.	  The	  number	  of	  persisters	  decreases	  with	  increasing	  antibiotic	  dose	  (Figure	  3.9;	  F	  (1,	  50)	  =	  55.62,	  p	  =	   1.16	   x	   10-­‐9),	   and	   this	   experiment	   also	   shows	   a	   significant	   dose	   by	   resistant	  colony	  interaction	  term	  (F	  (1,	  50)	  =	  6.780,	  p	  =	  0.0121).	  These	  results	  are	  consistent	  with	  the	  hypothesis	  that	  resistant	  cells	  are	  breaking	  down	  the	  antibiotic	  in	  their	  vicinity,	   facilitating	   persister	   growth:	  more	   resistant	   cells	   and	   lower	   antibiotic	  concentrations	  will	  lead	  to	  a	  more	  rapid	  reduction	  in	  antibiotic	  concentration.	  	  	  	  
	  	  
	  
Figure	   3.9:	   The	   number	   of	   persisters	   decreases	  with	   increasing	   antibiotic	   dose.	  Mean	  persister	  colonies	  over	  time	  at	  a	  variety	  of	  ampicillin	  doses:	  100	  (¿),	  32	  (¢)	  and	  10	  µg	  ml-­‐1	  (p)	  with	  ~20	  resistant	  colonies	  per	  plate.	  Data	  not	  shown	  for	  10	  µg	  ml-­‐1	  after	  3	   days	   as	   colonies	   were	   too	   numerous	   to	   count	   (n=7,	   sqrt	   transformed).	   Dose	   has	   a	  highly	  significant	  effect	  on	  number	  of	  persisters	  F	  (1,	  50)	  =	  55.62,	  p	  =	  1.16	  x	  10-­‐9.	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3.3.6 Persisters	  are	  neither	  transconjugants	  nor	  spontaneous	  resistance	  mutants	  Persister	  colonies	  did	  not	  grow	  when	  re-­‐plated	  onto	  ampicillin	  agar,	   indicating	  that	   they	   were	   not	   resistant	   to	   ampicillin,	   either	   by	   spontaneous	   mutation	   or	  conjugation	  with	  resistant	  cells;	  nor	  did	  PCR	  using	  pCT	  specific	  primers	  amplify	  products	  (Figure	  3.10).	  	  
	  
Figure	  3.10:	  Persisters	  do	  not	  amplify	  pCT	  specific	  products.	  PCR	  with	  pCT	  specific	  primers	   detected	   no	   pCT	   in	   persister	   colonies.	   Lane	   1:	   pCT	   free	   control	   (MG1655	  
ΔlacZYA);	   Lanes	   2-­‐4:	   pCT	   positive	   controls	   (MG1655	   +	   pCT	   and	   two	   pCT	   plasmid	  extracts);	  Lanes	  5-­‐14:	  persister	  colonies;	  Lanes	  15-­‐18:	  resistant	  colonies.	  	  Three	   further	   assays	   were	   conducted	   to	   examine	   the	   phenotypes	   of	   potential	  persisters.	   These	   were	   not	   fully	   replicated	   experiments,	   but	   provide	   an	  indication	  of	  persister	  ampicillin	  susceptibility	  in	  comparison	  with	  resistant	  and	  susceptible	  strains.	  The	  first	  assays	  were	  two	  ampicillin	  MIC	  tests	  (Figure	  3.11	  A	  &	  B)	   for	   persisters	   selected	   on	   ampicillin	   and	   nalidixic	   acid.	   The	   nalidixic	   acid	  selected	  persisters	  had	  no	  prior	  exposure	  to	  ampicillin,	  in	  order	  to	  rule	  out	  any	  selection	   for	  ampicillin	   tolerance.	  Persisters	  showed	  no	  difference	   in	  ampicillin	  tolerance	  compared	  to	  susceptibles,	  whether	  selected	  on	  ampicillin	  or	  nalidixic	  acid.	  The	  second	  assay	  was	  a	  growth	  curve	  at	  a	  sub-­‐lethal	  ampicillin	  dose,	  2	  µg	  ml-­‐1	  (Figure	  3.11	  C),	  which	  indicates	  that	  persisters	  may	  have	  slightly	  increased	  ampicillin	   tolerance.	   Increased	   tolerance	   of	   low	   doses	   of	   antibiotic	   in	   cells	  previously	   exposed	   to	   the	   same	   drug	   has	   been	   demonstrated	   by	   Adam	   et	   al.	  (2008),	  who	  suggest	  that	  this	  is	  an	  epigenetic	  effect.	  Further	  data	  is	  required	  to	  confirm	   this	   result,	   including	   replication	  with	   nalidixic	   acid	   selected	  persisters	  with	  no	  previous	  exposure	  to	  ampicillin.	  






	  	  	  	  	  	  
	  
	  
Figure	  3.11:	  Persister	  ampicillin	  susceptibility	  assays.	  (A	  &	  B)	  Ampicillin	  MIC	  assays	  for	   resistant	   (p),	   susceptible	   (¢)	   and	   persister	   cells	   (☐).	   (A)	   persisters	   selected	   on	  ampicillin	   (n	   =	   10);	   (B)	   persisters	   selected	   on	   nalidixic	   acid	   (persisters	   n	   =	   19,	  susceptibles	  n	  =	  3,	  resistant	  n	  =	  1).	  	  (C)	  Growth	  curves	  over	  10	  hours	  in	  LB	  broth	  with	  2	  
µg	  ml-­‐1	  ampicillin	  (persisters	  n	  =	  7,	  resistant	  and	  susceptible	  cells	  n	  =	  1).	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3.4 Discussion	  
3.4.1 The	  cost	  of	  plasmid	  carriage	  The	   results	   of	   competition	   experiments	   in	   low	   nutrient	   conditions	   and	   using	  cefotaxime	   are	   curious,	   as	   they	   suggest	   that	   stressed	   conditions	   reduce	   the	  ability	   of	   susceptible	   bacteria	   to	   compete	   with	   resistant	   bacteria	   at	   sub-­‐MIC	  doses.	  This	   appears	   to	   counter	   the	   generally	   accepted	  view	   that	   slow	  growing,	  nutrient	   depleted	   cells	   are	   more	   tolerant	   to	   antibiotics,	   as	   many	   drugs	   target	  growing	   cells,	   leaving	   non-­‐growing	   or	   very	   slow	   growing	   cells,	   including	  persisters,	   largely	  unaffected	  (Hobby	  et	  al.	  1942;	  Tuomanen	  et	  al.	  1986;	  Gilbert	  et	   al.	   1990;	   Cozens	   et	   al.	   1986).	   Although	   it	   has	   also	   been	   shown	   that	  susceptibility	  can	  decrease	  with	  increased	  growth	  rate,	  this	  study	  highlighted	  the	  critical	   effect	   of	   environmental	   conditions	   on	   this	   response	   (McKenney	   1997).	  Rate	  of	  killing	  has	  been	  shown	  to	  be	  proportional	  to	  growth	  rate	  (Tuomanen	  et	  al.	   1986),	   which	   should	   give	   an	   advantage	   to	   susceptible	   cells	   in	   a	   nutrient	  depleted	  environment,	  as	  a	  slow	  growth	  rate	  will	  reduce	  killing	  and	  allow	  more	  cells	   to	   survive	   until	   the	   antibiotic	   is	   cleared	   by	   their	   resistant	   neighbours.	  However,	   this	   is	   not	   what	   I	   have	   observed.	   Instead,	   susceptibles	   are	   less	  competitive	  in	  the	  low	  nutrient	  environment	  at	  sub-­‐MIC	  doses.	  I	  suggest	  that	  the	  lower	   growth	   rate	   of	   the	   susceptibles	   in	   nutrient	   limited	   conditions	   may	  somewhat	  mitigate	   the	  detrimental	   effects	  of	  plasmid	   carriage	  on	   the	   resistant	  strain,	   thus	   reducing	   the	   relative	   fitness	  of	   susceptible	  bacteria.	  Dugatkin	  et	   al.	  (2005)	   and	  Perlin	   et	   al.	   (2009)	   demonstrate	   the	   	   cost	   associated	  with	   plasmid	  carriage	  and	  resistance,	  which	  can	  be	  exploited	  by	  susceptible	  strains,	  which	  do	  not	   carry	   either	   the	   plasmid	   or	   the	   resistance	   gene.	   Similar	   results	  were	   seen	  using	   cefotaxime	   instead	   of	   ampicillin.	   Cefotaxime	   has	   been	   shown	   to	   have	  remarkable	  potency	  against	  Enterobacteriaceae,	  producing	  an	  bactericidal	  effect	  at	   MIC	   doses	   (Jones	   &	   Thornsberry	   1982;	   Neu	   1982).	   I	   suggest	   that	   a	   similar	  mechanism	  to	  the	  nutrient	  limited	  model	  is	  at	  work	  here,	  meaning	  that	  the	  cost	  of	   plasmid	   carriage	   is	   again	   mitigated	   by	   reduced	   susceptible	   fitness,	   even	   at	  sub-­‐MIC	  doses.	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3.4.2 Sociality	  of	  resistance	  is	  dependent	  on	  persisters	  The	   resistant	   strain	   shows	   protective	   clearance	   of	   β-­‐lactams,	   facilitating	   the	  growth	   of	   susceptible	   E.	   coli,	   only	   under	   very	   specific	   conditions.	   I	   posit	   that	  these	  susceptibles	  are	  ‘persister’	  cells:	  natural	  variants	  present	  at	  low	  frequency	  in	   the	   susceptible	   population,	   which	   survive	   high	   antibiotic	   concentration	   by	  dormancy	   (Lewis	   2010).	   Very	   high	   densities	   of	   susceptible	   bacteria	   in	   my	  experiments	   increase	   the	  numbers	  of	  persisters	   to	   a	  detectable	   level.	  Once	   the	  level	   of	   antibiotic	   is	   sufficiently	   reduced	   by	   the	   resistant	   cells,	   they	   begin	   to	  appear.	  This	  explains	  both	  the	  lag	  before	  susceptibles	  appear,	  and	  the	  increase	  in	  numbers	   of	   persisters	   over	   time,	   as	   they	   switch	   back	   to	   metabolic	   activity	   at	  random	  (Balaban	  2004).	  Persister	  cells	  survive	  the	  initial	  high	  concentration	  of	  antibiotic	   by	   remaining	   dormant,	   but	   crucially	   their	   ability	   to	   grow	   is	   a	   social	  trait	  as	  it	  is	  dependent	  on	  the	  frequency	  of	  neighbouring	  β-­‐lactamase	  producers.	  	  	  	  Persistence,	  therefore,	  facilitates	  cheating	  and	  the	  exploitation	  of	  antibiotic	  free	  space	  provided	  by	  the	  resistant	  cells.	  	  
3.4.3 β-­‐lactams	  may	  have	  variable	  effects	  	  The	  observation	  that	  there	  is	  no	  social	  benefit	  for	  the	  susceptible	  strain	  except	  in	  the	   presence	   of	   persisters	   contrasts	   with	   previous	   work	   demonstrating	  protective	   clearance	   of	   antibiotics	   by	   resistant	   strains	   (Dugatkin	   et	   al.	   2005;	  Perlin	   et	   al.	   2009;	   Clark	   et	   al.	   2009;	   Yurtsev	   et	   al.	   2013).	   One	   possible	  explanation	  for	  this	  difference	  is	  that	  different	  strains	  and	  experimental	  set-­‐ups	  may	   produce	   altered	   antibiotic	   tolerance.	   In	   this	   experiment	   I	   show	   that	   any	  dose	  above	  the	  MIC	  is	  bactericidal	  to	  all	  growing	  E.	  coli.	  The	  bactericidal	  action	  of	  
β-­‐lactams	  is	  known	  to	  be	  variable	  and	  dependent	  on	  the	  specific	  drug,	  the	  strain,	  growth	   rate	   and	   stage,	   and	   the	   nutrient	   availability	   (Hobby	   et	   al.	   1942)	  (Tuomanen	  et	  al.	  1986)	  (Rolinson	  et	  al.	  1977;	  Cozens	  et	  al.	  1986).	  It	  is	  therefore	  possible	  that	  the	  experimental	  design	  of	  the	  earlier	  papers	  facilitated	  susceptible	  tolerance	  of	  doses	  above	  MIC,	  either	  through	  strain	  selection	  or	  some	  element	  of	  the	  growth	  conditions,	  producing	  a	  bacteriostatic	   response	   to	  ampicillin	   rather	  than	   a	   bactericidal	   effect.	   This	   tolerance	   effect	   has	   been	   seen	   for	   mercury	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resistance,	  where	  a	  threshold	  exists	  above	  which	  susceptible	  cells	  are	  inhibited	  but	  not	  killed	  (Ellis	  et	  al.	  2007).	  	  
3.4.4 Pre-­‐clearance	  of	  antibiotic	  required	  for	  susceptible	  growth	  Perhaps	   a	   more	   likely	   explanation	   is	   that	   the	   part-­‐batch,	   part-­‐chemostat	  conditions	  used	   in	   these	  previous	  studies	   facilitate	  more	  rapid	  and	  generalised	  clearance	  of	  antibiotic	  than	  the	  strict	  batch	  culture	  method	  I	  have	  employed.	  The	  model	  used	  by	  Dugatkin	  et	  al.	  (2005)	  and	  Perlin	  et	  al.	  (2009)	  allows	  build	  up	  of	  
β-­‐lactamases	   in	   one	   half	   of	   the	   chamber,	   and	   periodically	   replenishes	   the	  antibiotic	  in	  the	  other	  half.	  This	  build	  up	  of	  enzyme	  facilitates	  rapid	  breakdown	  of	   the	   antibiotic,	   similar	   to	   the	   earlier	   chemostat	   model	   described	   by	   Levin	  (1988).	  Here	  coexistence	  occurs	  only	  when	  susceptibles	  are	  added	  to	  an	  already	  established	   resistant	   culture	   (carrying	   the	   degradative	   chloramphenicol	   acetyl	  transferase	  gene).	  In	  a	  subsequent	  study,	  Dugatkin	  and	  colleagues	  recognise	  that	  enzyme	   accumulation	   may	   be	   a	   contributory	   factor,	   and	   therefore	   exchange	  between	   the	   two	  sides	  of	   the	  chamber	  and	   the	   frequency	  of	  antibiotic	  addition	  are	   increased	   (Clark	   et	   al.	   2009).	   Far	   fewer	   susceptibles	   survive	   in	   this	  experiment	   than	   the	   previous	   two.	   In	   their	   1986	   model,	   Lenski	   &	   Hattingh	  (Lenski	   &	   Hattingh	   1986)	   state	   that	   there	   is	   a	   set	   of	   conditions	   under	   which	  susceptible	   and	   resistant	   strains	   can	   coexist	   only	   if	   the	   resistant	   bacteria	   are	  already	  established.	   I	   suggest	   that	   this	  may	  be	  an	   important	   factor	   in	  previous	  observations	  of	  social	  resistance,	  and	  that	  rapid	  and/or	  prior	  antibiotic	  clearance	  is	  needed	  for	  non-­‐persisters	  to	  survive	  at	  high	  antibiotic	  doses.	  	  	  
3.4.5 Free	  enzyme	  facilitates	  faster	  antibiotic	  degradation	  The	   homogenous	   broth	   culture	   environment	   may	   facilitate	   more	   rapid	   break	  down	   of	   antibiotic	   simply	   by	   bringing	   more	   enzymes	   into	   contact	   with	   their	  substrate,	   as	   the	   law	   of	   mass	   action	   states.	   In	   addition,	   passive	   extracellular	  release	  of	  β-­‐lactamases	  from	  the	  gram	  negative	  periplasm	  (‘leakage’;	  Livermore	  1995)	  will	  have	  a	  greater	  impact	  in	  broth	  culture	  than	  in	  the	  solid	  batch	  culture	  environment.	   In	  my	   experiments,	   any	   exogenous	   enzyme	  would	   diffuse	   slowly	  through	   the	   agar,	   reinforcing	   the	   spatial	   structure	   of	   the	   environment,	   rather	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than	  clearing	  substantially	  more	  antibiotic.	  Both	  Clark	  et	  al.	  (2009)	  and	  Perlin	  et	  al.	   (2009)	   find	   substantially	   more	   extracellular	   β-­‐lactamase	   in	   cultures	   where	  protective	   clearance	   is	   seen.	   Curiously,	   Perlin	   et	   al	   (2009)	   also	   suggest	   that	  extracellular	   β-­‐lactamase	   is	   more	   common	   when	   E.	   coli	   is	   competed	   with	  
Salmonella	   than	   when	   it	   is	   grown	   alone.	   This	   could	   be	   an	   indication	   that	  
Salmonella	  has	  evolved	  to	  exploit	  the	  β-­‐lactamase	  producers,	  perhaps	  by	  causing	  them	   to	   increase	   production	   and	   secretion	   of	   β-­‐lactamases,	   thereby	   forcing	  cooperation.	  	  Yurtsev	  et	  al.	  (2013)	  propose	  that	  at	  very	  high	  antibiotic	  doses	  lysis	  of	   resistant	   cells,	   leading	   to	   the	   release	   of	  β-­‐lactamases	   into	   the	   environment,	  could	  speed	  up	  antibiotic	  degradation	  and	  increase	  cooperation.	  I	  suggest	  that	  if	  the	  dose	   is	  high	  enough	  to	   lyse	  resistant	  cells,	  susceptible	  cells	  will	  not	  survive	  unless	  there	  are	  persisters	  present.	  	  
3.4.6 Protective	  clearance	  is	  not	  dependent	  on	  ‘shared’	  resistance	  Dugatkin	   et	   al.	   (2005),	   Perlin	   et	   al.	   (2009)	   and	   Clark	   et	   al.	   (2009)	   all	   draw	   a	  distinction	   between	   ‘self-­‐limited’	   and	   ‘shared’	   resistance,	   based	   on	   the	  localisation	  of	  the	  enzyme.	  The	  results	  of	  this	  study	  question	  this	  differentiation,	  as	   no	   modifications	   to	   pCT	   have	   been	   made	   to	   alter	   the	   enzyme	   localisation,	  which	   is	   naturally	   largely	   periplasmic	   (Livermore	   1995).	   Yurtsev	   et	   al.	   (2013)	  point	   out	   that	   the	   site	   of	   antibiotic	   action	   determines	   the	   degree	   to	  which	   the	  resistant	   cells	   benefit	   from	   the	   public	   good,	   but	   that	   this	   does	   not	   affect	   the	  overall	   resistant-­‐susceptible	   dynamic,	   which	   is	   determined	   by	   the	   rate	   of	  degradation	   alone.	   More	   β-­‐lactamase	   was	   found	   in	   the	   supernatant	   of	   the	  ‘shared’	  resistance	  strain,	  due	  to	  breaking	  off	  of	  the	  enzyme	  from	  the	  cell	  (Clark	  et	  al.	  2009),	  confirming	  the	  ‘altruistic’	  nature	  of	  resistance	  compared	  to	  the	  ‘self’	  resistance	   strain.	   However,	   this	   breaking	   off	   from	   the	   cell	   appears	   to	   incur	   a	  fitness	   cost	   for	   the	   ‘shared’	   resistance	   strain.	   This	   fact,	   coupled	   with	   free	   β-­‐lactamase	   increasing	   the	   rate	   of	   degradation,	   could	   explain	   the	   survival	   of	   the	  susceptibles,	  rather	  than	  the	  enzyme	  localisation.	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3.4.7 Conclusions	  and	  outlook	  Theory	   and	   my	   data	   suggest	   that	   the	   conditions	   for	   coexistence	   are	   quite	  specific:	  the	  initial	  antibiotic	  concentration	  must	  not	  exceed	  the	  lethal	  dose,	  and	  the	  rates	  of	  degradation	  and	  antibiotic	  influx	  must	  not	  allow	  the	  dose	  to	  increase	  (Lenski	   &	   Hattingh	   1986).	   Experiments	   with	   mercury	   resistance	   confirm	   that	  frequency	   dependent	   coexistence	   of	   resistant	   and	   susceptible	   genotypes	   is	  strongly	  dose	  dependent	  (Ellis	  et	  al.	  2007).	  In	  my	  study,	  using	  batch	  culture,	  no	  dose	   greater	   than	   the	   MIC	   could	   be	   found	   that	   allowed	   the	   coexistence	   of	  resistant	  and	  susceptible	  bacteria,	  unless	  the	  susceptibles	  made	  the	  phenotypic	  switch	  to	  persistence.	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Chapter	  4: Plasmid	  sequencing	  	  	  	  
4.1 Introduction	  
4.1.1 The	  ‘cheat’	  plasmid	  hypothesis	  Antibiotic	  resistance	  conferred	  by	  the	  enzymatic	  breakdown	  of	  drugs,	  such	  as	  β-­‐lactamases,	  has	  the	  potential	  to	  be	  a	  cooperative	  trait	  (Chapter	  3,	  Section	  3.1.1).	  These	   antibiotic	   resistance	   genes	   are	   often	   carried	   on	   plasmids.	   Horizontal	  transfer	  of	  plasmid	  carried	  resistance	  genes	  to	  plasmid-­‐free	  cells	  would	  ensure	  that	  all	  cells	  share	  the	  cost	  of	  public	  good	  (β-­‐lactamase)	  production,	  and	  prevent	  the	  evolution	  of	  social	  cheats:	  cells	  which	  benefit	  from	  the	  enzyme	  produced	  by	  co-­‐operators,	   but	   which	   do	   not	   themselves	   produce	   the	   public	   good.	   Plasmid	  incompatibility	   groups	   and	   mating	   types	   can	   affect	   the	   spread	   of	   plasmids,	  leading	  to	  the	  idea	  of	  ‘cheat’	  plasmids	  (Figure	  4.1).	  A	  ‘cheat’	  plasmid	  is	  of	  similar	  size	   to	   the	   resistance	   plasmid,	   carrying	   similar	   genes	   and	   in	   the	   same	  incompatibility	   group,	   but	   crucially	   it	   does	   not	   carry	   the	   resistance	   gene.	  Carriage	  of	  the	  ‘cheat’	  plasmid	  would	  prevent	  cells	  from	  obtaining	  the	  resistance	  plasmid	   via	   conjugation,	   facilitating	   the	   existence	   of	   susceptible	   cheats	   in	   the	  population,	  which	  can	  exploit	  the	  public	  good	  produced	  by	  other	  cells.	  A	  cheat-­‐type	  plasmid	  has	  been	   successfully	   competed	  with	   resistance-­‐plasmid	   carrying	  cells,	   by	   replacing	   the	   plasmid’s	   ampicillin	   resistance	   gene	   with	   kanamycin	  resistance	  (Dugatkin	  et	  al.	  2005).	  	  	  It	   has	   been	   proposed	   that	   ‘Trojan	   horse’	   susceptible	   cheats	   could	   invade	   and	  displace	   resistant	   populations,	   facilitating	   clearance	   of	   an	   infection	   with	  antibiotics	   (Brown	   et	   al.	   2009).	   ‘Cheat’	   plasmids	   could	   block	   the	   spread	   of	  resistance	  genes	  by	  horizontal	  transfer,	  and	  thus	  invade	  resistant	  populations	  in	  this	  way.	  In	  addition,	  incompatibility-­‐based	  plasmid	  displacement	  using	  artificial	  plasmid	   constructs	   carrying	   key	   features	   of	   the	   displacement	   target	   has	   been	  successful	  for	  plasmid	  curing	  (Hale	  et	  al.	  2010),	  confirming	  that	  incompatibility	  with	  highly	  similar	  plasmids	  is	  a	  viable	  mechanism	  for	  manipulation	  of	  plasmid	  carriage.	   Potential	   ‘cheat’	   plasmids	   have	   been	   identified	   in	   environmental	   and	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Figure	   4.1:	   ‘Cheat'	   plasmids	   prevent	   the	   transfer	   of	   resistance	   plasmids	   to	  
susceptible	  cells.	  (A)	  Resistant	  cells	  (blue)	  can	  transfer	  resistance	  plasmids	  to	  plasmid-­‐free	   susceptible	   cells	   (white).	   (B)	   Susceptible	   cells	   bearing	   the	   ‘cheat’	   plasmid	   cannot	  receive	  the	  resistance	  plasmid.	  	  
4.1.2 Plasmids	  used	  in	  this	  chapter	  The	   extended-­‐spectrum	   β-­‐lactamase	   resistance	   plasmid,	   pCT,	   was	   identified	  from	   a	   veterinary	   outbreak	   of	   E.	   coli	  C159/11,	   by	   Liebana	   et	   al.	   (2006).	   Four	  additional	  E.	   coli	  clones	  were	   isolated	   from	   environmental	   (strain	   24456)	   and	  veterinary	  (strains	  Cow63,	  Cow52	  and	  Cow23)	  samples	  from	  the	  same	  outbreak	  farm.	   These	   strains	   appear	   to	   carry	   plasmids	   of	   similar	   size	   to	   pCT,	   and	  were	  confirmed	  as	  positive	  using	  a	  pCT	  specific	  PCR	  screening	  (M.	  O.	  Stokes,	  personal	  communication,	  (Stokes	  et	  al.	  2012)).	  Little	  is	  known	  about	  these	  plasmids,	  other	  than	  that	  they	  do	  not	  carry	  the	  CTX-­‐M-­‐14	  resistance	  gene	  present	  in	  pCT.	  Their	  apparent	   similarity	   to	   pCT,	   coupled	   with	   the	   absence	   of	   the	   resistance	   gene,	  made	  them	  ideal	  candidate	  ‘cheat’	  plasmids.	  	  
	  
4.1.3 Aims	  The	  aims	  of	  this	  chapter	  were	  firstly,	  to	  sequence	  the	  four	  plasmids	  isolated	  from	  the	   same	   outbreak	   site	   as	   pCT:	   p24456,	   pCow63,	   pCow52	   and	   pCow23;	   and	  secondly,	   to	   annotate	   and	   characterise	   these	   plasmids,	   to	   determine	   their	  potential	  ‘cheat’	  status	  and	  to	  identify	  any	  genes	  or	  features	  of	  interest.	  In	  order	  
A	  	   B	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to	  be	  a	  potential	  cheat,	  a	  plasmid	  must	  be	  of	  the	  same	  incompatibility	  group	  as	  pCT	  (IncK),	  and	  must	  not	  carry	  the	  resistance	  gene	  CTX-­‐M-­‐14.	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4.2 Methods	  
4.2.1 Sample	  preparation	  and	  sequencing	  Plasmids	   were	   isolated	   from	   the	   four	   strains	   using	   a	   High	   Speed	   Midi	   Kit	  (Qiagen),	  and	  an	  agarose	  gel	  of	  the	  extractions	  was	  run	  as	  described	  by	  Gonzalez	  et	   al.	   (1982).	   Plasmid	   extractions	   were	   stored	   in	   TE	   buffer	   at	   -­‐20°C	   until	  sequencing.	  Extracted	  plasmid	  DNA	  was	  quantified	  fluorometrically	  using	  Quant-­‐iT	   PicoGreen	   dsDNA	   assay	   kit	   (Invitrogen,	   Life	   Technologies	   Ltd.,	   Paisley,	   UK)	  and	   POLARstar	   Galaxy	   fluorometer	   (BMG	   Labtech	   Ltd.,	   Aylesbury,	   UK)	   and	  diluted	  to	  approximately	  5	  ng	  μl-­‐1	  DNA	  in	  TE	  buffer.	  Sequencing	  was	  conducted	  using	  the	  454	  GS-­‐FLX	  Titanium	  series	  sequencer	  (Roche	  Diagnostics	  Ltd.,	  Basel,	  Switzerland).	   Libraries	   were	   prepared	   from	   the	   plasmid	   DNA	   using	   the	   Rapid	  Library	   Preparation	  Kit,	   as	   specified	   by	   the	  Rapid	   Library	   Preparation	  Method	  Manual	  (Roche	  Diagnostics	  Ltd.,	  October	  2009).	  Briefly,	  DNA	  was	  fragmented	  by	  nebulisation,	   and	   the	   four	   libraries	   tagged	   with	   unique	   multiplex	   identifier	  adaptors,	  allowing	  them	  to	  be	  processed	  as	  one	  pooled	  library.	  This	  library	  was	  analysed	  for	  average	  fragment	  size	  and	  concentration	  using	  the	  high	  sensitivity	  DNA	  kit	  and	  2100	  Bioanalyser	  (Agilent	  Technologies	  Ltd.,	  Santa	  Clara,	  USA).	  DNA	  concentration	   was	   optimised	   for	   emPCR	   (emulsion	   PCR),	   to	   obtain	   optimum	  bead	   enrichment	   of	   around	   8%,	   and	   finally	   emPCR	  was	   conducted	   to	   produce	  enriched	  beads	   for	  sequencing.	  These	  enriched	  beads	  were	  then	  taken	   forward	  for	   sequencing,	   as	   described	   in	   the	   Roche	   GS	   FLX	   Titanium	   Series	   Sequencing	  Method	   Manual	   (Roche	   Diagnostics	   Ltd.,	   October	   2009).	   Initial	   assembly	   of	  sequences	  was	  done	  using	  the	  GS	  de	  novo	  Assembler	  (Newbler)	  program	  (Roche	  Diagnostics	  Ltd).	  	  
4.2.2 Contig	  closing	  Initial	  assembly	  produced	  contigs	  of	  varying	  size	  for	  the	  four	  plasmids.	  PCR	  was	  used	   to	   join	   contigs	   together	   and	   circularise	   the	   sequences	   of	   p24456	   and	  pCow63.	  Primers	  were	  designed	  using	   existing	   contig	   sequences,	  with	  primers	  directed	  outwards	  from	  the	  contig	  ends,	   testing	  all	  possible	  contig	   joins.	  Contig	  orientations	   were	   altered	   using	   Geneious	   (Biomatters	   2012),	   and	   primers	  designed	   using	   Primer3	   (Rozen	   &	   Skaletsky	   2000).	   Table	   4.1	   gives	   primer	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sequences	   and	   individual	  melting	   temperatures	   (Tm).	   	   Annealing	   temperatures	  were	  determined	  for	  each	  primer	  pair	  combination	  by	  subtracting	  5°C	  from	  the	  mean	   Tm.	   For	   full	   PCR	   protocol	   and	   conditions	   see	   Chapter	   2,	   Section	   2.2.1.	  Primer	   combinations	   that	   produced	   a	   product	   were	   then	   sequenced.	   The	   PCR	  products	  were	  cleaned	  up	  using	  Exo1	  (Fisher	  Scientific)	  and	  TSAP	  (Promega	  UK)	  both	   at	   final	   concentration	   0.045	   units	   μl-­‐1.	   Clean	   up	  mixes	  were	   incubated	   at	  37°C	   for	   30	   minutes,	   followed	   by	   80°C	   for	   15	   minutes.	   Sequencing	   reactions	  were	   conducted	   using	   BigDye®	   terminator	   v3.1	   cycle	   sequencing	   kit	   (Life	  Technologies	   Ltd.)	   with	   both	   forward	   and	   reverse	   diagnostic	   primers.	   Cycling	  conditions	  were	  as	  follows:	  96°C	  for	  1minute,	  followed	  by	  25	  cycles	  of:	  96°C	  for	  10	  seconds,	  50°C	   for	  5	   seconds,	  60°C	  or	  4	  minutes.	   Sequencing	   reactions	  were	  cleaned	   up	   using	   ethanol/sodium	   acetate	   precipitation.	   The	   sequencing	   runs	  were	  conducted	  by	  AHVLA	  Scientific	  (AHVLA,	  Weybridge,	  UK).	  	  	  	  
Plasmid	   Name	   Sequence	  (5’-­‐3’)	   Tm	  (°C)	  	  p24456	   contig	  1	  F	   CCCAGCAGATCTGAGAGTCC	   61.4	  contig	  1	  R	   AAATGATTTTCACCGGCAAG	   53.2	  contig	  2	  F	   ACGGATGCACCTGAACTACC	   59.4	  contig	  2	  R	   GCAAGTTCAGAGGCAGGAAC	   59.4	  	  	  	  pCow63	  
contig	  1	  F	   AGCGCAGGATGTGAGCTAAT	   57.3	  contig	  1	  R	   GTACGGGCTGCTATCTCTGC	   61.4	  contig	  2	  F	   CGTAATTACCACCGGCAGAT	   57.3	  contig	  2	  R	   GATTGAATGCCCCTTGAGAA	   55.3	  contig	  3	  F	   CCTGGATGCGACAGGTAAAT	   57.3	  contig	  3	  R	   GCCTCTGTAAGCCTTTTTCG	   57.3	  contig	  4	  F	   CAGACCAGTTGGCAGAATCA	   57.3	  contig	  4	  R	   GGTGAAAGATCCCCCTGTT	   57.3	  
	  
Table	  4.1:	  Contig	  closing	  primer	  sequences	  with	  melting	  temperatures.	  	  
4.2.3 Sequence	  analysis	  All	   contigs	   larger	   than	   1000	   bp	   were	   screened	   using	   NCBI	   Nucleotide	   BLAST	  (http://blast.ncbi.nlm.nih.gov/Blast.cgi)	  to	  exclude	  chromosomal	  contamination.	  Contigs	   were	   excluded	   only	   if	   BLAST	   matches	   were	   clearly	   chromosomal	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contaminants	   i.e.	   top	  10	  matches	  having	  high	   identity	   (>95%)	   to	  chromosomal	  loci,	   and	   no	   plasmid	  matches	   present.	   	  Matches	   to	   phage	   or	   transposon	   genes	  were	   retained	   at	   this	   stage.	   Contigs	   smaller	   than	   1000	   bp	   were	   excluded.	  Alignment	   of	   contigs	   and	   contig-­‐closing	   sequences	   were	   carried	   out	   using	  Geneious	  (Biomatters	  2012).	  	  	  Sequence	   and	   structural	   homology	   between	   the	   partially	   closed	   plasmid	  sequences	  and	  pCT	  was	  assessed	  using	  Mauve	  (Darling	  et	  al.	  2010).	  Annotation	  of	  the	  sequences	  was	  carried	  out	  using	  RAST	  (Overbeek	  et	  al.	  2014)	  and	  Artemis	  (Rutherford	   et	   al.	   2000;	   Berriman	   &	   Rutherford	   2003),	   and	   sequences	   were	  visualised	   using	   DNAPlotter	   (Carver	   et	   al.	   2009).	   In	   addition,	   the	   sequence	   of	  pCow63	  was	  uploaded	  to	  the	  Joint	  Genome	  Institute’s	  (JGI)	  Integrated	  Microbial	  Genomes	   (IMG)	   database	   (Markowitz	   et	   al.	   2014),	   which	   provides	   annotation	  and	  comparison	   tools,	   facilitating	  comparison	  with	  genomes	  and	  metagenomes	  held	  in	  the	  database.	  This	  also	  allowed	  comparison	  between	  the	  IMG	  and	  RAST	  annotations	  of	  pCow63.	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4.3 Results	  
4.3.1 Plasmid	  identification	  Plasmids	  of	  appropriate	  size	  (~93	  Kb)	  were	  successfully	  isolated	  from	  the	  four	  E.	  
coli	  strains	  (Figure	  4.2).	  The	  gel	  shows	  two	  bands	  of	  high	  Mw	  (above	  the	  10	  Kb	  marker)	   for	   all	   strains,	   probably	   due	   to	   the	   supercoiled	   and	   open	   circular	  plasmid	   formations.	  Extractions	   from	  Cow63	  and	  Cow23	  have	  additional	   lower	  Mw	  bands	   at	   around	  4	  Kb	  and	  1	  Kb	   respectively,	   due	   either	   to	   the	  presence	  of	  additional	   small	   plasmids	   in	   the	   extraction,	   or	   to	   contamination	   with	   small	  genomic	   DNA	   fragments.	   	   Genomic	   and	   small	   plasmid	   contaminants	   were	  excluded	  after	  sequencing.	  	  	  
	  
Figure	  4.2:	  Gel	  showing	  plasmid	  extractions	  from	  E.	  coli	  strains.	  pCT	  	  is	  included	  for	  comparison,	  and	  is	  approximately	  93	  Kb.	  Lane	  1	  contains	  2-­‐log	  ladder	  (NEB).	  
	  
4.3.2 pCow52/24456	  assembly	  	  Sequence	   assembly	   with	   the	   GS	   de	   novo	   assembler	   (Roche	   Diagnostics	   Ltd.)	  produced	  one	   large	  contig	  of	  103643	  bp	  for	  pCow52	  and	  two	  contigs	  of	  85629	  bp	  and	  18013	  bp	  for	  p24456	  (total	  length	  103642	  bp).	  All	  but	  one	  of	  the	  smaller	  contigs	  (>1000	  bp)	  were	  identified	  as	  genomic	  contamination	  using	  BLAST	  and	  were	   therefore	   excluded.	   p24456	   had	   one	   1250	   bp	   contig	   identified	   as	   a	  transposase/prophage	  DNA.	  The	  Mauve	  alignment	  indicates	  very	  high	  homology	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between	  pCow52	  and	  p24456	  (Figure	  4.4,	  rows	  1	  and	  2),	  with	  the	  exception	  of	  the	  smallest,	  1250	  bp,	  contig	  of	  p24456.	  Subsequent	  Geneious	  alignment	  showed	  just	   four	   SNPs	   between	   p24456	   and	   pCow52.	   Three	   of	   these	   were	   additional	  nucleotides	   in	   single-­‐base	   runs,	   located	   in	   the	   pCow52	   plasmid	   at	   bases	   6310	  (A),	  92630	  (T)	  and	  99949	  (T).	  These	  single	  base	  runs	  are	  likely	  to	  be	  error	  prone	  both	   within	   the	   cell	   and	   in	   the	   sequencing	   run.	   There	   is	   just	   one	   transition	  substitution;	  an	  A	  in	  pCow52	  at	  position	  base	  8639	  replaces	  a	  G	  in	  p24456.	  	  	  Contig	  closing	  PCR	  and	  sequencing	  successfully	   joined	  contig	  1	  (85629	  bp)	  and	  contig	   2	   (18013	   bp)	   of	   p24456,	  with	   primers	   contig	  1	  F	   and	   contig	  2	  R	  (Table	  4.2),	   producing	   a	   432	   bp	   sequencing	   product	   which	   perfectly	   aligned	   to	   the	  contigs	  1	  and	  2,	  creating	  a	  linear	  plasmid	  (Figure	  4.3).	  Although	  primers	  contig	  1	  
R	   and	  contig	  2	  F	  did	  produce	  a	  PCR	  product,	   sequencing	   from	  the	   forward	  and	  reverse	   primers	   did	   not	   overlap,	   so	   it	   is	   not	   possible	   to	   confirm	   this	   join.	  Unfortunately	  the	  alignment	  with	  pCow52	  also	  fails	  to	  confirm	  this	  join,	  as	  there	  are	  just	  four	  bases	  of	  potential	  overlap	  between	  the	  contig	  ends.	  Further	  PCR	  and	  sequencing	  is	  required	  to	  fully	  circularise	  this	  plasmid.	  
	  
Figure	  4.3:	  Contig	  closing	  of	  p24456.	  This	  figure	  shows	  the	  alignment	  of	  concatenated	  contigs	  1	  &	  2	  (top),	  with	  the	  432	  bp	  consensus	  sequence	  produced	  by	  primers	  contig	  1	  F	  and	  contig	  2	  R	  (bottom).	  	  The	  fact	  that	  PCR	  products	  were	  generated	  with	  both	  primer	  sets,	  joining	  contigs	  1	   and	   2,	   and	   that	   BLAST	   identification	   suggested	   phage	   or	   transposase	   DNA	  indicates	   that	   contig	   3	   (1250	   bp)	   is	   not	   part	   of	   this	   plasmid,	   and	   is	   probably	  genomic,	  small	  plasmid	  or	  phage	  contamination.	  From	  this	  we	  can	  conclude	  that	  these	   plasmids	   are	   the	   same,	   and	   henceforth	   will	   be	   referred	   to	   as	  pCow52/24456.	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Figure	  4.4:	  Mauve	  alignment	  of	  plasmid	  sequences.	  Each	  horizontal	  line	  represents	  a	  plasmid	  sequence,	  from	  top	  to	  bottom	  these	  are:	  p24456,	  pCow52,	  pCow63,	  pCow23,	  pCT05	  and	  pCH03.	  pCT05	  is	  the	  sequence	  of	  the	  resistance	  plasmid	  pCT,	  and	  pCH03	  is	  an	  unrelated	  plasmid	  sequence	  for	  comparison	   (from	   a	   chicken	   isolate	   carrying	   the	   β-­‐lactamase	   CTX-­‐M-­‐1;	   not	   linked	   to	   the	   outbreak	   farm	   in	   this	   study,	   R.	   J.	   Ellis,	   personal	  communication).	  Coloured	  blocks	  indicate	  regions	  of	  alignment	  between	  sequences,	  the	  colour	  intensity	  within	  the	  blocks	  represents	  the	  similarity	  profile;	  the	  average	  level	  of	  conservation	  in	  that	  region	  of	  the	  genome	  sequence.	  Connector	  lines	  join	  corresponding	  blocks	  in	  different	  sequences.	  Blocks	  above	   the	  centre	   line	  align	   in	   the	   forward	  direction,	  and	  blocks	  below	  the	   line	  align	   in	   the	  reverse	  orientation.	  Red	  vertical	   lines	  separate	  contigs.
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4.3.3 Features	  of	  pCow52/24456	  RAST	   identified	   128	   coding	   sequences	   (CDS)	   in	   pCow52/24456,	   whereas	  Artemis	   detected	   228	   CDS.	   This	   disparity	   is	   largely	   explained	   by	   102	   CDS	  categorised	   as	   ‘no	   product’	   by	   Artemis.	   Figure	   4.5	   shows	   all	   CDS	   identified	   by	  Artemis,	  with	  some	  key	  features	  marked.	  The	  following	  sections	  highlight	  some	  key	  plasmid	  maintenance	  and	  virulence	  genes	  identified	  on	  pCow52/24456	  and	  the	  other	   two	  plasmids,	  but	   these	  are	  not	  exhaustive	   lists.	  For	  a	   full	   list	  of	  CDS	  identified	  by	  RAST	  for	  all	  plasmids,	  please	  see	  Appendix	  1.	  	  Surprisingly,	   pCow52/24456	   is	   not	   an	   IncK	   incompatibility	   group	   plasmid,	   as	  indicated	  by	  previous	  work	  (M.	  O.	  Stokes,	  personal	  communication).	  It	  is	  in	  fact	  an	   IncF	   plasmid,	   carrying	   replication	   proteins	   repA1	   and	   repA3	   of	   FII	   replicon	  and	  repE	  of	  FIA	   replicon	   (Villa	   et	   al.	   2010).	  pCow52/24456	  carries	  28	  plasmid	  transfer	   genes	   (22	   tra	   and	   6	   trb	   genes),	  with	   almost	   identical	   structure	   to	   the	  standard	   IncF	   transfer	   region	   (Willetts	   &	   Skurray	   1980;	   Lawley	   et	   al.	   2004).	  Artemis,	   but	   not	   RAST,	   detected	   the	   traS	   gene	   and	   curiously	   neither	   detected	  
trbA.	   BLAST	   searching	   of	   the	   region	  where	   trbA	   should	   be	   (between	   traQ	   and	  traF)	  also	  failed	  to	  identify	  any	  genes.	  TrbA	  is	  of	  unknown	  function,	  and	  insertion	  mutations	  within	  this	  gene	  do	  not	  significantly	  affect	  transfer	  ability,	  suggesting	  that	  pCow52/24456	   is	   likely	   to	  be	   conjugative	   (Frost	   et	   al.	   1994;	  Lawley	  et	   al.	  2004).	  Several	  other	  archetypal	  plasmid	   features	  were	   identified	   including:	   the	  classical	  toxin/antitoxin	  plasmid	  addiction	  system	  ccdA/ccdB	  (Kobayashi	  2004);	  the	   plasmid	   partitioning	   proteins	  parA/parB	   	   (Funnell	   &	   Slavcev	   2004);	   and	   a	  common	   feature	   of	   IncF	   plasmids,	   the	   non-­‐essential	   but	   highly	   conserved	   ssb,	  single	   stranded	   binding	   protein,	   and	   psiA/B	   SOS	   stress	   response	   inhibitor	  (Lawley	   et	   al.	   2004).	   Neither	   annotation	   program	   identified	   the	   partitioning	  related	   site	   parS	   which	   should	   be	   located	   downstream	   of	   parA/parB	   and	   is	  essential	   for	   plasmid	   stability.	   RAST	   also	   identified	   an	   ABC-­‐type	   bacteriocin	  transporter	  protein,	   however	   sequence	   searching	  with	   the	  BAGEL3	  bacteriocin	  mining	  software	  failed	  to	  identify	  any	  bacteriocin	  genes	  (van	  Heel	  et	  al.	  2013).	  In	  addition	   to	   these	   plasmid	  maintenance	   genes,	   pCow52/24456	   also	   carries	   the	  iron	  scavenging	  operon,	   iroA,	  at	  position	  8589-­‐18156,	  which	  encodes	  genes	   for	  salmochelin	  siderophore	  production	  and	  uptake	  (Lin	  et	  al.	  2005).	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Figure	   4.5:	   pCow52/24456.	   All	   coding	   sequences	   (CDS)	   detected	   by	   Artemis	   are	  shown	  in	  turquoise.	  The	  inner	  row	  highlights	  some	  genes	  of	  interest.	  Dark	  blue:	  plasmid	  transfer;	   Light	   blue:	   plasmid	   maintenance/replication;	   Orange:	   virulence;	   Red:	   Rep	  genes;	   Green:	   miscellaneous	   other.	   The	   graphs	   indicate	   sequence	   GC	   ratio:	   purple	   <	  average,	  yellow	  >	  average.	  	  	  
4.3.4 Assembly	  and	  features	  of	  pCow23	  	  Sequencing	   of	   pCow23	   produced	   22	   contigs	   of	   plasmid	   origin	   >1000	   bp,	   with	  four	   >10000	   bp,	   the	   largest	   of	   these	   being	   30121	   bp,	   and	   a	   total	   length	   of	   >	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160000	   bp.	   Contig	   closing	   was	   not	   attempted	   for	   pCow23	   due	   to	   the	   large	  number	   of	   contigs,	   and	   it	  was	   therefore	   analysed	   as	   a	   concatenated	   sequence.	  The	  Mauve	   alignment	   shows	   large	   regions	   of	   homology	   between	   pCow23	   and	  pCow52/24456,	  particularly	   in	   the	   red,	   fuschia	   and	   teal	   coloured	  boxes,	  which	  also	  show	  some	  homology	  to	  pCT	  (Figure	  4.4,	  row	  4).	  This	  alignment	  also	  shows	  13	   contigs	  with	   no	   homology	   to	   the	   other	   plasmids.	   Although	  BLAST	   searches	  identified	   all	   of	   these	   contigs	   as	   being	   of	   plasmid	   origin,	   the	   initial	   plasmid	  extraction	  showed	  two	  bands	  of	  approximately	  4	  Kb.	  It	   is	  possible	  that	  some	  of	  these	   contigs	   represent	   smaller	   plasmid	   contamination.	   However,	   the	   unique	  sequence	  represents	  approximately	  60	  Kb,	  and	  it	  seems	  unlikely	  that	  this	  would	  be	  entirely	  the	  result	  of	  contamination	  with	  a	  4	  Kb	  plasmid.	  	  	  As	   with	   pCow52/24456,	   RAST	   annotation	   identified	   fewer	   CDS	   than	   Artemis	  annotation,	   just	  211	  compared	   to	  366.	  However,	  260	  of	   these	  were	  designated	  ‘no	  product’,	  and	  only	  2	  potential	  gene	  products	  were	  identified	  outside	  the	  four	  largest	   contigs	   (1-­‐4,	   respectively	   30121,	   23107,	   18219	   and	   13852	   bp).	   Like	  pCow52/24456,	  pCow23	   is	   an	   IncF	  plasmid,	   carrying	   repA1	   of	   the	  FII	   replicon	  
and	   repE	  of	   FIA	   replicon,	  but	  unlike	  pCow52/24456	   it	   also	   carries	   repA	   of	   FIB	  replicon	   (Villa	   et	   al.	   2010).	   pCow23	   carries	   an	   almost	   complete	   IncF	   transfer	  region,	  split	  across	  contig	  1,	  traX-­‐	  traN,	  and	  contig	  4,	  traC-­‐	  traM.	  There	  is	  just	  one,	  non-­‐essential,	  gene	  missing;	  trbG,	  and	  there	  are	  two	  copies	  of	  both	  traM	  and	  traC	  (Lawley	  et	  al.	  2004).	  The	  division	  of	   the	   transfer	  region	  across	  contigs	  1	  and	  4	  suggests	  that	  perhaps	  these	  contigs	  should	  be	  joined.	  	  	  There	  are	  several	  other	  similarities	  between	  pCow23	  and	  pCow52/24456:	  IncF	  features	   such	   as	   ssb	  and	   psiA/B;	   the	   stability	   locus	   of	   IncFII	   plasmid	   NR1	   and	  RepA2	  copB	  regulatory	  protein	  (Tabuchi	  et	  al.	  1992;	  Tabuchi	  et	  al.	  1988;	  Dong	  et	  al.	   2004);	   and	   the	   toxin/antitoxin	   system	   ccdA/ccdB.	  pCow23	   also	   appears	   to	  have	  a	  second	  post-­‐segregational	  killing	  system,	  mvpT/mvpA,	  located	  within	  the	  
trbH	  region,	  as	  described	  by	  Sayeed	  et	  al.	  (2000).	  Other	  plasmid-­‐associated	  genes	  were	   also	   identified,	   including	   the	   DNA	   binding	   protein,	   artA,	  which	   regulates	  horizontal	   and	   vertical	   plasmid	   transmission	   (Ni	   et	   al.	   2009),	   and	   the	   error-­‐prone	  DNA	  polymerase	  V,	  umuC,	  (the	  plasmid	  version	  is	  called	  mucB	  (Goldsmith	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et	  al.	  2000))	  which	  is	  involved	  in	  stress	  response	  (P.	  Reuven	  &	  Eldar	  2011;	  N.	  B.	  Reuven	   et	   al.	   1999;	   Maor-­‐Shoshani	   et	   al.	   2000).	   In	   addition,	   RAST	   annotation	  identified	  a	  colicin	  D	  gene	  on	  contig	  7	  (position	  738-­‐	  2381),	  which	  was	  confirmed	  using	   BAGEL3	   (van	   Heel	   et	   al.	   2013)	   (Figure	   4.6).	   Although	   the	   BAGEL3	  annotation	  calls	  ORF	  008	   ‘Pyocin	  S’,	  BLAST	  searching	  confirms	   that	   it	   is	   in	   fact	  colicin	   D	   (Roos	   et	   al.	   1989).	   The	   S-­‐type	   pyocins	   of	   Pseudomodas	   pyogenes	   are	  highlight	  similar	  to	  colicins	  in	  their	  domain	  structure,	  so	  this	  is	  the	  likely	  cause	  of	  confusion	  in	  annotation	  (Cascales	  et	  al.	  2007).	  ORF	  003	  of	  contig	  7	  encodes	  the	  essential	  colicin	  immunity	  gene.	  	  
	  
Figure	   4.6:	   pCow23	   contig	   7	   carries	   colicin	  B.	  ORF	  008	  encodes	  colicin	  B,	  and	  ORF	  003	  the	  corresponding	  colicin	  immunity	  gene.	  Image	  produced	  using	  BAGEL3	  (van	  Heel	  et	  al.	  2013).	  	  Alongside	   these	   plasmid	  maintenance	   genes,	   pCow23	   also	   carries	   a	   number	   of	  virulence-­‐associated	   genes:	   the	   putative	   fluoride	   ion	   transporter/camphor	  resistance	  gene	  crcB	  (Sand	  2003);	  the	  Salmonella	  virulence	  genes	  vagC	  and	  vagD	  	  (Pullinger	  &	  Lax	  1992);	   the	  manganese	  uptake	  operon	  sitA,	  -­‐B,	  -­‐C,	  -­‐D	   (Davies	  &	  Walker	  2007;	   Sabri	   2006);	   the	   aerobactin	   siderophore	   synthase	   genes,	   iucA/D,	  	  and	  a	  partial	  siderophore	  receptor	  operon	  iutA	  (de	  Lorenzo	  et	  al.	  1986);	  the	  	  K88	  fimbrial	   genes	   faef,	   -­‐g,	   -­‐h,	   -­‐i,	   -­‐j,	   associated	   with	   binding	   to	   the	   pig	   intestine	  (Bakker	   et	   al.	   1992);	   and	   finally	   espC,	   an	   enterotoxin	   associated	   with	   EPEC	  (enteropathogenic	  E.	  coli)	  strains	  (Salinger	  et	  al.	  2008).	  	  	  Multiple	  gene	  copies	  are	  present	  on	  pCow23.	  This	  repetition	  is	  likely	  due	  to	  the	  large	  number	  of	  contigs	  that	  have	  not	  been	  successfully	  closed.	  Re-­‐sequencing	  of	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the	  plasmid	  would	   allow	   contigs	   to	  be	   assembled	  more	   completely,	   and	  would	  identify	  true	  gene	  duplications.	  	  	  
	  
Figure	   4.7:	   pCow23.	   Orange/brown	   line	   indicates	   individual	   contigs.	   All	   coding	  sequences	  (CDS)	  detected	  by	  Artemis	  are	  shown	  in	  turquoise.	  The	  inner	  row	  highlights	  some	   genes	   of	   interest.	   Dark	   blue:	   plasmid	   transfer;	   Light	   blue:	   plasmid	  maintenance/replication;	   Orange:	   virulence;	   Red:	   Rep	   genes;	   Green:	   miscellaneous	  other.	  The	  graphs	  indicate	  sequence	  GC	  ratio:	  purple	  <	  average,	  yellow	  >	  average.	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4.3.5 Assembly	  and	  features	  of	  pCow63	  	  Sequencing	  of	  pCow63	  produced	  four	  contigs	  of	  88710,	  3176,	  1551	  and	  670	  bp.	  Contig	   joining	  PCR	   and	   sequencing	   connected	   contigs	   2,	   4	   and	  1	   in	   that	   order.	  Successful	  primer	  pairs	  and	  their	  resulting	  product	  sizes	  are	  given	  in	  Table	  4.2.	  Sequencing	   of	   the	   product	   from	   contig	   1	   F	   and	   contig	   2	   R	   primers	   was	  inconclusive,	   as	   sequencing	   from	   the	   forward	   and	   reverse	   primers	   did	   not	  overlap.	  However,	  primers	  designed	  for	  contig	  3	  (Table	  4.1)	  formed	  no	  product	  with	   any	   other	   primer.	   	   It	   therefore	   seems	   likely	   that	   contigs	   1	   and	   2	   are	  contiguous.	   This	   could	   be	   confirmed	   with	   further	   PCR	   and	   sequencing.	   Given	  these	   results,	   the	   1551	   bp	   contig	   3	   was	   excluded	   from	   further	   analysis	   of	  pCow63,	   giving	   a	   total	   length	   92556	   bp.	   The	   plasmid	   extraction	   (Figure	   4.2)	  shows	  a	  band	  of	  approximately	  1	  Kb.	  It	  is	  possible	  that	  this	  corresponds	  to	  contig	  3,	   and	  may	  be	  a	   smaller	  plasmid	  present	   in	   the	  extraction.	  RAST	  annotation	  of	  this	  contig	   identified	   just	  three	  CDS;	  two	  hypothetical	  proteins	  and	  the	  plasmid	  replication	  associated	  gene,	  repA,	  indicating	  that	  this	  is	  indeed	  plasmid	  DNA.	  	  
Primer	  1	   Primer	  2	   Product	  (bp)	  Contig	  2	  F	   Contig	  4	  R	   677	  Contig	  4	  F	   Contig	  1	  R	   752	  Contig	  1	  F	   Contig	  2	  R	   1300	  
	  
Table	  4.2:	  Contig	  joining	  primers	  for	  pCow63.	  	  The	  uniqueness	  of	  pCow63	  can	  clearly	  be	  seen	   in	   the	  Mauve	  alignment	  (Figure	  4.4,	  row	  3).	  It	  shows	  almost	  no	  homology	  with	  the	  other	  plasmids	  in	  this	  study,	  with	   pCT05	   or	   with	   pCH03.	   BLAST	   searches	   reveal	   that	   it	   also	   has	   very	   little	  homology	  with	   other	   sequenced	   plasmids.	   pCow63	  was	   annotated	   using	   RAST	  and	  also	  the	  JGI	  IMG/ER	  annotation	  pipeline.	  The	  outcomes	  of	  the	  two	  tally	  well,	  with	   RAST	   identifying	   117	   CDS	   (contig	   4	   was	   omitted	   in	   error),	   and	   IMG/ER	  identifying	   122	   (Figure	   4.8).	   Just	   18	   of	   these	   were	   genes	   encoding	   known	  proteins	   or	   functions,	   33	   CDS	   were	   of	   phage	   or	   pro-­‐phage	   origin	   and	   the	  remainder	  were	  hypothetical	  proteins	  and	  genes	  with	  unknown	  functions.	  Very	  few	  common	  plasmid	  features	  were	  identified:	  the	  repE	  gene	  of	  the	  FIA	  replicon,	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and	  the	  FIC	  replicon	  associated	  repL	  gene,	   the	  plasmid	  stability	  genes	  parA	  &	  B	  and	   two	   separate	   toxin/antitoxin	   loci:	   phd/doc	   and	   higA/B	   (Figure	   4.8).	   The	  
phd/doc	  addiction	  system	  is	  associated	  with	  prophage	  P1,	  as	  are	  clpX	  and	  xerD.	  
XerD	   is	   a	   phage	   specific	   recombinase	   and	   clpX	   is	   ATP-­‐dependent	   protease,	  involved	   in	   degradation	   of	   the	   doc	   toxin	   (Lehnherr	   &	   Yarmolinsky	   1995;	  Lehnherr	   et	   al.	   1993).	   pCow63	   also	   carries	   genes	   that	   are	   not	   commonly	  associated	   with	   either	   plasmids	   or	   phage	   including	   genes	   for	   glutamate	  metabolism,	   nucleotide	   metabolism	   (dUTPase),	   a	   stomatin/prohibitin-­‐like	  membrane	  protease,	  and	  an	  N6	  adenine-­‐specific	  DNA	  methylase.	  	  	  





	  	  	  
	  
	  
Figure	   4.8:	   pCow63.	   Contigs	   are	   shown	   in	   the	   order	   2,	   4,	   1	   with	   a	   total	   length	   92556	   bp.	   Cream	   colour	   indicates	   genes	   involved	   in	  replication/recombination	  &	  repair,	  but	  the	  majority	  of	  these	  are	  unknown	  or	  hypothetical	  proteins.	  Some	  key	  genes	  identified	  by	  both	  RAST	  and	  IMG/ER	   are	   highlighted	   in	   colour	   and	   gene	  names/products	   given.	  Black	   indicates	  RNA.	   Figure	  produced	  using	   JGI	   IMG/ER	   chromosome	  viewer	  (Markowitz	  et	  al.	  2014).	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4.4 Discussion	  
4.4.1 These	  are	  not	  potential	  ‘cheat’	  plasmids	  Perhaps	   the	   most	   pertinent	   fact	   uncovered	   through	   sequencing	   of	   these	   four	  plasmids	  is	  that	  they	  are	  not	  in	  the	  IncK	  incompatibility	  group,	  and	  are	  therefore	  not	   candidate	   ‘cheat’	   plasmids	   for	   competition	  with	   pCT.	   Both	   pCow52/24456	  and	  pCow23	  are	  IncF	  plasmids.	  It	  is	  likely	  that	  pCow63	  is	  also	  IncF,	  as	  it	  carries	  
repE	   and	   repL	   genes	   associated	   with	   IncF,	   but	   it	   is	   difficult	   to	   draw	   firm	  conclusions	  about	  pCow23	  with	  so	   few	  plasmid-­‐associated	  genes	  to	  work	  with.	  With	   hindsight,	   it	   would	   have	   been	   wise	   to	   ascertain	   the	   plasmids’	  incompatibility	   before	   sequencing,	   perhaps	   using	   the	   replicon	   typing	   PCR	  method	  of	  Carattoli	  et	  al.	  (2005)	  used	  in	  Chapter	  5	  of	  this	  thesis.	  However,	  some	  interesting	   and	   unusual	   features	   were	   found	   in	   these	   plasmids,	   which	   are	  discussed	  below.	  	  
4.4.2 IncF	  plasmids	  and	  virulence	  All	   the	   plasmids	   sequenced	   here	   are	   in	   the	   IncF	   incompatibililty	   group.	   IncF	  plasmids	   are	   generally	   associated	  with	  Enterobacteriaceae,	  and	   are	   one	   of	   the	  most	   common	   plasmid	   types,	   found	   across	   a	   range	   of	  E.	   coli	   hosts	   from	   avian	  pathogenic	  strains	  to	  human	  commensal	  strains	  (Johnson	  et	  al.	  2007).	  They	  are	  usually	  large,	  >100	  Kb,	  often	  carry	  multiple	  replicons,	  and	  have	  been	  associated	  with	  virulence	  genes	  such	  siderophores	  and	  the	  CTX-­‐M-­‐15	  β-­‐lactamase	  (Villa	  et	  al.	  2010).	  pCow52/24456	  and	  pCow23	  fit	  this	  image	  of	  IncF	  plasmids	  well;	  both	  are	   large	   and	   carry	  multiple	   replicons	   and	  virulence	  genes.	  The	   iroA	  operon	  of	  pCow52/24456	   has	   been	   shown	   to	   be	   an	   important	   virulence	   factor	   in	   avian	  pathogenic	   E.	   coli	   strains,	   and	   has	   been	   found	   in	   avian	   CTX-­‐M	   carrying	   E.	   coli	  (Stokes	   et	   al.	   2012;	  Caza	   et	   al.	   2008).	   pCow23	   carries	   a	  multitude	  of	   virulence	  factors,	   including	  siderophore	  and	  manganese	  uptake	  operons,	  as	  well	  as	  EPEC	  associated	   features	   such	   as	   fimbriae	   and	   the	   espC	   entertoxin	   (Salinger	   et	   al.	  2008).	   K88	   fimbriae	   have	   been	   associated	   with	   binding	   to	   the	   pig	   intestine,	  which	   is	   surprising	   given	   that	   this	   is	   a	   plasmid	   isolated	   from	   a	   cattle	   farm	  (Bakker	  et	  al.	  1992).	  However,	  further	  information	  about	  other	  livestock	  on	  the	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farm	  is	  not	  available,	  so	  it	  is	  not	  possible	  to	  determine	  whether	  this	  plasmid	  may	  have	   transferred	   from	   another	   host	   animal,	   or	   whether	   these	   fimbriae	   are	  present	   in	   bovine	   enteric	   E.	   coli.	   Phenotype	   or	   gene-­‐expression	   assays	   are	  required	   to	   determine	   which	   (if	   any)	   of	   the	   virulence	   genes	   identified	   are	  functional,	  especially	  for	  those	  genes	  that	  appear	  to	  be	  in	  partial	  operons,	  such	  as	  the	  pCow23	  aerobactin	  uptake	  operon.	  Further	  information	  about	  the	  plasmids’	  host	   strains	  would	   also	   be	   useful	   for	   determining	   the	   functionality	   of	   plasmid	  genes.	  However,	   these	  strains	  were	   isolated	  from	  the	  site	  of	  a	  veterinary	  E.	  coli	  outbreak	  (Liebana	  et	  al.	  2006),	  so	  it	  seems	  likely	  that	  there	  may	  be	  other	  virulent	  strains	  present.	  	  	  
4.4.3 pCow63	  is	  unique	  pCow63	   appears	   to	   be	   a	   unique	  plasmid.	   It	   shows	   little	   similarity	   to	   the	   other	  plasmids	  in	  this	  study,	  and	  carries	  few	  genes	  of	  known	  function.	  It	  appears	  to	  be	  largely	  comprised	  of	  phage-­‐associated	  DNA,	  with	  very	  few	  plasmid	  maintenance	  genes	   and	   no	   discernable	   host	   beneficial	   genes.	   The	   functional	   genes	   it	   does	  carry	   appear	   to	   be	   a	   mishmash	   of	   bacterial	   metabolic	   genes	   that	   are	   not	  generally	  carried	  on	  plasmids.	  This	  could	  be	  a	  result	  of	  recombination	  with	  the	  host,	   or	   it	   is	   possible	   that	   these	   genes	   were	   transposed	   via	   faulty	   phage	  replication	  and	  insertion.	  Although	  pCow63	  is	  not	  a	  candidate	  ‘cheat’	  plasmid	  for	  pCT,	  as	  it	  is	  not	  IncK,	  it	  could	  potentially	  be	  a	  cheat	  plasmid	  in	  another	  system,	  as	  it	   does	   not	   carry	   any	   virulence	   or	   resistance	   genes.	   It	   is	   also	   an	   example	   of	   a	  potential	  cryptic	  plasmid:	  a	  plasmid	  that	  confers	  no	  apparent	  benefit	  to	  its	  host.	  Curing	   the	   host	   strain	   of	   pCow63	   and	   comparing	   any	   fitness	   changes	   could	  confirm	  this.	  Sequencing	  of	   this	  plasmid	  highlights	   just	  how	  little	  we	  still	  know	  about	  plasmids:	  what	   is	   its	   function	  (if	  any)?	  How	   is	   it	  maintained?	  Why	  has	   it	  not	  been	  lost?	  These	  themes	  are	  discussed	  further	  in	  Chapter	  6	  of	  this	  thesis.	  	  
4.4.4 Conclusions	  and	  outlook	  This	  study	  has	  identified	  two	  IncF	  plasmids,	  pCow52/24456	  and	  pCow23,	  and	  a	  novel	   plasmid,	   pCow63,	   from	   the	   same	   sample	   site	   as	   the	   IncK	   CTX-­‐M-­‐14	  carrying	   plasmid,	   pCT.	   The	   variation	   found	   in	   this	   study	   demonstrates	   the	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diversity	   of	   plasmids	   being	   sustained	   by	   the	  E.	   coli	  population	   at	   the	   isolation	  farm.	   The	   fact	   that	   both	   resistance	   and	   non-­‐resistance	   plasmids,	   and	  multiple	  plasmids	   of	   the	   same	   incompatibility	   group	   are	   maintained	   is	   an	   interesting	  observation	   about	   the	   ability	   of	   bacterial	   populations	   to	   sustain	   plasmid	  ‘parasites’.	   It	   is	   also	   interesting	   to	   note	   that	   pCow52/24456	   is	   found	   in	   both	  veterinary	   (Cow52)	   and	   environmental	   (24456)	   isolates,	   indicating	   that	  plasmids	  may	  pass	  between	   these	  distinct	   communities.	   Further	   contig	   joining	  and	  re-­‐sequencing	  is	  required	  to	  complete	  the	  sequencing	  of	  these	  plasmids,	  but	  as	  draft	  sequences	  they	  can	  still	  provide	  insights	  into	  the	  plasmid	  diversity	  of	  the	  outbreak	   farm.	  Although	  not	   possible	  within	   the	   scope	   of	   this	   thesis,	   curing	   of	  pCow63	  carrying	  strains	  coupled	  with	  gene	  knockouts	  and	  phenotypic	  analysis	  could	  yield	  interesting	  results	  about	  the	  unknown	  features	  of	  this	  plasmid.	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Chapter	  5: Plasmid	  field	  study	  	  	  
5.1 Introduction	  	  
5.1.1 Plasmid	  communities	  Disease-­‐causing	  bacteria	  are	  a	  research	  priority,	  so	  it	  is	  understandable	  that	  the	  majority	   of	   plasmid	   population	   studies	   have	   focussed	   on	   clinically	   relevant	  plasmids,	   in	  particular	   those	   carrying	  virulence	  genes	  and	  antibiotic	   resistance	  (Johnson	   &	   Nolan	   2009;	   Carattoli	   2011;	   Marcade	   et	   al.	   2008;	   Pallecchi	   et	   al.	  2007;	   Dröge	   et	   al.	   2000;	   Hopkins	   et	   al.	   2006).	   In	   addition,	  many	   studies	   have	  relied	   on	   selectable	  markers,	   such	   as	   antibiotic	   or	   heavy	  metal	   tolerance,	   or	   a	  specific	   metabolic	   pathway,	   to	   isolate	   bacteria	   and	   plasmids.	   For	   example,	  Burton	  et	  al.	  (1982)	  isolated	  plasmids	  from	  polluted	  and	  unpolluted	  river	  sites,	  but	  selected	  for	  host	  bacteria	  able	  to	  tolerate	  pollution-­‐mimicking	  media,	  and	  so	  excluded	   any	   strains	   (and	   therefore	   plasmids),	   which	   were	   not	   pollution	  tolerant.	   Although	   this	   probably	   produced	   a	   representative	   sample	   from	   the	  polluted	  site,	  it	  is	  less	  good	  for	  the	  unpolluted	  site.	  Few	  studies	  have	  investigated	  plasmid	   populations	   in	   a	   ‘natural’	   setting,	   that	   is,	   a	   non-­‐clinical	   environment	  without	  selection	  for	  specific	  traits.	  	  	  One	  such	  study,	  which	  non-­‐selectively	  examined	  plasmid	  populations	   from	  soil	  and	  fresh	  water	  found	  that	  overall	  plasmid	  presence	  was	  not	  evenly	  distributed	  across	   populations:	   in	   each	   environment,	   one	   host	   subgroup	   had	   very	   high	  plasmid	   prevalence	   (up	   to	   100%),	   and	   contained	   multiple	   plasmids,	   whereas	  other	  strains	  carried	  no	  plasmids	  at	  all	  (Beilstein	  et	  al.	  2008).	  This	  may	  indicate	  that	   some	   strains	   are	  more	   successful	   plasmid	   recipients	   and/or	   are	   better	   at	  retaining	   plasmids,	   corroborating	   the	   findings	   of	   Gordon	   (1992),	   who	  demonstrated	  that	  the	  number	  of	  native	  plasmids	  in	  a	  strain	  affects	  its	  ability	  to	  receive	  further	  plasmids:	   the	  presence	  of	  small	  plasmids	   increased	  the	  transfer	  rate,	  whereas	   presence	   of	   large	   plasmids,	   or	   indeed	   no	   plasmids,	   decreased	   it.	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Sobecky	   and	   coworkers	   (Cook	  et	   al.	   2001;	   Sobecky	  2002;	   Sobecky	   et	   al.	   1997)	  have	   studied	   marine	   plasmid	   communities	   extensively,	   finding	   variation	   in	  plasmid	  prevalence	   across	   sites	   and	  over	   time,	   	   and	   a	   bi-­‐modal	   distribution	   of	  plasmid	   size,	   with	   small	   and	   large	   plasmids	   the	   most	   prevalent,	   echoing	   the	  results	  of	  Beilstein	  et	  al.	  (2008)	  and	  Gordon	  (1992).	  	  	  pMLST	   (plasmid	   multi	   locus	   sequence	   typing)	   has	   been	   used	   to	   identify	   the	  prevalence	   of	   plasmids	   in	   livestock,	   and	   has	   demonstrated	   the	   presence	   of	  identical	   ESBL	   genes	   and	   plasmids	   in	   livestock	   and	   humans,	   suggesting	   the	  transfer	   of	   bacteria	   and	   plasmids	   through	   the	   food	   chain	   (Dierikx	   et	   al.	   2012;	  Dierikx	  et	  al.	  2010;	  Hordijk	  et	  al.	  2013;	  Hall	  et	  al.	  2011).	  However,	  these	  studies	  selected	  bacteria	  on	  the	  basis	  of	  resistance,	  thus	  excluding	  other	  host	  strains	  and	  plasmids.	   In	  addition,	  some	  sample	  sizes	  were	  small,	  and	  herd	  and	  host	  animal	  replication	   was	   low,	   giving	   little	   indication	   of	   the	   structure	   of	   the	   bacterial	  population	  (Hordijk	  et	  al.	  2013;	  Dierikx	  et	  al.	  2010).	  	  
5.1.2 Plasmids	  within	  hosts	  Plasmids	   do	   not	   exist	   as	   isolated	   entities.	   Smalla	   &	   Sobecky	   (2002)	   state	   that	  “attempts	   to	  assess	   the	  HGP	  [horizontal	  gene	  pool]	  should	   ideally	  be	  combined	  with	  the	  study	  of	  structural	  and	  functional	  diversity	  of	  microbial	  communities”,	  and	   Thomas	   (2004)	   concludes	   that	   future	   research	   must	   enable	   us	   to	  “understand	   better	   how	   plasmids	   interact	   within	   microbial	   communities”.	  Plasmid	  populations	  can	  be	  seen	  as	  analogous	  to	  parasite	  populations	  in	  higher	  organisms,	   where	   it	   is	   recognised	   that	   host	   population	   structure	   can	   have	   a	  major	   impact	   on	   the	   parasites,	   and	   vice	   versa	   (Schmid-­‐Hempel	   2001).	   How	  plasmid	  population	   structure	   relates	   to	   the	  host	   bacterial	   population	   structure	  could	  provide	  insights	   into	  plasmid	  maintenance	  and	  host-­‐plasmid	  coevolution,	  for	   example	   the	   relative	   importance	   of	   vertical	   vs.	   horizontal	   plasmid	  transmission	   (Harrison	   &	   Brockhurst	   2012).	   Mechanisms	   of	   plasmid	  identification	  which	  dissociate	  plasmids	  from	  hosts	  (Section	  5.1.3)	  clearly	  inhibit	  this	  type	  of	  community	  analysis,	  and	  to	  date	  few	  studies	  have	  examined	  natural	  plasmid	  and	  host	  communities.	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5.1.3 Plasmid	  isolation	  strategies	  Three	   principal	   methods	   are	   used	   to	   isolate	   and	   identify	   plasmids:	   i)	  endogenous,	   culture-­‐based	   techniques;	   ii)	   exogenous	  mating-­‐based	   techniques;	  and	   iii)	   molecular	   techniques	   (Smalla	   &	   Sobecky	   2002).	   Endogenous	   plasmid	  isolation	   requires	   host	   cell	   culture:	   strains	   must	   be	   isolated	   and	   cultured	   to	  obtain	   clonal	   colonies	   from	  which	  plasmids	   can	  be	   extracted.	  This	  method	  has	  obvious	  limitations:	  bacteria	  which	  are	  difficult	  (or	  impossible)	  to	  culture	  in	  the	  laboratory	  will	   be	   ignored;	   the	  most	   prevalent	   strains	   in	   the	   environment	  will	  dominate,	  often	  overlooking	  rare	  strains	  and	  species;	  and	   in	  addition,	   selective	  media	   containing	   antibiotics	   are	   often	   required	   to	   isolate	   the	   desired	   bacteria	  (Smalla	   et	   al.	   2005).	   However,	   the	   great	   advantage	   of	   endogenous	   isolation	   is	  that	  the	  host	  strain	  is	  known.	  	  	  Exogenous	  plasmid	   isolation	  does	  not	   require	  bacterial	   culture.	  Also	  known	  as	  ‘plasmid	   capture’,	   this	   technique	   involves	   a	   marked	   ‘capture’	   strain	   which	  acquires	  plasmids	  of	   interest	  via	  conjugation	  (Bale	  et	  al.	  1988).	  Two	  variations	  exist:	   bi-­‐parental	   mating,	   where	   a	   self-­‐transmissible	   target	   plasmid	   transfers	  directly	   to	   the	   capture	   strain	   (Dahlberg	   et	   al.	   1997);	   and	   tri-­‐parental	   mating,	  where	   a	   second	  marked	  plasmid	   is	  mobilised	  by	   the	   target	  plasmid	   (Top	  et	   al.	  1994).	   Bi-­‐parental	   mating	   requires	   the	   target	   plasmid	   to	   carry	   a	   selectable	  marker,	   whereas	   tri-­‐parental	   mating	   utilizes	   a	   secondary	   marked	   plasmid.	  However,	  the	  major	  limitation	  of	  these	  techniques	  is	  that	  they	  require	  the	  target	  plasmid	   to	   transfer	   to	   the	   capture	   strain,	   ruling	   out	   collection	   of	   non-­‐transmissible	  or	  narrow	  host	  range	  plasmids.	  Moreover,	  these	  methods	  give	  no	  information	  about	  the	  original	  plasmid	  host.	  	  	  Plasmids	   can	   also	   be	   identified	   using	   molecular	   techniques,	   for	   example:	   PCR	  based	   strategies	   such	   as	   replicon	   typing	   (Carattoli	   et	   al.	   2005);	   hybridization	  probes	   (Couturier	   et	   al.	   1988);	   pMLST	   (Garcia-­‐Fernandez	   et	   al.	   2008);	   and	  recently,	   plasmid	   motility-­‐based	   identification	   (Garcillán-­‐Barcia	   et	   al.	   2011).	  These	   techniques	   have	   the	   advantage	   of	   being	   high	   throughput,	   and,	   like	  exogenous	  methods,	   do	   not	   require	   culture.	   They	   can	   even	   use	   environmental	  DNA	   extracts	   (Carattoli	   et	   al.	   2005;	   Elsas	  &	  Bailey	   2002;	   Sobecky	   et	   al.	   1997).	  
	   99	  
Although	   this	   facilitates	   the	   collection	   of	   massive	   plasmid	   presence	   data	   sets,	  environmental	  DNA	   extracts	   have	   the	  major	   disadvantage	   of	   not	   retaining	   any	  individual	   plasmids	   for	   further	   study.	   Moreover,	   as	   with	   exogenous	   methods,	  these	   molecular	   approaches	   do	   not	   give	   information	   about	   the	   host	   bacterial	  population.	  Combination	  strategies,	  where	  molecular	   techniques	  are	  applied	   to	  endogenously	  or	  exogenously	  obtained	  plasmids,	  provide	  a	  balance	  between	  the	  high-­‐throughput	  molecular	  techniques,	  and	  the	  specificity	  of	  plasmid	  extraction.	  Couturier	   probes	   (Couturier	   et	   al.	   1988)	   have	   been	   successfully	   used	   for	  molecular	   analysis	   of	   endogenously	   isolated	   plasmids,	   allowing	   plasmids	   to	   be	  assigned	  a	  replicon	  (incompatibility)	  type	  (Sobecky	  et	  al.	  1997).	  	  	  
5.1.4 Aims	  The	   original	   aim	   of	   this	   chapter	  was	   to	   identify	   antibiotic	   resistance	   plasmids	  and	  corresponding	  susceptible	  ‘cheat’	  plasmids	  in	  a	  natural	  bacterial	  population:	  enteric	   E.	   coli	   from	   cattle	   (see	   Chapter	   4,	   Section	   4.1.1	   for	   an	   explanation	   of	  ‘cheat’	   plasmids).	   Identification	   of	   ‘cheat’	   plasmids	   required	   non-­‐selective	  isolation	  methods,	  making	  this	  study	  an	  ideal	  opportunity	  to	  examine	  a	  natural	  plasmid	   population	   in	   a	   non-­‐selective	   way:	   the	   only	   selection	   criterion	   for	  plasmid	  isolation	  was	  that	  the	  host	  must	  be	  E.	  coli.	  	  	  This	   study	   combines	   endogenous,	   culture-­‐based	   plasmid	   isolation	   with	   PCR	  based	  plasmid	  replicon	  identification	  and	  a	  novel	  method	  of	  host	  genotyping,	  to	  provide	  a	  picture	  of	  both	  the	  host	  and	  plasmid	  populations	  in	  a	  high-­‐throughput	  manner.	   	   This	   chapter	   presents	   an	   overview	   of	   a	   very	   large	   data	   set:	  approximately	  25000	  E.	  coli	  were	  isolated,	  and	  to	  date	  527	  have	  been	  genotyped	  and	  screened	   for	  plasmids	  and	  antibiotic	   susceptibility.	  Such	  a	  substantial	  data	  set	   presents	   a	   unique	   opportunity	   to	   examine	   the	   ecology	   of	   a	   ‘real’	   plasmid	  population.	   Fundamental	   questions	   about	   the	   coexistence	   of	   resistant	   and	  susceptible	   plasmids,	   plasmid	   and	   host	   diversity-­‐abundance	   relationships,	  plasmid	  movement	  within	  populations,	  and	  population	  structuring	  of	  both	  host	  and	  plasmid	  are	  addressed.	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5.2 Methods	  
5.2.1 Sample	  collection	  &	  isolation	  of	  E.	  coli	  Bovine	   faecal	  samples	  (cowpats)	  were	  collected	   from	  9	  sites	  across	  Surrey	  and	  Berkshire:	  4	  farms	  (sites	  A,	  D,	  R	  &	  W)	  and	  5	  nature	  reserves	  with	  grazing	  cattle	  (sites	   CC,	   OC,	   RH,	   TM	   and	   WC).	   Sampling	   was	   conducted	   in	   a	   hierarchical	  manner:	  10	  cowpats	  were	  sampled	  from	  each	  site	  and	  10	  E.	  coli	  were	  screened	  from	  each	  pat	  (unless	  numbers	  were	  too	  low,	  in	  which	  case	  all	  available	  pats/	  E.	  
coli	  were	  screened).	  E.	  coli	   survival	   in	  cowpats	   in	   the	   field	   is	  good	   for	  up	   to	  30	  days,	  but	  fresh	  pats	  were	  selected	  when	  possible	  (van	  Kessel	  et	  al.	  2007).	  	  Approximately	   2	   g	   faecal	   matter	   was	   collected	   from	   each	   pat	   using	   sterile	  collecting	   tubes	  with	   spoon	   lids	   (Nunc™,	  Thermo	  Scientific,	  UK).	   Samples	  were	  returned	  to	  the	  laboratory	  where	  they	  were	  stored	  at	  10°C	  until	  processing.	  All	  samples	  were	  processed	  with	  24	  hours	  of	  collection	  by	  homogenisation	  in	  5	  ml	  sterile	   0.85%	   w/v	   NaCl	   followed	   by	   centrifugation	   at	   500	   g	   for	   2	   minutes	   to	  pellet	   the	   solid	   material.	   The	   supernatants	   were	   diluted	   100-­‐fold	   with	   sterile	  0.85%	  w/v	  NaCl,	  and	  100	  µl	  was	  plated	  onto	  HiCrome™	  Coliform	  Agar	  containing	  5	   mg	   l-­‐1	   novobiocin	   (Sigma,	   UK).	   Total	   coliform	   counts	   were	   recorded	   after	  overnight	  incubation	  at	  37°C.	  Ten	  colonies	  per	  cowpat	  sample	  were	  re-­‐streaked	  onto	  HiCrome™	  plates	   to	  obtain	  clonal	  colonies.	  Overnight	  cultures	   in	  LB	  broth	  were	   inoculated	   from	   these	   clonal	   colonies	   for	   testing	   with	   Kovac’s	   Reagent	  (Sigma).	  10	  µl	  Kovac’s	  Reagent	  was	  added	  to	  150	  µl	  overnight	  culture;	  a	  cherry	  red	  colour	  confirms	  presence	  of	  E.	  coli.	   Isolated	  colonies	  were	  stored	  long	  term	  in	  80%	  glycerol	  at	  -­‐80°C.	  	  
5.2.2 DNA	  extraction	  &	  plasmid	  replicon	  typing	  Overnight	   cultures	  were	  set	  up	   in	  2	  ml	  LB	  broth	   in	  24	  well	  plates.	  These	  were	  centrifuged	   at	   5500	   g	   for	   5	   minutes	   and	   the	   pellet	   resuspended	   in	   0.5	   ml	  molecular	  grade	  H2O.	  This	   suspension	  was	  boiled	   for	  10	  minutes	  at	  100°C	  and	  then	  centrifuged	  at	  4500	  g	  for	  5	  minutes	  (Johnson	  &	  Brown	  1996).	  Supernatants	  were	   used	   as	   templates	   for	   replicon	   typing	   PCR	   and	   flagellin	   sequencing.	   Best	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results	  were	  obtained	  when	  supernatants	  were	  used	  immediately,	  but	  they	  were	  also	  stored	  at	  -­‐20°C.	  	  Replicon	   typing	   PCR	   was	   used	   to	   identify	   plasmids	   in	   isolated	   E.	   coli.	   This	  method	  comprises	  3	  multiplex-­‐PCR	  panels	  with	  18	  primer	  pairs	  recognising	  the	  major	  plasmid	   incompatibility	  groups	  of	   the	  Enterobacteriaceae	   (Carattoli	  et	  al.	  2005;	  Johnson	  et	  al.	  2007).	  PCR	  reagent	  concentrations	  were	  as	  follows:	  0.4mM	  dNTPs,	   0.625	   units	   Taq	   (Qiagen)	   and	   2.4	   μM	   of	   each	   primer	   in	   the	   multiplex	  panel.	   0.5	   μl	   boiled	   lysate	   template	   was	   added	   to	   each	   24.5	   μl	   reaction	   mix.	  Cycling	   conditions	   were:	   initial	   denaturation,	   95°C,	   5	  minutes,	   followed	   by	   30	  cycles	   of	   denaturation	   (95°C,	   30	   seconds),	   annealing	   (60°C,	   30	   seconds)	   and	  extension	   (72°C,	  90	  seconds)	  and	  a	   final	  extension,	   step	  of	  72°C	   for	  5	  minutes.	  PCR	  product	  sizes	  indicate	  the	  presence	  of	  specific	  plasmid	  replicon(s).	  	  	  
5.2.3 E.	  coli	  genotyping	  
E.	  coli	  isolates	  were	  genotyped	  by	  sequencing	  the	  variable	  region	  of	  the	  flagellin	  gene,	   fliC.	   This	  method	   is	   an	   adaptation	  of	   previous	   genotyping	  methods	  using	  whole	  gene	  sequencing	  (Wang	  et	  al.	  2006),	  and	  PCR-­‐RFLP	  (restriction	  fragment	  length	   polymorphism)	   (Machado	   et	   al.	   2000).	  Whole	   gene	   sequencing	  was	   not	  practicable	   for	   such	  a	   large	   sample	   size	   (>500	   isolates)	  given	   the	   length	  of	   the	  
fliC	  gene	  (between	  0.9-­‐2.5Kb).	  A	  novel	  genotyping	  method	  involving	  sequencing	  the	  variable	  region	  of	   fliC	  was	  developed.	  The	   fliC	  gene	  was	  amplified	  using	  the	  PCR-­‐RFLP	  primers	  described	  by	  Machado	  et	  al.	  (2000)(Table	  5.1).	  Standard	  PCR	  reagents	   can	   be	   seen	   in	   Chapter	   2,	   Section	   2.2.1.	   Cycling	   conditions	   were	   as	  follows:	   initial	   denaturation,	   95°C,	   2	   minutes,	   followed	   by	   30	   cycles	   of	  denaturation	   (95°C,	   40	   seconds),	   annealing	   (50°C,	   30	   seconds)	   and	   extension	  (72°C,	   120	   seconds)	   and	   a	   final	   extension	   step	   of	   72°C	   for	   3	   minutes.	   PCR	  products	  were	  cleaned	  up	  using	  Exo1	  (Fisher	  Scientific)	  and	  TSAP	  (Promega	  UK,	  Southamption,	  UK)	  both	   at	   final	   concentration	  0.045	  units	   μl-­‐1.	   Clean	  up	  mixes	  were	   incubated	   at	   37°C	   for	   30	   minutes,	   followed	   by	   80°C	   for	   15	   minutes.	  Sequencing	   reactions	   were	   conducted	   using	   BigDye®	   terminator	   v3.1	   cycle	  sequencing	  kit	  (Life	  Technologies	  Ltd.	  Paisley,	  UK)	  using	  the	   fliC	  2	  primer	  only.	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Sequencing	  cycling	  conditions	  were	  as	  follows:	  96°C	  for	  1	  minute,	  followed	  by	  25	  cycles	  of:	  96°C	  for	  10	  seconds,	  50°C	  for	  5	  seconds,	  60°C	  or	  4	  minutes.	  Sequencing	  reactions	   were	   cleaned	   up	   using	   ethanol/sodium	   acetate	   precipitation.	  Sequencing	   runs	  were	   conducted	   by	   the	   Department	   of	   Zoology,	   University	   of	  Oxford,	  UK.	  Trimmed	  sequences	  were	  searched	  against	  the	  whole	  flagellin	  gene	  sequences	  of	  Wang	  et	   al.	   (2003)	  using	  Geneious	   (Biomatters	  2012).	   Sequences	  were	  assigned	  a	  flagellin	  type	  (H-­‐antigen	  type)	  when	  they	  had	  at	  least	  200	  bp	  of	  high	  identity	  (>95%)	  with	  one	  fliC	  sequence.	  Where	  several	  matches	  were	  made	  the	   match	   with	   highest	   identity	   was	   selected.	   This	   method	   allowed	   97%	  sequences	  to	  be	  assigned	  a	  flagellin	  type.	  	  	  
Primer	   Sequence	  (5’-­‐3’)	   Size	  (nt)	  
fliC	  1	   CAAGTCATTAATACMAACAGCC	   22	  
fliC	  2	   GACATRTTRGAVACTTCSGT	   20	  	  
Table	   5.1:	   Primers	   for	   flagellin	   typing.	   Primers	   were	   taken	   from	   Machado	   et	   al.	  (2000),	  and	  include	  ‘wobble’	  bases:	  M	  (A/C),	  R	  (A/G),	  V	  (G/A/C),	  S	  (G/C).	  	  
E.	   coli	   H-­‐antigen	   types	   were	   placed	   into	   one	   of	   four	   subgroups	   as	   defined	   by	  Wang	  	  et	  al.	  (2003).	  These	  are	  based	  on	  H-­‐antigen	  groupings	  of	  variable	  region	  of	  the	  flagellin	  gene	  (V),	  which	  was	  sequenced	  (Table	  5.2).	  Wang	  et	  al.	  (2003)	  failed	  to	  categorise	   the	  H16	  group	  based	  on	   its	  V	  region	  sequence,	  but	  place	   it	   in	   the	  Ec1b	   group	  based	   on	   the	   conserved	  C1	   and	  C2	   regions.	   They	   suggest	   that	   this	  failure	  is	  due	  to	  recent	  recombination	  in	  the	  V	  region	  of	  the	  gene.	  	  
Ec1a	   Ec1b	   Ec2	   Se2	  H6	  H7	  H12	  H14	  H15	  
H18	  H19	  H20	  H28	  H31	  
H32	  H37	  H41	  H49	  
H4	  H5	  H10	  H16	  H33	  
H38	  H39	  H42	  H56	  	  
H8	  H11	  H21	  H27	  
H2	  H48	  	  
	  
Table	  5.2:	  E.	  coli	  H-­‐antigen	  subgroupings	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5.2.4 Antibiotic	  susceptibility	  screening	  The	   susceptibility	   of	   E.	   coli	   isolates	   to	   ampicillin,	   cefotaxime	   and	  chloramphenicol	   was	   assessed	   by	   disc	   diffusion	   assays.	   MIC	   breakpoints	   and	  interpretation	   of	   zone	   diameters	   were	   taken	   from	   The	   British	   Society	   for	  Antimicrobial	  Chemotherapy	  Guidelines	  version	  11.1	  (May	  2012).	  Susceptibility	  testing	  methods	  were	  adapted	  from	  Andrews	  et	  al.	  (2005).	  Overnight	  cultures	  in	  1.5	  ml	  LB	  broth	  in	  24	  well	  plates	  were	  initiated	  from	  single	  colonies.	  Plates	  were	  inoculated	  with	  bacteria	  by	  spreading	  in	  three	  directions	  with	  a	  sterile	  swab.	  Six	  antibiotic	  discs	  were	  placed	  at	  uniform	  intervals	  using	  sterile	  forceps	  (Table	  5.3).	  The	  zones	  of	  inhibition	  were	  measured	  after	  overnight	  incubation	  at	  37°C,	  using	  a	  disc	  diameter	   template.	  Two	  doses	  were	  used	   for	  each	  antibiotic,	  and	  strains	  were	  determined	  to	  be	  resistant	  if	  they	  scored	  positively	  with	  both	  discs.	  	  
Antibiotic	   Doses	  (μg	  ml	  -­‐1)	   Clearance	  zone	  diameter	  (mm)	  Ampicillin	   2	   10	   15	  Cefotaxime	   5	   30	   30	  Chloramphenicol	   10	   30	   21	  
	  
Table	  5.3:	  Antibiotic	  disc	  doses	  and	  diameters	  of	  clearance.	  	  	  
5.2.5 Statistical	  analysis	  All	  statistical	  analyses	  were	  conducted	  in	  R	  (R	  Core	  Team	  2013).	  Plasmid	  and	  H-­‐antigen	  diversity	  were	  calculated	  using	  the	  Shannon	  diversity	  index	  (Spellerberg	  &	   Fedor	   2003)	   using	   the	   Vegan	   package	   in	   R	   (Oksanen	   et	   al.	   2013).	   Linear	  regressions	  were	   carried	   out	   to	   assess	   the	   affect	   of	   E.	   coli	   abundance	   on	   both	  plasmid	  and	  H-­‐antigen	  diversity,	  and	  also	  to	  compare	  both	  diversity	  measures.	  In	  addition,	   a	  mixed	  model	   incorporating	   ‘site’	   as	   a	   random	  effect	  was	   conducted	  using	  the	  R	  package	  nlme	  (Pinheiro	  et	  al.	  2007).	  Restricted	  maximum	  likelihood	  (REML)	   lme	   models	   were	   converted	   to	   maximum	   likelihood	   (ML)	   models	   to	  allow	   model	   comparison	   using	   ANOVA.	   Plasmid	   replicon	   distribution	   across	  subgroups	  was	   assessed	   using	   a	  mosaic	   plot,	   produced	   using	   the	   vcd	   package	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(Hornik	   et	   al.	   2006).	   Hierarchical	   F-­‐statistics	   were	   calculated	   using	   HierFstat	  (Goudet	  2004;	  de	  Meeûs	  &	  Goudet	  2007).	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5.3 Results	  	  
5.3.1 Antibiotic	  resistance	  is	  rare	  In	   total	  24483	  colonies	  were	   isolated	   from	  84	  cowpats	  across	  9	  sites.	  Of	   these,	  527	   isolates	  were	  genotyped	  and	  screened	   for	  plasmid	  replicons	  and	  antibiotic	  susceptibility.	   Somewhat	   surprisingly,	   very	   low	   levels	   of	   antibiotic	   resistance	  were	  found:	  of	  the	  527	  isolates	  just	  14	  (less	  that	  3%)	  were	  resistant	  to	  any	  of	  the	  antibiotics	   tested:	  9	   isolates	  were	  ampicillin	   resistant,	  4	  were	   chloramphenicol	  resistant,	  and	  just	  1	  was	  resistant	  to	  cefotaxime.	  No	  multi-­‐resistant	  isolates	  were	  found.	  Resistant	  isolates	  were	  found	  in	  5	  of	  the	  9	  sites,	  with	  sites	  A,	  CC,	  OC	  and	  W	  resistance-­‐free.	  The	  absence	  of	  resistance	  from	  sites	  A	  and	  CC	  may	  be	  an	  artefact	  of	  low	  E.	  coli	  recovery	  from	  these	  sites	  (see	  Section	  5.3.2	  below),	  but	  despite	  this	  the	  number	  of	  resistant	  isolates	  is	  much	  lower	  than	  was	  anticipated.	  The	  rarity	  of	   antibiotic	   resistance	   made	   it	   impossible	   to	   test	   for	   the	   co-­‐occurrence	   of	  resistant	  and	  susceptible	  bacteria,	  and	  therefore	  the	  presence	  of	  ‘cheat’	  plasmids.	  	  
5.3.2 E.	  coli	  abundance	  is	  a	  poor	  predictor	  of	  plasmid	  diversity	  	  It	  seems	  logical	  that	  a	  larger	  E.	  coli	  population	  may	  support	  a	  greater	  variety	  of	  plasmid	   replicons.	   In	  order	   to	   test	   this,	   regression	  was	   conducted	  with	   total	  E.	  
coli	  abundance	  against	  plasmid	  replicon	  diversity	  (Shannon	  diversity).	  When	  the	  data	  was	  pooled	  by	  site,	  E.	  coli	   abundance	  was	  a	  moderately	  good	  predictor	  of	  plasmid	   replicon	  diversity	   (F	   (1,	  7)	   =	  5.61,	  R2	  =	  0.3656,	  p=	  0.0497;	  Figure	  5.1	  A,	  dashed	   line).	   However,	   this	   diversity-­‐abundance	   relationship	   appears	   to	   be	  skewed	  by	  sites	  A	  and	  CC,	  where	  low	  numbers	  of	  E.	  coli	  were	  isolated	  (Figure	  5.1	  A,	   open	   circles).	   When	   these	   sites	   were	   excluded,	   the	   diversity-­‐abundance	  relationship	  was	  not	  significant	  (F	  (1,	  5)	  =	  3.643,	  R2	  =	  0.3058,	  p	  =	  0.1146;	  Figure	  5.1	  A,	  solid	  line).	  When	  data	  was	  pooled	  by	  individual	  cowpat,	  E.	  coli	  abundance	  explains	  a	  smaller	  amount	  of	  the	  variance	  in	  plasmid	  replicon	  diversity,	  but	  this	  relationship	   is	   highly	   significant	   (F	   (1,	  82)	   =	   30.45,	   R2	   =	   0.2619,	  p	   =	   3.90	   x	   10-­‐7,	  Figure	  5.1	  B).	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Figure	  5.1:	  Plasmid	  replicon	  diversity	  vs.	  E.	  coli	  abundance.	  (A)	  Site	  level.	  When	  all	  sites	   are	   included,	  E.	  coli	   abundance	   is	   a	   good	   predictor	   of	   plasmid	   diversity	   (F	   (1,	  7)	   =	  5.61,	   R2	   =	   0.3656,	   p=	   0.0497,	   dashed	   line).	   However,	   when	   sites	   with	   low	   E.	   coli	  abundance	   were	   excluded	   (open	   circles),	   this	   relationship	   is	   not	   significant	   (F	   (1,	   5)	   =	  3.643,	  R2	  =	  0.3058,	  p	  =	  0.1146,	  solid	  line).	  (B)	  Pat	  level.	  E.	  coli	  abundance	  is	  a	  reasonably	  good	  predictor	  of	  plasmid	  replicon	  diversity	  at	  the	  pat	  level	  (F	  (1,	  82)	  =	  30.45,	  R2	  =	  0.2619,	  
p	  =	  3.90	  x	  10-­‐7).	  Diversity	  is	  Shannon	  diversity.	  
A	  
B	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The	  weak	   correlation	   between	  diversity	   and	   abundance	   could	   be	   explained	   by	  differences	   between	   sites.	   Pat	   level	   plasmid	   replicon	   diversity	   and	   total	  E.	   coli	  were	  modelled	  using	  a	  mixed	  effects	  model	  with	  site	  as	  the	  random	  effect	  (AIC	  91.32).	  Figure	  5.2	  shows	  variation	  in	  the	  slope	  of	  this	  relationship	  between	  sites:	  there	  is	  generally	  a	  positive	  correlation	  between	  plasmid	  replicon	  diversity	  and	  
E.	   coli	   abundance,	   with	   the	   exception	   of	   sites	   OC	   and	   R,	   which	   show	   slight	  negative	   trends.	  Despite	   these	  differences,	   there	   is	  no	  significant	  decline	   in	   the	  model’s	  explanatory	  power	  when	  the	  random	  effect	   is	  excluded	  (AIC	  90.87,	  p	  =	  0.213),	   indicating	  that	   the	  random	  effect	  of	  site	   is	  not	   important.	  Overall,	   these	  data	  suggest	  that	  E.	  coli	  abundance	  does	  not	  significantly	  affect	  plasmid	  replicon	  diversity	  at	  the	  site	  level,	  but	  is	  significant	  at	  the	  pat	  level.	  
Figure	  5.2:	  Pat	  level	  plasmid	  replicon	  diversity	  vs	  E.	  coli	  abundance	  for	  each	  of	  the	  
nine	   sites.	   Each	   panel	   represents	   the	   pat	   level	   data	   for	   one	   site.	   Total	   E.	   coli	   was	  transformed	   by	   the	   addition	   of	   the	   minimum	   detectable	   value	   to	   allow	   zeros	   to	   be	  plotted.	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5.3.3 Replicons	  are	  not	  evenly	  distributed	  across	  E.	  coli	  subgroups	  The	  majority	  of	  E.	  coli	  isolates	  contained	  at	  least	  one	  plasmid	  replicon;	  just	  26	  %	  (136	  isolates)	  had	  no	  detectable	  plasmids.	  Of	  the	  18	  possible	  replicons	  picked	  up	  by	   the	  screen	  8	  were	  detected.	  There	  was	  one	  clear	  dominant	   type,	  FIB,	  which	  was	  found	  in	  352	  isolates	  (67%).	  Of	  the	  other	  replicon	  types	  identified,	  FIA	  and	  P	  were	   common	   (>	   100	   isolates);	   FIC	   and	   I1	   were	   moderately	   common	   (>	   30	  isolates);	  and	  B/O,	  K/B	  and	  Y	  were	  rare	  (<	  10	  isolates).	  The	  full	  plasmid	  and	  H-­‐antigen	  data	  sets	  can	  be	  seen	  in	  Appendix	  2.	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The	  mosaic	  plot	  (Figure	  5.3)	  highlights	  non-­‐even	  distribution	  of	  replicons	  across	  
E.	  coli	  subgroups.	  Significantly	  more	  replicons	  than	  independence	  would	  expect	  were	   found	   for:	   Y	   in	   Ec1a;	   P	   in	   Ec2;	   I1,	   FIA	   and	   FIC	   in	   Se2.	   The	   replicon	  distribution	   for	   subgroup	   Se2	   is	   particularly	   striking,	   especially	   as	   this	   is	   the	  smallest	   subgroup	   (n	   =	   72).	   3	   replicon	   types	   are	   overrepresented	   in	   Se2,	  including	  FIC,	  which	  has	  the	  only	  Pearson	  residual	  of	  >	  4,	  indicating	  significance	  at	   the	   99.99%	   level.	   Significantly	   fewer	   replicons	   than	   independence	   predicts	  were	  found	  for:	  I1,	  FIA	  and	  FIC	  in	  Ec1a;	  Y	  and	  P	  in	  Ec1b;	  P	  in	  Se2.	  Curiously,	  the	  largest	   subgroup,	   Ec1a	   (n	   =	   327),	   shows	   the	   most	   underrepresentation	   of	  plasmid	  replicons.	  Distribution	  of	  E.	  coli	  with	  no	  plasmids	  is	  even	  across	  all	  four	  subgroups,	  as	  are	  the	  distributions	  of	  the	  most	  and	  least	  common	  plasmid	  types,	  FIB	   (n	   =	   352)	   and	   pooled	   K/B	   and	   B/O	   (KB,	   n	   =	   7).	   The	   colourfulness	   of	   the	  mosaic	  plot	  clearly	  demonstrates	  that	  plasmids	  are	  not	  evenly	  distributed	  across	  
E.	  coli	  subgroups	  in	  this	  study.	  	  
5.3.4 E.	  coli	  diversity	  can	  predict	  plasmid	  diversity	  
E.	  coli	  genotype	  diversity	  was	  calculated	  as	  Shannon	  diversity	  of	  H-­‐antigen	  types	  at	   the	   site	   level.	   Figure	   5.4	   shows	   that	   this	   H-­‐antigen	   diversity	   correlates	  significantly	   with	   plasmid	   replicon	   diversity.	  When	   all	   sites	   were	   included,	   H-­‐antigen	   diversity	   is	   a	   reasonably	   good	   predictor	   of	   plasmid	   diversity	   (F	   (1,	  7)	   =	  6.518,	   R2	   =	   0.4082,	   p	   =	   0.0379,	   Figure	   5.4,	   dashed	   line).	  When	   the	   low	  E.	   coli	  abundance	   sites,	   A	   and	   CC,	   were	   excluded	   (Figure	   5.4,	   open	   circles)	   this	  relationship	  has	  greater	  explanatory	  power	  and	  significance	  (F	  (1,	  5)	  =	  9.498,	  R2	  =	  0.5862,	  p	  =	  0.0274,	  solid	   line).	   It	   is	   interesting	  to	  note	  that	  E.	  coli	  diversity,	  not	  abundance,	  affects	  the	  diversity	  of	  plasmids	  in	  the	  population.	  	  
	   110	  
	  
Figure	   5.4:	   Plasmid	   replicon	  diversity	   correlates	  with	  H-­‐antigen	  diversity.	  When	  all	   sites	   are	   included,	   H-­‐antigen	   diversity	   is	   a	   reasonably	   good	   predictor	   of	   plasmid	  diversity	   (F	   (1,	  7)	   =	   6.518,	   R2	   =	   0.4082,	   p	   =	   0.0379,	   dashed	   line).	  When	   the	   low	  E.	   coli	  abundance	  sites	  are	  excluded	  (open	  circles)	  this	  relationship	  becomes	  more	  significant	  (F	   (1,	  5)	   =	  9.498,	  R2	  =	  0.5862,	  p	   =	  0.0274,	   solid	   line).	  Both	  are	  Shannon	  diversity	  at	   site	  level.	  	  
5.3.5 E.	  coli	  diversity	  &	  population	  structure	  In	  addition	   to	  studying	   the	  plasmid	  population,	   it	   is	  also	   important	   to	  consider	  the	   host	   E.	   coli	   population.	   Regression	   was	   conducted	   with	   total	   E.	   coli	  abundance	   against	   H-­‐antigen	   diversity	   at	   the	   site	   level.	   E.	   coli	   abundance	  was	  found	   to	  be	  a	  poor	  predictor	  of	  H-­‐antigen	  diversity,	  both	  when	   low	  abundance	  sites	  are	  included	  (F	  (1,7)	  =	  1.1002,	  R2	  =	  0.0124,	  p=	  0.3291,	  Figure	  5.5	  dashed	  line)	  and	  when	  they	  are	  excluded	  (F	  (1,5)	  =	  3.5051,	  R2	  =	  0.2945,	  p	  =	  0.1201,	  	  Figure	  5.5	  solid	  line).	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It	  was	   observed	   that	  within	   each	   pat	  most	  E.	   coli	   were	   of	   the	   same	  H-­‐antigen	  type.	  Hierarchical	  F-­‐statistics	  were	  calculated	  to	  assess	  the	  contribution	  of	  sites,	  and	   pats	   within	   sites	   to	   the	   E.	   coli	  population	   structure:	   how	   much	   genotype	  variation	   (different	   H-­‐antigen	   types)	   can	   be	   explained	   by	   each	   level	   of	   the	  hierarchy	  (pat,	  site).	  Both	  pat	  within	  site	  (F	  pat/site	  =	  0.457,	  p	  =	  1	  x	  10-­‐4),	  and	  site	  (F	   site/total	   =	   0.197,	   p	   =	   1	   x	   10-­‐4)	   were	   found	   to	   have	   strong	   effects	   on	   the	  population	  structure	  of	  E.	  coli	  (10	  000	  permutations).	  In	  other	  words,	  20%	  of	  the	  observed	  genotype	  variation	  can	  be	  explained	  by	  site,	  and	  46%	  of	  this	  variation	  can	   be	   explained	   by	   pat	   within	   site,	   corresponding	   to	   great	   and	   very	   great	  genetic	  differentiation	  respectively	  (Holsinger	  &	  Weir	  2009;	  Wright	  1978).	  	  	  
	  
Figure	   5.5:	   H-­‐antigen	   diversity	   vs.	   E.	   coli	   abundance.	   E.	   coli	   abundance	   is	   a	   poor	  predictor	  of	  H-­‐antigen	  diversity,	  both	  when	   low	  abundance	  sites	  are	   included	  (F	  (1,	  7)	  =	  1.1002,	  R2	  =	  0.0124,	  p=	  0.3291,	  dashed	  line)	  and	  when	  they	  are	  excluded	  (F	  (1,	  5)	  =	  3.5051,	  R2	  =	  0.2945,	  p	  =	  0.1201,	  solid	  line).	  H-­‐antigen	  diversity	  is	  Shannon	  diversity	  per	  site.	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5.4 Discussion	  	  
5.4.1 Antibiotic	  resistance	  and	  the	  food	  chain	  It	   has	   been	   proposed	   that	   farm	   animals	   may	   be	   important	   carriers	   of,	   and	  reservoirs	  for,	  ESBL	  genes	  (Carattoli	  2008).	  However,	  data	  on	  the	  prevalence	  of	  ESBL	  producing	  bacteria	  in	  food	  or	  food-­‐animals	  is	  highly	  variable,	  ranging	  from	  0.2%	  to	  40%	  (Liebana	  et	  al.	  2013).	  This	  difference	  is	  highlighted	  by	  the	  contrast	  between	   data	   in	   this	   study	   and	   a	   previous	   study	   of	   faecal	   samples	   from	   dairy	  cattle	   by	   Sawant	   et	   al.	   (2007):	   <	   3	   %	   of	   E.	   coli	   were	   resistant	   to	   ampicillin,	  chloramphenicol	  or	   cefotaxime	   in	  my	  study,	  whereas	  48	  %	  and	  20	  %	  of	  E.	  coli	  were	  resistant	  to	  ampicillin	  and	  chloramphenicol	  respectively	   in	  Sawant	  et	  al.’s	  work.	   It	   is	   of	   course	   possible	   that	   the	   E.	   coli	   sampled	   in	   this	   study	   carry	  resistance	   to	   antibiotics	   other	   than	   those	   tested.	   However,	   the	   lack	   of	   ESBL	  resistance	  is	  noteworthy	  as	  it	  may	  indicate	  that	  resistance	  in	  livestock	  is	  not	  as	  prevalent	  as	   is	  supposed.	  Five	  of	   the	  nine	  sites	   in	  the	  study	  were	  small	  grazing	  herds	  kept	  on	  nature	  reserves.	  It	  is	  highly	  likely	  that	  these	  cattle	  have	  had	  very	  low	  exposure	  to	  antibiotics,	  and	  the	   low	  levels	  of	  resistance	   found	  suggest	   that	  this	  means	  of	  cattle	  rearing	  may	  reduce	  the	  prevalence	  of	  resistance.	  If	  this	  is	  the	  case,	  it	  provides	  hope	  that	  the	  implementation	  of	  control	  measures	  could	  have	  a	  positive	  impact	  on	  the	  spread	  of	  resistance:	  all	  is	  not	  lost.	  This	  data	  suggests	  that	  not	   all	   E.	   coli	   populations	   are	   rife	   with	   antibiotic	   resistance.	   The	   spread	   of	  antibiotic	   resistant	   organisms	   through	   the	   food	   chain	   is	   considered	   to	   be	   a	  significant	   risk	   to	   public	   health,	   but	   if	   resistance	   in	   livestock	   can	   be	  managed	  effectively,	  this	  risk	  may	  be	  minimised	  (Liebana	  et	  al.	  2013).	  	  
5.4.2 High	  numbers	  IncF	  plasmids	  Replicon	  typing	  detected	  a	  large	  number	  of	  plasmids,	  with	  74	  %	  of	  E.	  coli	  isolates	  testing	   positive	   for	   at	   least	   one	   replicon.	   Perhaps	   unsurprisingly,	   the	   most	  commonly	   detected	   replicons	  were	   IncF	   (FIA,	   FIB	   and	   FIC).	   IncF	   plasmids	   are	  one	   of	   the	   most	   common	   plasmid	   types	   in	   the	   Enterobacteriaceae,	   are	   found	  across	  a	  range	  of	  host	  animals	  (Johnson	  et	  al.	  2007),	  and	  have	  previously	  been	  identified	  as	  the	  most	  common	  plasmids	  in	  enteric	  E.	  coli	  from	  cattle	  (Hordijk	  et	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al.	  2013)	  Interestingly	  for	  this	  thesis,	  the	  plasmids	  sequenced	  in	  Chapter	  4	  were	  also	   IncF,	   and	  were	   isolated	   from	  E.	   coli	   from	   a	   cattle	   farm.	   IncF	   plasmids	   are	  often	   associated	   with	   virulence	   genes	   and	   antibiotic	   resistance,	   in	   particular	  ESBLs	   (Villa	   et	   al.	   2010).	   None	   of	   the	   plasmids	   sequenced	   in	   Chapter	   4	   carry	  ESBL	   genes,	   and	   considering	   the	   lack	   of	   resistance	   observed	   in	   this	   study,	   it	  seems	  unlikely	  that	  these	  plasmids	  do	  either.	  Further	  sequencing	  of	  a	  selection	  of	  these	   plasmids	   would	   give	   a	   fuller	   picture	   of	   the	   non-­‐resistant	   IncF	   plasmid	  population,	   complementing	   the	  work	   in	   Chapter	   4,	   and	   providing	   insights	   into	  the	   differences	   between	   these	   plasmids	   and	   their	   resistant	   counterparts.	   It	  should	  be	  noted	  that	  previous	  studies	  have	  found	  IncF	  replicon	  probes	  to	  be	  the	  most	   successful	   in	   detecting	   plasmids	   from	   wild	   strains,	   with	   other	   probes	  sometimes	  having	  difficulty	  detecting	  plasmids	  (Hales	  et	  al.	  1992;	  Kobayashi	  &	  Bailey	   1994).	   Plasmid	   DNA	   extraction	   and	   sequencing	   may	   therefore	   identify	  additional	  plasmids	  missed	  due	  to	  this	  detection	  issue,	  as	  well	  as	  small	  plasmids	  which	  might	  not	  have	  detectable	  replicons.	  	  
5.4.3 Host	  diversity	  determines	  plasmid	  diversity	  Perhaps	   the	  most	   interesting	   finding	   in	   this	   study	   is	   that	   host	   abundance	   has	  little	  effect	  on	  plasmid	  replicon	  diversity,	  whereas	  host	  diversity	  has	  a	  significant	  effect	   (although	   some	  pat-­‐level	   effect	  was	   seen).	  This	   finding,	   that	   it	   is	   not	   the	  number	   of	   available	   hosts	   but	   their	   diversity	   that	   affects	   replicon	   diversity	  suggests	   the	   association	   of	   plasmid	   replicons	   with	   specific	   host	   types,	   and	  plasmid	   spread	   by	   vertical	   transmission	   rather	   than	   conjugation.	   The	  observation	   that	   plasmid	   replicons	   are	   not	   evenly	   distributed	   across	   E.	   coli	  subgroups	   -­‐	   that	   certain	   replicons	   are	   over-­‐	   or	   underrepresented	   in	   certain	  subgroups	  -­‐	  also	  supports	  the	  idea	  that	  specific	  plasmid	  replicons	  are	  associated	  with	  specific	  hosts	  in	  this	  population.	  Moreover,	  the	  structure	  of	  the	  host	  E.	  coli	  population,	  where	  E.	   coli	   within	   one	   pat	   (animal)	   are	  mostly	   of	   one	  H-­‐antigen	  type,	   would	   support	   plasmid	   persistence	   via	   vertical	   transmission,	   as	  opportunities	   for	   conjugation	   within	   the	   gut	   would	   be	   limited	   without	   high	  segregation	  rates	  (see	  Section	  5.4.4).	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The	   data	   suggesting	   strong	   associations	   of	   plasmid	   replicons	  with	   hosts	   could	  indicate	  coevolution	  of	  plasmids	  and	  hosts	  through	  altered	  conjugation	  rate,	  loss	  of	  genes	  or	  changes	  in	  gene	  expression	  (Slater	  et	  al.	  2008;	  Harrison	  &	  Brockhurst	  2012).	   It	   would	   be	   interesting	   to	   ascertain	   whether	   the	   plasmids	   in	   this	  population	  are	  conjugative,	  whether	  host	  strains	  can	  be	  cured	  of	  plasmids	  (and	  what	   effect	   this	   has),	   and	   what	   the	   rates	   of	   segregation	   are.	   This	   would	   give	  further	   information	  as	   to	  whether	   these	  plasmids	  are	  moving	   towards	  obligate	  symbiosis	  with	  their	  host,	  or	  whether	  the	  population	  is	  just	  so	  clonal	  that	  there	  is	  no	  chance	  of	  horizontal	  transfer.	  In	  addition,	  this	  data	  only	  gives	  information	  at	  the	  level	  of	  the	  replicon:	  it	  is	  not	  possible	  to	  say	  whether	  the	  plasmids	  within	  one	  pat	   or	   E.	   coli	   genotype	   are	   identical.	   Further	   plasmid	   sequencing,	   or	   pMLST,	  available	   for	   IncF	   and	   IncI	   plasmids	   (Villa	   et	   al.	   2010;	   Garcia-­‐Fernandez	   et	   al.	  2008),	  would	  allow	  finer	  resolution	  of	  the	  plasmid	  population.	  	  In	   addition,	   sequencing	   of	   plasmids	  would	   allow	   plasmid	   recombination	   to	   be	  examined.	   As	   this	   study	   identified	   only	   plasmid	   replicons,	   it	   is	   not	   possible	   to	  assess	  whether	  these	  replicons	  represent	   independent	  plasmids,	  whether	  these	  plasmids	  are	  the	  same,	  or	  whether	  several	  rep	  genes	  may	  be	  carried	  on	  the	  same	  plasmid	   due	   to	   recombination.	   Co-­‐occurrence	   of	   several	   replicons	   in	   the	   same	  host	   could	  provide	   the	  opportunity	   for	  plasmids	   to	   recombine,	  generating	  new	  plasmid	   variants.	   In	   particular,	   IncF	  plasmids	   are	   known	   to	  be	   large	   and	  often	  carry	   multiple	   rep	   genes	   (as	   demonstrated	   in	   Chapter	   4	   of	   this	   thesis).	   Co-­‐occurring	  FIA,	  FIB	  and	  FIC	  replicons	  may	   in	   fact	   represent	   large	  multi-­‐replicon	  recombinant	  plasmids,	  rather	  than	  several	  small	  plasmids.	  	  	  
5.4.4 E.	  coli	  population	  structure	  Host	  population	  structure	  is	  recognized	  as	  a	  key	  determinant	  of	  genetic	  diversity	  in	  parasites	  (van	  den	  Broeck	  et	  al.	  2014).	  As	  plasmids	  can	  be	  considered	  to	  act	  as	  parasites,	   it	   follows	   that	   the	  population	  structure	  of	  host	   cells	  may	  also	  have	  a	  large	   influence	  of	  plasmid	  genetic	  diversity.	   It	   is	   therefore	  vital	   to	  consider	   the	  host	   population	   structure	   when	   examining	   plasmid	   populations.	   In	   this	   study,	  many	  pats	  appear	  to	  contain	  clonal	  E.	  coli	  populations:	  all	   isolates	  from	  a	  given	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pat	  have	  the	  same	  H-­‐antigen	  type.	  We	  can	  assume	  that	  each	  pat	  is	  independent	  (from	  one	  animal),	  and	  from	  this	  we	  can	  infer	  that	  the	  E.	  coli	  population	  within	  one	   cow	   is	   largely	   clonal.	   In	   fact,	   this	   may	   be	   an	   underestimate	   of	   between-­‐animal	   variation,	   as	  multiple	   pats	   from	  one	   animal	  may	   have	   been	   sampled.	   A	  previous	   study	   (with	   a	  much	   smaller	   sample	   size,	   n	   =	   99;	   Sawant	   et	   al.	   2007)	  found	   that	   multiple	   animals	   at	   the	   same	   farm	   carried	   E.	   coli	   of	   the	   same	  subgroup,	   but	   that	   subgroups	   were	   not	   found	   on	   more	   than	   one	   farm.	  Unfortunately,	  despite	  using	  direct	  animal	  sampling,	   it	   is	  not	  possible	   to	  assess	  the	  clonality	  of	  E.	  coli	  populations	  within	  animals	  in	  this	  study,	  as	  only	  1-­‐2	  E.	  coli	  isolates	  were	  tested	  per	  animal.	  However,	  other	  studies	  have	  demonstrated	  that	  the	  enteric	  E.	  coli	  populations	  of	  cattle	  consist	  of	   few	  dominant	  E.	  coli	   subtypes	  and	   many	   transient	   subtypes,	   which	   may	   appear	   only	   once	   (Anderson	   et	   al.	  2006;	   Jenkins	   et	   al.	   2003).	   Human	   enteric	   E.	   coli	   have	   also	   shown	   a	   similar	  pattern	  (Caugant	  et	  al.	  1981).	  My	  data	  fits	  well	  with	  this	  model	  of	  one	  dominant	  and	  several	  less	  common	  E.	  coli	  subtypes,	  and	  the	  larger	  numbers	  of	  pats	  and	  E.	  
coli	   sampled	   adds	   weight	   to	   the	   conclusion,	   although	   it	   is	   not	   possible	   to	   say	  whether	   the	   less	   common	   subtypes	   are	   transient	   as	   all	   the	   samples	   were	  collected	  at	  one	  time	  point.	  	  	  A	   highly	   clonal,	   low	   diversity,	   E.	   coli	   population	   within	   an	   animal	   has	  implications	   for	   the	   plasmid	   population.	   As	   discussed	   in	   Section	   5.4.3	   above,	  plasmid	   diversity	   correlates	   strongly	  with	   host	   diversity,	   so	   that	   a	   clonal	   host	  population	   is	   likely	   to	  have	  a	   clonal	  plasmid	  population.	  However,	   transient	  or	  rare	  E.	  coli	  subtypes	  could	  introduce	  new	  plasmids	  to	  the	  system	  via	  conjugation.	  Indeed	  Caugant	  et	  al.	   (1981)	   	   found	  changes	   in	   the	  plasmid	  profiles	  of	   the	   two	  dominant	  E.	  coli	  subtypes	  in	  a	  human	  gut	  over	  the	  course	  of	  their	  study.	  	  	  
5.4.5 Conclusions	  and	  outlook	  This	   study	   presents	   some	   fundamental	   ecology	   of	   enteric	  E.	   coli	   and	   plasmids	  from	   cattle.	   It	   has	   found	   surprisingly	   low	   levels	   of	   resistance,	   giving	  hope	   that	  alternative	  means	   of	   cattle	   rearing	  may	   lead	   to	   lower	   prevalence	   of	   antibiotic	  resistance.	   It	  has	  also	  demonstrated	   the	   link	  between	  host	  E.	  coli	  diversity	  and	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plasmid	   diversity,	   and	   found	   that	   E.	   coli	   populations	   are	   highly	   structured.	  Further	   sequencing	   of	   plasmids	  would	   allow	  us	   to	   build	   a	   fuller	   picture	   of	   the	  plasmid	   population,	   in	   particular	   IncF	   plasmids,	   complementing	   the	   work	   in	  Chapter	  4	  of	  this	  thesis.	  DNA	  extraction	  and	  sequencing	  may	  also	  uncover	  small	  plasmids	  that	  were	  missed	  by	  replicon	  typing,	  and	  enable	  more	  accurate	  analysis	  of	  plasmid	  mobility.	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Chapter	  6: Parasitic	  plasmid	  persistence	  and	  conjugation	  	  
6.1 Introduction	  
6.1.1 Plasmid	  persistence	  and	  parasitism	  Three	   fundamental	   forces	   governing	   plasmid	   persistence	   were	   identified	   by	  Levin	   and	   Stewart	   over	   30	   years	   ago:	   the	   rate	   of	   conjugation,	   the	   rate	   of	  segregational	  loss	  and	  the	  cost	  of	  plasmid	  carriage	  to	  the	  host	  (Stewart	  &	  Levin	  1977;	   Levin	   &	   Stewart	   1980).	   	   For	   plasmids	   to	   persist	   in	   a	   population,	   the	  relationship	  between	  these	  parameters	  can	  be	  summarized	  by	  the	  equation:	  	  Transfer	  Rate	  >	  Cost	  of	  Carriage	  +	  Segregation	  Rate	  	  Plasmids	  can	  be	   lost	   from	  a	  population	  by	  segregation,	  where	  plasmids	  are	  not	  equally	   distributed	   amongst	   daughter	   cells	   during	   cell	   division.	   This	  segregational	  loss	  may	  be	  exacerbated	  by	  a	  high	  cost	  of	  plasmid	  carriage:	  more	  costly	  plasmids	  may	  be	   lost	  at	  a	  greater	   rate.	  Conversely,	   these	   factors	  may	  be	  mitigated	  by	  high	  rates	  of	  conjugation:	  horizontal	  transfer	  to	  plasmid-­‐free	  cells.	  	  	  The	  survival	  of	  plasmids	  which	  provide	  some	  selective	  advantage	  to	  their	  host	  in	  a	  specific	  environment	  appears	   to	  be	  straight	   forward	  (Stewart	  &	  Levin	  1977),	  and	   persistence	   through	   the	   carriage	   of	   transiently	   beneficial	   genes,	   which	  facilitate	   growth	   in	   a	   particular	   niche	   (an	   ‘accessory	   genome’),	   is	   a	   common	  explanation	   (Eberhard	  2003).	  However,	   although	   this	   theory	   could	   explain	   the	  localization	  of	  many	  apparently	  non-­‐essential	  genes	  to	  plasmids,	  and	  their	  lack	  of	  essential	  ‘housekeeping’	  genes	  (although	  see	  section	  6.1.3	  below,	  and	  Galibert	  et	  al.	   (2001),	   it	   invokes	  the	  controversial	   theory	  of	  population-­‐level	  selection,	  and	  fails	  to	  explain	  the	  existence	  of	  plasmids	  carrying	  beneficial	  traits	   in	  the	  face	  of	  transfer	   of	   these	   genes	   to	   the	   chromosome	   (Thomas	   2004;	   Eberhard	   1990;	  Bergstrom	   et	   al.	   2000).	   As	   Eberhard	   (1990)	   bluntly	   states	   “this	   and	   other	  
explanations…	  are	  probably	  wrong”.	  In	  reality,	  not	  all	  plasmids	  confer	  an	  obvious	  advantage,	  and	  beneficial	  plasmids	  are	  also	   found	  beyond	   their	  adaptive	  niche.	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The	   challenge	   is	   to	   explain	   the	   survival	   of	   these	   cryptic	   and	   residual	  plasmids.	  Theory	   predicts	   that	   plasmids	   can	   be	   maintained	   parasitically,	   without	  conferring	  an	  advantage	  to	  their	  host	  if	  the	  parameters	  of	  the	  above	  equation	  can	  be	   balanced	   appropriately,	   i.e.	   high	   conjugation,	   low	   cost	   and	   low	   segregation	  rate	  (Figure	  6.1).	  However,	  this	  has	  been	  difficult	  to	  demonstrate	  experimentally	  (Gordon	  1992;	  Bahl	  et	  al.	  2007;	  Freter	  et	  al.	  1983;	  Simonsen	  1991).	  	  
	  
Figure	  6.1:	  Factors	  affecting	  the	  survival	  of	  plasmid	  bearing	  and	  plasmid	  free	  cells.	  The	  plasmid	  bearing	  cells	  must	  balance	  the	  cost	  of	  plasmid	  carriage	  and	  the	  segregation	  rate	  with	  conjugation	  rate	  in	  order	  to	  survive.	  Adapted	  from	  Lili	  et	  al.	  (2007).	  	  The	   rate	  of	   conjugation	   is	   key	   to	   the	  argument	   against	  parasitism:	   are	   rates	  of	  transfer	   high	   enough	   in	   ‘real’	   populations	   for	   plasmids	   to	   be	   maintained	  parasitically?	   Early	   work	   by	   Lundquist	   &	   Levin	   (1986)	   demonstrated	   the	  importance	  of	   conjugation	   for	  plasmid	  carrier	   invasion	   from	  rare	   in	   laboratory	  broth	  culture,	  but	  only	  two	  of	  the	  seven	  plasmids	  tested	  were	  able	  to	  invade.	  In	  addition,	  both	  this	  study	  and	  the	  subsequent	  work	  by	  Simonsen	  et	  al	  (1990)	  used	  laboratory	   plasmids	   almost	   exclusively.	   It	   is	   likely	   that	   transfer	   rates	   of	   wild	  plasmids	  would	  differ	  from	  those	  produced	  artificially	  in	  the	  laboratory.	  Indeed	  transfer	  rates	  of	  plasmids	  isolated	  from	  wild	  E.	  coli	  populations	  have	  been	  shown	  to	   be	   too	   low	   to	   support	   parasitic	   plasmid	   maintenance	   based	   on	   Stewart	   &	  Levin’s	  models	  (Gordon	  1992).	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6.1.2 Alternative	  models	  of	  plasmid	  persistence	  The	  ‘local	  adaptation	  hypothesis’,	  proposed	  by	  Eberhard	  (1990),	  states	  that	  new	  species	   colonizing	   a	   site	   may	   obtain	   beneficial	   site-­‐specific	   genes	   by	   plasmid	  acquisition,	  and	  that	  in	  return,	  plasmid	  transfer	  to	  incoming	  clones	  will	  result	  in	  plasmid	   association	   with	   superior	   (fitter)	   host	   backgrounds,	   allowing	   the	  plasmid	   to	   increase	   in	   frequency.	   Bergstrom	   et	   al.	   (2000)	   expand	   upon	   these	  ideas	   and	   update	   the	   1977	   model	   (Stewart	   &	   Levin	   1977)	   to	   accommodate	  reportedly	   low	   conjugation	   rates	   (Gordon	   1992)	   and	   the	   transfer	   of	   beneficial	  genes	   to	   the	   chromosome.	   They	   propose	   that	   over	   time,	   plasmid	   carried	  beneficial	  genes	  will	  move	  to	  the	  chromosome	  and	  plasmids	  will	  be	   lost	  unless	  there	   are	   regular	   selective	   sweeps	   through	   the	   host	   population.	   Plasmids	  may	  transfer	  to	  the	  incoming	  (fitter)	  host	  background	  and	  thus	  ‘hitchhike’	  to	  success.	  Plasmid	   carried	   gene	   copies	   may	   also	   transfer	   across	   species	   and	   strain	  boundaries,	   thus	  avoiding	  deletion	  through	  selective	  sweeps	  in	  one	  host.	  These	  scenarios	  both	  emphasize	  the	  importance	  of	  conjugation	  but	  struggle	  to	  explain	  plasmid	   persistence	   in	   the	   absence	   of	   a	   benefit	   to	   the	   host,	   suggesting	   that	  cryptic	  plasmids	   either:	   i)	   have	   a	  hidden	  benefit	  we	   are	  unaware	  of;	   ii)	   are	   ‘in	  transit’	   and	  must	   gain	   a	   beneficial	   gene	   or	   be	   lost;	   or	   iii)	   exist	   parasitically	   by	  evolving	  to	  have	  almost	  no	  cost.	  	  	  Reevaluation	   of	   the	  models	   derived	   from	   Stewart	  &	   Levin	   (1977)	   has	   led	   to	   a	  very	  different	  conclusion:	  that	  plasmids	  can	  persist	  parasitically	  via	  oscillations	  between	  plasmid-­‐bearing	  and	  plasmid-­‐free	  cells,	  negating	  the	  need	  for	  complex	  heterogeneous	   population	   models	   such	   as	   hitchhiking	   and	   ecotype	   switching,	  and	   allowing	   stable	   existence	   of	   cryptic	   plasmids	   (Lili	   et	   al.	   2007).	   This	   stable	  coexistence	   of	   plasmid-­‐free	   and	   plasmid-­‐bearing	   cells	   is	   also	   supported	   by	   a	  novel	   modeling	   approach	   allowing	   the	   burden	   of	   plasmid	   carriage	   to	   change	  stochastically,	  independently	  of	  previous	  time	  points	  (Ponciano	  et	  al.	  2007).	  This	  method	   is	   biologically	   neat,	   as	   it	   allows	   environmental	   and	   ecological	   factors	  affecting	   plasmid	   cost	   to	   be	   modeled,	   so	   that	   for	   example,	   compensatory	  mutations	   could	   reduce	   the	   cost	   of	   carriage	   or	   that	   removal	   of	   a	   selective	  pressure	   (i.e.	   antibiotic	   treatment)	   could	   increase	   the	   cost.	   It	   should	   be	   noted	  that	  the	  effect	  of	  coevolution	  of	  a	  host/plasmid	  combination	  is	  likely	  to	  lead	  to	  a	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downward	  trend	  in	  plasmid	  cost,	  rather	  than	  stochastic	  variation	  (Dionisio	  et	  al.	  2005;	   Dahlberg	   &	   Chao	   2003;	   Bouma	   &	   Lenski	   1988).	   Moreover,	   the	   model	  explains	   only	   some	   of	   their	   data	   (four	   out	   of	   seven	   experiments)	   better	   than	  models	   derived	   from	   Stewart	   &	   Levin,	   (1977).	   However,	   as	   with	   the	   model	  proposed	   by	   Lili	   et	   al.	   (2000),	   this	   model	   predicts	   some	   stable	   coexistence	   of	  plasmid-­‐free	  and	  plasmid-­‐bearing	  strains,	  and	  additionally	  allows	  estimation	  of	  the	   key	   parameter	   causing	   plasmid	   loss:	   segregation	   rate,	   plasmid	   cost	   or	  conjugation	  rate	  (Figure	  6.1).	  
	  
6.1.3 Plasmid	  and	  host	  (co-­‐)	  evolution	  	  Evolution	  of	  the	  plasmid,	  the	  host	  cell	  and/or	  coevolution	  of	  the	  two	  can	  have	  a	  major	   impact	   on	   the	   key	   parameters	   of	   plasmid	   survival	   (Figure	   6.1).	   Plasmid	  evolution	   can	   reduce	   the	   cost	   of	   carriage	   to	   zero	   over	   just	   420	   generations	  (Dionisio	  et	  al.	  2005).	  In	  contrast,	  host	  evolution	  over	  500	  generations	  (with	  no	  detectable	  change	  in	  the	  plasmid)	  can	  not	  only	  reduce	  to	  the	  cost	  of	  carriage	  to	  zero,	   but	   can	   also	   confer	   a	   significant	   fitness	   advantage	   to	   plasmid	   carriers	  (Bouma	  &	  Lenski	  1988).	  There	   is	  also	  middle	  way:	  coevolution	  of	   the	  host	  and	  plasmid	  (Dahlberg	  &	  Chao	  2003).	  Harrison	  &	  Brockhurst	  (2012)	  propose	  three	  mechanisms	   by	   which	   coevolution	   can	   reduce	   the	   cost	   of	   plasmid	   carriage:	  altered	  conjugation	  rate,	  loss	  of	  genes	  and	  changes	  in	  gene	  expression.	  	  	  The	   first	  mechanism	   they	   propose	   is	   altered	   conjugation	   rate.	   This	  may	   seem	  inexplicable	  at	   the	  gene	  or	  plasmid	   level,	  but	  could	  be	  beneficial	  at	   the	   level	  of	  the	   cell:	   conjugation	   is	   metabolically	   costly,	   inhibits	   (temporarily)	   replication,	  and	  may	  make	  cells	  more	  vulnerable	   to	  phage	  attack	   (Thomas	  2004;	  Eberhard	  1990).	  Plasmid	  evolution	  can	  be	  seen	  as	  analogous	  to	  the	  evolution	  of	  symbiosis,	  where	  coadaptation	  of	  plasmid	  and	  host	  could	  be	  a	  step	  on	  the	  road	  to	  obligate	  symbiosis	  and	   the	   ‘domestication’	  of	  plasmids	   (Slater	  et	   al.	  2008).	   	   Slater	  et	   al.	  cite	   the	   example	   of	   the	   large,	   apparently	   obligate-­‐symbiont	   plasmids	   of	  
Sinorhizobium	  meliloti.	  One	  of	  these	  plasmids,	  pSymB,	  appears	  to	  have	  lost	  most	  of	  its	  transfer	  genes,	  and	  gained	  an	  essential	  housekeeping	  gene,	  suggesting	  that	  it	   is	  well	  down	   the	  path	   towards	  obligate	   symbiosis	   (Galibert	   et	   al.	   2001).	  The	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host	   can	   also	   affect	   the	   transfer	   rate	   by	   modulating	   plasmid	   gene	   expression,	  highlighting	  the	  importance	  of	  coevolution	  of	  host	  and	  plasmid	  (Dahlberg	  &	  Chao	  2003).	   The	   second	  mechanism	   proposed	   is	   loss	   of	   genes.	   This	   seems	   a	   logical	  way	   to	   reduce	   the	   cost	   of	  plasmid	   carriage,	   as	   fewer	   genes	  means	   less	  DNA	   to	  replicate,	  as	  well	  as	  reducing	  the	  cost	  of	  gene	  expression.	  However,	  it	  seems	  that	  this	  mechanism	   is	   less	   common	   in	   reality	   than	  might	   be	   expected.	  Dahlberg	  &	  Chao	  (2003)	  examined	  the	  evolution	  of	  two	  plasmids	  and	  their	  hosts	  over	  1100	  generations	   in	   antibiotic-­‐free	   broth	   culture,	   and	   found	   that	   most	   lineages	  retained	   a	   costly	   antibiotic	   resistance	   gene.	   In	   addition,	   just	   one	   replicate	   had	  reduced	  plasmid	  copy	  number	  -­‐	  another	  form	  of	  gene	  loss	  -­‐	  and	  moreover,	  one	  replicate	   had	   increased	   copy	   number.	   Again,	   this	   appears	   to	   be	   a	   complex	  mechanism,	   perhaps	   due	   to	   the	   tension	   between	   copy	   number	   and	   plasmid	  stability	  (Thomas	  2004).	  The	  final	  mechanism,	  plasmid	  cost,	  may	  be	  reduced	  by	  altered	   gene	   expression,	   regulated	   by	   either	   the	   plasmid	   or	   the	   host.	   As	  mentioned	  above,	  Dahlberg	  &	  Chao	   suggest	   that	   conjugation	   is	   limited	   in	   their	  evolved	   strains	   by	   actions	   of	   the	   host	   to	   suppress	   gene	   expression.	   However,	  tight	  regulation	  of	  gene	  expression	  can	  also	  be	  encoded	  by	  the	  plasmid,	  as	  seen	  in	  the	  Inc-­‐P1	  family	  (Schlüter	  et	  al.	  2007;	  Heuer	  et	  al.	  2007).	  	  Although	  the	  key	  factors	  affecting	  plasmid	  maintenance	  remain	  true,	  subsequent	  experimental	   and	   theoretical	   work	   has	   suggested	   that	   this	   is	   perhaps	   a	  simplification,	  and	  that	  other	  factors	  such	  as	  population	  density,	  environmental	  fluctuation	   and	   (co-­‐)	   evolution	   of	   host	   and	   plasmid	   are	   equally	   important	  (Thomas	  2004;	  Harrison	  &	  Brockhurst	  2012;	  Slater	  et	  al.	  2008;	  Simonsen	  1991).	  Furthermore,	   it	   seems	   that	   estimations	   of	   these	   key	   parameters	   affecting	  plasmid	  survival	  are	  still	  open	  to	  debate.	  It	  is	  nevertheless	  clear	  that	  conjugation	  plays	  a	   critical	   role	   in	  plasmid	  persistence	   (Sia	   et	   al.	   1995;	  Easter	   et	   al.	   1997),	  and	  that	  horizontal	  transfer	  does	  occur	  in	  biologically	  meaningful	  contexts,	  such	  as	  the	  gut	  (Freter	  et	  al.	  1983).	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6.2.1 Strains	  &	  culture	  techniques	  The	   strains	   used	   in	   this	   chapter	   are	   E.	   coli	   K-­‐12	   MG1655	   and	   the	   MG1655	  ΔlacZYA	  mutant.	   The	   plasmids	   are	   pCT	   and	   its	   non-­‐conjugative	   derivative	   pCT	  ΔtrbA.	   pCT	   carries	   the	   ESBL	   resistance	   gene	   CTX-­‐M-­‐14	   (Cottell	   et	   al.	   2011).	  Plasmids	  were	  transformed	  into	  both	  host	  backgrounds.	  The	  wild	  type	  MG1655	  strain	  is	  blue	  in	  the	  presence	  of	  X-­‐Gal	  &	  IPTG	  whereas	  the	  mutant	  ΔlacZYA	  strain	  is	  white.	  The	  fitness	  cost	  of	  the	  lacZYA	  knockout	  was	  assessed	  with	  competition	  in	  broth,	   the	   results	  of	  which	  can	  be	   seen	   in	  Chapter	  2,	   Section	  2.3.3.	  The	  blue	  MG1655	  strain	  appears	  to	  be	  slightly	  fitter	  in	  broth.	  Generic	  culture	  techniques	  and	  antibiotic	  specifications	  can	  also	  be	  seen	  in	  Chapter	  2,	  Section	  2.2.1.	  	  	  	  
6.2.2 Serial	  transfer	  experiments	  Serial	   transfer	  experiments	  were	  conducted	   in	  1	  ml	  LB	  broth	  +	  X-­‐Gal	   (0.02	  mg	  ml-­‐1)	   &	   IPTG	   (0.1	  mM)	   (Fisher	   Scientific)	   in	   24	  well	   plates	   (Costar®	   Corning®,	  Sigma-­‐Aldrich).	   All	   wells	   contained	   broth,	   but	   only	   alternate	   wells	   were	  inoculated	   to	   reduce	   and	   monitor	   for	   cross-­‐contamination	   (Figure	   6.2).	  Experimental	  mixes	  were	  initiated	  from	  fresh	  overnight	  cultures	  of	  two	  strains:	  four	   combinations	   of	   plasmid	   carriers	   and	   plasmid-­‐free	   cells	   were	   used	   (see	  further	   details	   below	   and	   Table	   6.1).	   OD600	   of	   these	   overnight	   cultures	   was	  measured	   and	   strains	   were	   diluted	   to	   approximately	   equal	   density,	   and	   then	  mixed	   to	   give	   the	   desired	   initial	   proportion	   of	   plasmid	   carriers.	   Inoculated	   24	  well	   plates	   were	   incubated	   at	   37°C	   and	   shaken	   at	   120	   rpm.	   Cultures	   were	  transferred	   to	   fresh	   broth	   every	   2-­‐3	   days	   in	   a	   Monday,	   Wednesday,	   Friday	  pattern.	  All	  transfers	  were	  conducted	  using	  filter	  tips	  in	  a	  laminar	  flow	  cabinet	  to	  reduce	  contamination	  risk,	  as	  no	  selective	  antibiotic	  was	  used.	  	  	  Samples	  were	   taken	   periodically	   from	   the	   cultures	   before	   transfer	   in	   order	   to	  measure	   the	  proportion	  of	   plasmid	   carrying	   cells.	   These	   samples	  were	   serially	  diluted,	   plated	   onto	   LB	  Agar	   +	   X-­‐Gal	  &	   IPTG	  with	   and	  without	   cefotaxime	   and	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incubated	   at	   37°C	   overnight.	   This	   allowed	   counts	   of	   plasmid-­‐free	   cells	   and	  plasmid	   carriers,	   including	   transconjugants,	   to	   be	   obtained.	   Estimates	   of	   the	  number	   of	   segregants	   were	   made	   by	   subtracting	   counts	   of	   original	   plasmid	  carriers	   on	   cefotaxime	   from	   counts	   on	   LB	  only	   plates.	   Samples	   from	   the	   serial	  transfers	   were	   also	   periodically	   stored	   in	   80%	   glycerol	   at	   -­‐80°C	   (Chapter	   2,	  Section	  2.2.1).	  	  	  	  
	  	  	  
Figure	  6.2:	  Serial	  transfer	  experiments.	  Mixtures	  of	  plasmid-­‐free	  and	  plasmid-­‐bearing	  cells	  were	  inoculated	  into	  alternate	  wells	  of	  a	  24	  well	  plate,	  containing	  LB	  broth	  +	  X-­‐Gal	  &	  IPTG.	  Cultures	  were	  incubated	  at	  37°C	  and	  shaken	  at	  120	  rpm.	  Transfers	  occurred	  every	  2-­‐3	  days,	  when	  cultures	  were	  diluted	  and	  re-­‐inoculated	  into	  fresh	  broth.	  Samples	  were	  taken	  periodically	  before	  transfer	  and	  plated	  onto	  cefotaxime	  containing	  plates	  to	  determine	  the	  proportion	  of	  plasmid-­‐carrying	  cells.	  	  
Serial	  transfer	  experiment	  1	  Experiment	   1	   used	   MG1655	   +	   pCT	   and	   MG1655	   +	   pCT	   ΔtrbA	   as	   the	   plasmid	  carrying	  strains,	  with	  MG1655	  ΔlacZYA	  as	  the	  plasmid-­‐free	  strain	  in	  both	  cases,	  and	   an	   initial	   proportion	   of	   plasmid	   carriers	   of	   approximately	   0.01.	   Three	  transfer	  regimes	  were	  used	   in	   this	  experiment	   to	  vary	  the	  bottleneck	   intensity.	  At	   transfer,	   the	   old	   culture	   was	   diluted	   with	   0.85%	   (w/v)	   saline	   either	   1:10,	  1:100	  or	  1:1000,	  and	  fresh	  broth	  was	  inoculated	  by	  a	  further	  1:10	  dilution.	  The	  total	  dilutions	  at	   transfer	  (including	  both	  saline	  dilution	  and	  broth	   inoculation)	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were	   therefore	   100-­‐,	   1000-­‐	   and	   10000-­‐fold	   for	   the	   low,	   medium	   and	   high	  bottleneck	  intensities	  respectively.	  There	  were	  six	  replicates	  for	  each	  treatment	  and	  the	  experiment	  lasted	  21	  days.	  	  










Table	   6.1:	   Combinations	   of	   plasmid	   carriers	   and	   plasmid-­‐free	   cells.	   All	   four	  combinations	  were	  used	  in	  serial	  transfer	  2,	  only	  the	  first	  two	  (with	  the	  plasmids	  in	  the	  MG1655	  host)	  were	  used	  in	  serial	  transfer	  1.	  	  
6.2.3 Serial	  transfer	  2	  end	  point	  assays	  Selected	   strains	   from	   serial	   transfer	   2,	  where	   the	   initial	   proportion	   of	   plasmid	  carriers	  was	   varied,	  were	   assessed	   for	   evolution	   of	   the	   host	   and	  plasmid	   after	  serial	   transfer	   for	   32	   days.	   Conjugative	   pCT	   carrying	   strains	   were	   selected	   to	  assess	   any	   change	   in	   the	   cost	   of	   plasmid	   carriage	   or	   rates	   of	   conjugation.	   In	  
Blue	  strain	   White	  strain	  MG1655	  +	  pCT	   MG1655	  ΔlacZYA	  MG1655	  	  +	  pCT	  ΔtrbA	   MG1655	  ΔlacZYA	  MG1655	   MG1655	  ΔlacZYA	  +	  pCT	  MG1655	   MG1655	  ΔlacZYA	  +	  pCT	  ΔtrbA	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addition,	   a	   strain	   that	   maintained	   a	   particularly	   high	   proportion	   of	   plasmid	  carriers	  in	  the	  serial	  transfer	  (MG1655	  ΔlacZYA	  +	  pCT	  ΔtrbA	  evolved	  strain	  2B1),	  was	   assessed	   for	   altered	   fitness	   in	   comparison	   to	   the	   ancestor.	   Strains	   were	  revived	  from	  serial	  transfer	  glycerol	  stocks	  and	  streaked	  out	  twice	  to	  obtain	  pure	  single	  colonies.	  	  
6.2.3.1 Competition	  experiments	  Competition	   experiments	   were	   conducted	   to	   assess	   the	   relative	   fitness	   of	   the	  evolved	  and	  ancestral	  lineages,	  as	  described	  in	  Chapter	  2,	  Section	  2.2.4.	  Evolved	  lineages	   were	   competed	   against	   their	   opposite	   ancestral	   type,	   for	   example	  evolved	   MG1655+pCT	   would	   compete	   against	   ancestral	   MG1655	   ΔlacZYA.	  Competitions	  were	  conducted	  in	  1	  ml	  LB	  broth	  +	  X-­‐Gal	  &	  IPTG	  in	  24	  well	  plates.	  Overnight	  cultures	  of	  the	  competitors	  were	  diluted	  to	  approximately	  equally	  cell	  density	   and	  mixed	  1:1,	   then	   inoculated	   into	   broth	   by	   a	   1:5	   dilution.	   20	   μl	  was	  immediately	   taken	  and	  diluted	  to	  obtain	  the	  starting	  ratio.	  Broth	  cultures	  were	  incubated	   at	   37°C	   and	   shaken	   at	   120	   rpm	   for	   24	   hours.	   Final	   counts	   were	  obtained	   by	   serial	   dilution	   and	   plating	   onto	   LB	   agar	   +	   X-­‐Gal	   &	   IPTG	   +/-­‐	  cefotaxime.	  Relative	  fitness	  in	  broth	  competitions	  was	  calculated	  as	  described	  by	  Ross-­‐Gillespie	  et	  al.	  (2007):	  
v	  	  =	  	  x2(1	  –	  x1)/	  x1(1	  -­‐	  x2)	  	  Where	   v	   is	   the	   relative	   fitness	   of	  MG1655,	   x1	   is	   their	   initial	   proportion	   and	   x2	  their	  final	  proportion.	  	  	  These	   competition	   experiments	   were	   conducted	   for	   the	   four	   conjugative	   pCT	  carrying	   strains,	   two	  with	   pCT	  white	   background	   (1A3,	   1B6)	   and	   two	   in	   blue	  background	  (3A6,	  3B6).	  Six	  replicates,	  initiated	  from	  independent	  colonies,	  were	  performed	  for	  each	  strain.	  For	  strain	  1A3,	  2	  original	  plasmid	  carriers	  (white)	  and	  4	  transconjugants	  (blue)	  were	  used.	  Competitions	  were	  also	  conducted	  with	  the	  evolved	   strain	   2B1	   and	   its	   ancestor	   MG1655	   ΔlacZYA	   +	   pCT	   ΔtrbA.	   Twelve	  replicates,	   initiated	   from	   independent	   colonies,	   were	   used	   in	   these	   two	  competitions.	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6.2.3.2 Mating	  experiments	  Mating	   experiments	  were	   conducted	   to	   assess	   any	   changes	   in	   conjugation	   rate	  between	  evolved	  and	  ancestral	  lineages.	  Crosses	  were	  set	  up	  from	  independent	  donor	  and	  recipient	  cultures,	  and	  evolved	  lineages	  were	  again	  mated	  with	  their	  opposite	  ancestral	  type.	  OD600	  of	  overnight	  cultures	  were	  measured	  and	  cultures	  diluted	  to	  approximately	  the	  same	  density.	  	  Mixtures	  were	  made	  with	  a	  1:5	  ratio	  of	  donors	  to	  recipients	  and	  a	  1	  in	  5	  dilution	  into	  fresh	  LB	  broth	  +	  X-­‐Gal	  &	  IPTG,	  with	   a	   final	   volume	   of	   1	   ml.	   Mating	   experiments	   were	   conducted	   in	   24	   well	  plates,	   and	   incubated	  at	  37°C,	  220	   rpm	   for	  24	  hours.	   Initial	   and	   final	  mixtures	  were	   serially	  diluted	   and	  plated	  out	   onto	  LB	  +	  X-­‐Gal	  &	   IPTG	  +/-­‐	   cefotaxime	   to	  assess	  ratios.	  Conjugation	  rate	  was	  calculated	  by	  the	  equation:	  	   !"#$%&'$()*#$+%  !"#  !"#"$ = !"#$%  !"#$%&'$()*#$!%!"#$!  !"#"$% 	  
	  
6.2.4 Frequency	  dependence	  assay	  Data	   from	   serial	   transfer	   experiments	   indicated	   that	   plasmid	   carrier	   fitness	  might	  have	  a	   frequency	  dependent	  element.	   In	  order	  to	  assess	  this	  a	   frequency	  dependence	  assay	  was	  conducted.	  Here,	   competition	  experiments	  were	  carried	  out	   as	   described	   above	   (Section	   6.2.3.1)	   over	   a	   range	   of	   initial	   proportions	   of	  plasmid	  carriers	  from	  0.01-­‐0.9,	  using	  the	  non-­‐conjugative	  pCT	  ΔtrbA	  plasmid	  in	  both	  host	  backgrounds.	  	  	  
6.2.5 Statistical	  analysis	  The	  serial	   transfer	  experiments	  were	  designed	  such	   that	  a	   linear	  mixed-­‐effects	  (lme)	  model	  could	  be	  used	  to	  analyze	  the	  resulting	  data,	  with	  the	  proportion	  of	  plasmid	   carriers	   as	   the	   response	   variable;	   time,	   plasmid	   type,	   donor	   type	   and	  transfer	  regime	  as	  fixed	  effects;	  and	  replicate	  as	  a	  random	  effect.	  Modeling	  was	  conducted	   in	   R	   (R	   Core	   Team	   2013)	   using	   the	   nlme	   package	   (Pinheiro	   et	   al.	  2007).	   Restricted	  maximum	   likelihood	   (REML)	   lme	  models	   were	   converted	   to	  maximum	  likelihood	  (ML)	  models	  to	  allow	  model	  comparison	  using	  mixed	  model	  ANOVA.	  End	  point	  assays	  were	  compared	  using	  ANOVA	  or	  t	  	  tests	  as	  appropriate.	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6.3 Results	  




Figure	  6.3:	  Plasmid	  carriers	  decline	  in	  mixed	  non-­‐selective	  serial	  transfer.	  The	  rate	  of	  decline	  is	  faster	  for	  non-­‐conjugative	  plasmids,	  and	  decreases	  with	  bottleneck	  intensity	  from	  low	  (A)	  to	  moderate	  (B)	  and	  high	  (C).	  The	  mean	  rate	  of	  decline	  is	  significantly	  slower	  for	  wild	  type	  pCT	  (circles	  &	  solid	  line)	  carriers	  than	  non-­‐conjugative	  pCT	  ΔtrbA	  (diamonds	  &	  broken	  line)	  (p	  =	  0.028),	  and	  under	  low	  bottleneck	  intensity	  (A)	  one	  replicate	  retains	  pCT	  carriage.	  There	  is	  a	  significant	  interaction	  between	  the	  bottleneck	  regime	  and	  time	  (p	  =	  0.001),	  indicating	  that	  plasmid	  carriers	  decline	  faster	  at	  higher	  bottleneck	  intensity.	  The	  plasmid	  host	  background	  was	  MG1655	  and	  its	  competitor	  was	  plasmid-­‐free	  MG1655	  ΔlacZYA.	  Serial	  transfer	  was	  in	  non-­‐selective	  LB	  broth	  +	  X-­‐Gal	  &	  IPTG,	  with	  transfers	  every	  2-­‐3	  days.	  Lines	  connect	  mean	  predicted	  values	  from	  the	  model	  (Table	  6.2).	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Model	   Term	  removed	   AIC	   ΔAIC	   p	  
Maximal	  model	   -­‐	   414.415	   0	   -­‐	  2.	   plasmid:	  time:	  dilute	   415.076	   +0.661	   0.103	  
Minimal	  adequate	  model	   plasmid:	  dilute	   413.730	   -­‐1.346	   0.418	  4.	   plasmid:	  time	   416.551	   +2.821	   0.028*	  5.	   dilute:	  time	   422.110	   +8.380	   0.001*	  
Null	  model	   Mean	  only	   500.432	   +86.702	   <0.0001*	  
	  
Table	  6.2:	  Model	  simplification	  for	  serial	  transfer	  1.	  Serial	  transfer	  data	  was	  modeled	  using	  a	  linear	  mixed	  effect	  model	  with	  the	  proportion	  of	  plasmid	  carriers	  as	  the	  response	  variable,	  replicate	  as	  the	  random	  effect	  and	  time,	  plasmid	  type	  and	  dilution	  as	  fixed	  effects.	  The	  proportion	  plasmid	  carriers	  was	  log10	  transformed	  after	  addition	  of	  the	  minimal	  detectable	  value	  (5	  x	  10-­‐10).	  “Dilute”	  represents	  1/	  bottleneck	  regime	  i.e.	  for	  the	  moderate	  intensity	  regime:	  1/1000	  =	  0.001.	  “:”	  indicates	  an	  interaction	  term.	  Maximal	  model:	  
Proportion	  plasmid	  carriers	  ~	  plasmid:	  time:	  dilute	  +	  plasmid:	  dilute	  +	  plasmid:	  time	  +	  dilute:	  time	  +	  plasmid	  +	  time	  +	  dilute,	  random	  effect	  =	  replicate.	  	  
Terms	  were	  removed	  sequentially	  from	  the	  maximal	  model,	  and	  models	  compared	  using	  ANOVA.	  Simplifications	  were	  accepted	  if	  the	  models	  were	  not	  significantly	  different	  when	  a	  term	  was	  removed	  (p	  *	  indicates	  a	  significant	  difference).	  AIC	  (Akaike’s	  information	  criterion)	  values	  were	  also	  compared	  for	  a	  general	  downward	  trend.	  Note	  that	  the	  AIC	  values	  of	  model	  5	  and	  the	  null	  model	  are	  compared	  to	  the	  minimal	  adequate	  model	  rather	  than	  the	  previous	  iteration,	  as	  models	  4	  and	  5	  excluded	  significant	  terms.	  Main	  effects	  were	  not	  tested	  separately	  due	  to	  their	  inclusion	  in	  interaction	  terms	  (Nelder	  1977).	  The	  null	  model	  is	  also	  given	  for	  comparison.	  The	  minimal	  adequate	  model	  has	  significant	  effects	  of	  the	  plasmid:	  time	  interaction	  and	  the	  dilute:	  time	  interaction,	  as	  given	  by	  the	  model:	  
Proportion	  plasmid	  carriers	  ~	  plasmid:	  time	  +	  dilute:	  time	  +	  plasmid	  +	  time	  +	  dilute,	  random	  effect	  =	  replicate.	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Although	   Figure	   6.3	   suggests	   that	   conjugation	   may	   contribute	   somewhat	   to	  plasmid	  maintenance,	   Figure	   6.4	   shows	   that	   the	   effect	   of	   conjugation	   is	   highly	  variable	  between	  conjugative	  plasmid	  replicates.	  In	  three	  cases	  (replicates	  3	  and	  4	  of	   the	   low	   intensity	   regime	  and	   replicate	  6	   in	   the	  moderate	   regime)	  plasmid	  persistence	  is	  entirely	  dependent	  on	  transconjugants.	  However,	  in	  one	  replicate	  of	   the	   low	   intensity	   regime	   (where	   pCT	   is	   maintained	   at	   a	   relatively	   stable	  proportion)	  and	  one	  replicate	  in	  the	  moderate	  regime	  no	  transconjugants	  were	  detected	  at	  all.	  	  
	  
Figure	   6.4:	   The	   contribution	   of	   original	   plasmid	   carrying	   cells	   and	  
transconjugants	  to	  final	  plasmid	  carrying	  cell	  counts.	  Original	  plasmid	  carrying	  cells	  (dark	  blue)	   and	   transconjugants	   (light	  blue)	   (log10	  CFU	  ml-­‐1)	   in	   the	   low	  and	  moderate	  bottleneck	   intensity	   regimes.	  Bars	   represent	   cell	   counts	  at	  day	  21	   for	   individual	   serial	  transfer	   replicates	   with	   the	   conjugative	   pCT	   plasmid.	   Data	   is	   not	   shown	   for	   the	   high	  intensity	  regime,	  as	  plasmid	  carriers	  were	  undetectable	  in	  all	  replicates.	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It	   is	   possible	   that	   plasmid	   carriers	   were	   maintained	   by	   conjugation	   with	  segregants	  that	  had	  lost	  the	  plasmid.	  An	  attempt	  was	  made	  to	  estimate	  numbers	  of	  segregants	  in	  serial	  transfer	  2	  by	  subtracting	  the	  number	  of	  plasmid	  carriers	  on	   ampicillin	   plates	   from	   the	   number	   on	   antibiotic	   free	   plates.	   There	   are	  limitations	   to	   this	  method,	   as	   it	   is	  difficult	   to	   identify	  plasmid	  carriers	  on	  non-­‐selective	   plates	   amongst	   high	   densities	   of	   plasmid	   free	   cells,	   and	   in	   fact	   this	  estimate	   suggests	   wildly	   variable	   segregation	   rates,	   with	   the	   proportion	   of	  original	   plasmid	   carriers	   that	   are	   segregants	   ranging	   from	   0	   to	   0.99	   (for	   pCT	  ΔtrbA	  in	  the	  white	  background	  at	  day	  5).	  Although	  it	  is	  not	  possible	  to	  draw	  any	  conclusions	  about	  the	  importance	  of	  conjugation	  with	  segregants,	  it	  is	  clear	  that	  transconjugants	  do	  contribute	  to	  plasmid	  survival	  in	  both	  the	  low	  and	  moderate	  intensity	  bottleneck	  regimes.	  	  Across	   all	   three	   bottleneck	   regimes	   it	   can	   be	   seen	   that	   conjugation	   is	   not	  sufficient	  to	  maintain	  plasmid	  carriers,	  as	  levels	  drop	  below	  detection	  in	  1	  of	  6,	  3	  of	   6,	   and	   6	   of	   6	   cases	   for	   the	   low,	   moderate	   and	   high	   intensity	   regimes	  respectively.	  However,	   the	  conjugative	  plasmid	  does	  have	  slightly	   lower	  rate	  of	  decline	  than	  its	  non-­‐conjugative	  derivative	  (p	  =	  0.028,	  Table	  6.2),	  and	  the	  decline	  is	   slower	   with	   less	   intense	   bottlenecks	   (Figure	   6.3,	   p	   =	   0.001).	   This	   data	  highlights	  the	  importance	  of	  population	  dynamics	  for	  plasmid	  maintenance:	  with	  relatively	   low	   initial	   plasmid	   frequency	   (around	   0.01)	   and	   frequent	   high-­‐intensity	  bottlenecks,	  conjugation	  cannot	  maintain	  the	  plasmid	  in	  the	  absence	  of	  selection,	   while	   conjugation	   may	   be	   able	   to	   maintain	   the	   plasmid	   if	   the	  bottleneck	  intensity	  is	  low.	  	  	  
6.3.2 Plasmid	  carriers	  increase	  from	  extremely	  rare	  It	   can	   be	   seen	   from	   Figure	   6.2	   that	   there	   is	   a	   marked	   difference	   in	   plasmid	  survival	  between	  low	  and	  moderate	  intensity	  bottlenecks.	  In	  order	  to	  investigate	  whether	  hitchhiking	  can	  maintain	  the	  plasmid	  in	  the	  face	  of	  moderate	  intensity	  bottlenecks	   (Bergstrom	  et	  al.	  2000),	   the	  moderate	   intensity	  serial	   transfer	  was	  replicated	   with	   plasmids	   in	   both	   the	   white	   (MG1655	   ΔlacZYA)	   and	   blue	  (MG1655)	  backgrounds.	  The	  results	  from	  Chapter	  2	  indicate	  that	  the	  blue	  strain	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has	   slightly	   higher	   fitness	   in	   broth	   (Chapter	   2,	   Figure	   2.5),	   and	   therefore	   it	   is	  predicted	  that	  the	  plasmid	  should	  hitchhike	  to	  higher	  frequencies	  when	  moving	  from	  the	  white	  to	  the	  blue	  background.	  In	  order	  to	  force	  rapid	  extinction	  of	  the	  non-­‐conjugative	  plasmid,	  serial	  transfers	  were	  initiated	  with	  low	  proportions	  of	  resistant	  cells,	  from	  0.001-­‐	  0.00001	  (Figure	  6.5).	  The	  results	  are	  surprising.	  In	  all	  cases,	   the	  proportion	  of	   resistant	   cells	   increases	   to	  0.01	  –	  0.1.	  The	   fact	   that	   all	  plasmids	   increase	   in	   frequency,	   regardless	   of	   conjugational	   ability	   or	   host	  background,	   suggests	   that	   neither	   conjugation	   nor	   hitchhiking	   are	   key	   factors	  driving	  the	  increase.	  	  	  Although	   plasmid	   type	   has	   a	   significant	   effect	   on	   the	   proportion	   of	   plasmid	  carriers	  over	   time	   (p	   =	  0.009,	  Table	  6.3),	   the	  pattern	   for	  both	  plasmids	   is	  very	  similar	   over	   the	   first	   19	   days.	   This	   can	   be	   seen	   by	   the	   parallel	   curves	   of	   the	  model	   (Figure	   6.5).	   The	   non-­‐conjugative	   plasmids	   had	   a	   slightly	   higher	   initial	  proportion,	  but	  otherwise	  the	  shapes	  of	   the	  curves	  are	  the	  same.	  After	  19	  days	  the	   non-­‐conjugative	   plasmid	   actually	   declines	   slightly	   less	   steeply	   than	  conjugative	  pCT,	  suggesting	  that	  conjugation	  is	  not	  a	  key	  contributory	  factor	  to	  plasmid	   survival,	   despite	   the	   fact	   that	   transconjugants	   account	   for	   a	   large	  proportion	  of	  plasmid	  carriers	  in	  the	  pCT	  mixtures	  (Figure	  6.6).	  This	  difference	  in	   final	   proportion	   of	   plasmid	   carriers	   is	   curious,	   and	   could	   perhaps	   be	  attributed	   to	   reduced	   fitness	   cost	   of	   pCT	   ΔtrbA	   carriage	   due	   to	   the	   deletion,	  although	  it	  is	  also	  possible	  that	  this	  difference	  is	  merely	  a	  fluctuation	  that	  would	  even	  out	  over	  time.	  	  	  Contrary	   to	   the	   hitchhiking	   hypothesis,	   the	   model	   shows	   that	   plasmid	   host	  background	   (“donor”)	   does	   not	   have	   a	   significant	   effect	   on	   the	   proportion	   of	  plasmid	  carriers	  over	  time,	  and	  was	  in	  fact	  excluded	  from	  the	  model	  (p	  =	  0.125,	  Table	  6.3).	  This	  confirms	  that	  hitchhiking	  is	  not	  a	  contributory	  factor	  for	  plasmid	  prevalence	   in	   this	   experiment.	   This	   also	   corroborates	   the	   suggestion	   that	  conjugation	  is	  not	  a	  significant	  factor	  for	  plasmid	  survival	  as	  the	  non-­‐conjugative	  plasmid	  does	  just	  as	  well,	   if	  not	  better,	  than	  its	  conjugative	  counterpart	  (Figure	  6.5).	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A	   second	   non-­‐linear	   model	   with	   temporal	   pseudoreplication	   was	   used	   to	  incorporate	   an	   asymptotic	   relationship	   between	   plasmid	   frequency	   and	   time	  (Figure	   6.5C).	   The	   AIC	   value	   for	   this	   model	   is	   816.81,	   almost	   identical	   to	   the	  value	   for	   the	   linear	  model	   (AIC	  =	  816.87,	  Figure	  6.5	  A	  &	  B),	   indicating	   that	   the	  models	  have	  similar	  explanatory	  power.	  However	  this	  model	  is	  more	  biologically	  appropriate	   as	   the	   asymptotic	   shaped	   curve	   is	   often	   associated	   with	   negative	  frequency	  dependent	  selection	  (see	  Figure	  6.9	  below).	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Figure	  6.5:	  The	  proportion	  of	  plasmid	  carriers	  can	  increase	  from	  rare	  and	  can	  be	  





Figure	  6.5	  C:	  Asymptotic	  model	  of	  proportion	  of	  plasmid	  carriers	  against	  time.	  ‘Donor’	  was	  shown	  to	  be	  non-­‐significant	  in	  the	  linear	  model,	  and	  was	  therefore	  not	  included	  in	  this	   model.	   Replicates	   from	   both	   donor	   backgrounds	   are	   pooled	   for	   the	   pCT	   plasmid	  (left	  panel)	  and	  pCT	  ΔtrbA	  plasmid	  (right	  panel).	  A	  2-­‐parameter	  asymptotic	  exponential	  function	  of	  time	  was	  fitted	  y	  =	  a	  (1-­‐	  e-­‐bx),	  where	  a	  and	  b	  were	  estimated	  from	  the	  data	  (a	  =	   -­‐2;	  b	  =	  3,	  AIC	  =	  816.81).	  A	   three-­‐parameter	  model,	  y	  =	  a	   -­‐	  be-­‐cx,	  was	  not	  significantly	  different	   from	  the	  two	  parameter	  model	  (ANOVA,	  p	  =	  0.366,	  AIC	  =	  820.50).	  The	  model	  formula	  is:	  	  
Proportion  plasmid  carriers  ~  !   1 − !!!∗!"#$ |  plasmid  
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Model	   Term	  removed	   AIC	   ΔAIC	   p	  
Maximal	  model	   -­‐	   818.754	   0	   	  2.	   plasmid:	  donor:	  time	   816.459	   -­‐2.295	   0.774	  3.	  	   plasmid:	  donor:	  time2	   817.213	   +0.754	   0.123	  4.	   donor:	  time2	   817.059	   -­‐0.154	   0.174	  5.	   donor:	  time	   815.466	   -­‐1.593	   0.523	  6.	   plasmid:	  donor	   816.522	   +1.056	   0.081	  7.	   plasmid:	  time	   818.488	   +1.966	   	  	  0.046*	  8.	   plasmid:	  time2	   821.266	   +4.744	   0.009*	  
Minimal	  adequate	  model	   donor	   816.872	  	   +0.35	   0.125	  
Null	  model	   Mean	  only	   1184.158	   +367.286	   <0.0001*	  
	  
Table	   6.3:	   Model	   simplification	   for	   serial	   transfer	   2.	   Serial	   transfer	   data	   was	  modeled	  using	  a	  linear	  mixed	  effect	  model	  with	  the	  proportion	  of	  plasmid	  carriers	  as	  the	  response	   variable,	   replicate	   as	   the	   random	   effect	   and	   time,	   time2,	   plasmid	   type	   and	  donor	   type	   as	   fixed	   effects.	   Donor	   type	   indicates	   the	   initial	   host	   background	   of	   the	  plasmid	  (blue	  or	  white).	  The	  proportion	  of	  plasmid	  carriers	  was	  log10	  transformed	  after	  addition	   of	   the	   minimal	   detectable	   value	   (1	   x	   10-­‐6).	   The	   quadratic	   term,	   time2,	   is	  included	   in	   the	   model	   to	   allow	   for	   the	   curvature	   of	   the	   data,	   but	   interaction	   terms	  including	  time2:	  time	  were	  excluded,	  as	  this	  produces	  the	  cubic	  term,	  time3,	  creating	  an	  inappropriate	  curve.	  “:”	  indicates	  an	  interaction	  term.	  Maximal	  model:	  	  
Proportion	   plasmid	   carriers	  ~	   plasmid:	   donor:	   time	   +	   plasmid:	   donor:	   time2	   +	   donor:	  time2	  +	  donor:	  time	  +	  plasmid:	  donor	  +	  plasmid:	  time	  +	  plasmid:	  time2	  +	  plasmid	  +	  donor	  +	  time	  +	  time2,	  random	  effect	  =	  replicate.	  	  Terms	  were	  removed	  sequentially	  from	  the	  maximal	  model,	  and	  models	  compared	  using	  ANOVA.	   Simplifications	   were	   accepted	   if	   the	   models	   were	   not	   significantly	   different	  when	   a	   term	   was	   removed	   (p	   *	   indicates	   a	   significant	   difference).	   AIC	   (Akaike’s	  information	  criterion)	  values	  were	  also	  compared	  for	  a	  general	  downward	  trend.	  Note	  that	  the	  AIC	  values	  of	  model	  8	  and	  the	  minimal	  adequate	  model	  are	  compared	  to	  model	  6,	  rather	  than	  the	  previous	  iteration,	  as	  models	  7	  and	  8	  excluded	  significant	  terms.	  Main	  effects	  were	   not	   tested	   separately	  when	   included	   in	   interaction	   terms	   (Nelder	   1977).	  The	  null	  model	  is	  also	  given	  for	  comparison.	  The	  minimal	  adequate	  model	  is:	  	  	  Proportion	  plasmid	  carriers	  ~	  plasmid:	  time	  +	  plasmid:	  time2	  +	  plasmid	  +	  time	  +	  time2,	  random	  effect	  =	  replicate.	  	  
	  
	  143	  
Figure	   6.6:	   The	   contribution	   of	   original	   plasmid	   carrying	   cells	   and	  
transconjugants	   to	   final	   plasmid	   carrying	   cell	   counts.	   Original	   plasmid	   carriers	  (n/n)	   and	   transconjugants	   (n/n)	   (log10	   CFU	   ml-­‐1)	   in	   the	   blue	   and	   white	   host	  backgrounds.	   Bars	   represent	   cell	   counts	   at	   day	   32	   for	   individual	   serial	   transfer	  replicates	  with	  the	  conjugative	  pCT	  plasmid.	  	  	  
6.3.3 Evolved	  fitness	  advantages	  do	  not	  explain	  plasmid	  survival	  One	   possible	   explanation	   for	   the	   increase	   in	   proportion	   of	   plasmid	   carriers	   in	  serial	   transfer	  2	   is	   some	  evolutionary	   change	   in	  either	   the	  host	  or	   the	  plasmid	  (or	  both),	  which	  may	  compensate	  for	  the	  cost	  of	  plasmid	  carriage,	  or	  even	  make	  plasmid	   carriage	   advantageous.	   In	   order	   to	   examine	   this,	   several	   end-­‐point	  assays	   were	   conducted	   to	   give	   a	   preliminary	   comparison	   of	   evolved	   and	  ancestral	  lineages	  and	  to	  identify	  any	  obvious	  changes.	  
	  144	  
One	   replicate	   with	   the	   non-­‐conjugative	   plasmid	   in	   the	   blue	   host	   background	  (2b1)	  had	  a	  particularly	  high	   final	  proportion	  of	  plasmid	   carriers,	  0.24	   (Figure	  6.5	  A).	  Competition	  experiments	  were	  conducted	  to	  compare	  the	  relative	  fitness	  of	   this	   evolved	   lineage	   to	   the	   ancestral	  MG1655	  +	  pCT	  ΔtrbA	   (Figure	  6.7).	   The	  fitness	   of	   plasmid	   carriers	   was	   not	   significantly	   different	   in	   the	   evolved	   2B1	  strain	  (mean	  -­‐0.179)	  than	  the	  ancestral	  strain	  (mean	  -­‐0.194;	  t	  =	  0.123,	  p	  =	  0.903).	  	  
	  
Figure	   6.7	   The	   relative	   fitness	   of	   plasmid	   carriers	   is	   not	   significantly	   different	  between	   ancestral	   MG1655	   +	   pCT	   ΔtrbA	   (mean	   -­‐0.194,	   n	   =	   12)	   and	   the	   evolved	  derivative	  2b1	   (mean	   -­‐0.179,	  n	  =	  11)	   in	  broth	   competition	  with	  plasmid-­‐free	  MG1655	  ΔlacZYA	  (t	  =	  0.123,	  p	  =	  0.903).	  	  	  In	  addition	  to	  the	  2b1	  evolved	  strain,	  competition	  and	  mating	  experiments	  were	  conducted	  with	  evolved	  conjugative	  pCT	  carrying	  strains	  to	  assess	  whether	  any	  changes	   in	   fitness	   cost	   or	   conjugation	   rate	   had	   evolved	   over	   the	   course	   of	   the	  experiment	  (Figure	  6.8	  A).	  	  Lineages	  with	  the	  highest	  final	  proportion	  of	  plasmid	  carriers	   from	   each	   pCT	   plasmid	   treatment	   were	   selected.	   For	   plasmids	   in	   the	  white	  background,	  the	  evolved	  strains	  (1a3	  and	  1b6)	  did	  not	  differ	  significantly	  from	   the	  ancestor	   in	  plasmid	   carrier	   fitness	   (F	   =	  3.016,	  p	   =	  0.079).	   In	   the	  blue	  background,	  strain	  3a6	  has	  significantly	  higher	  relative	  fitness	  than	  the	  ancestor	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Figure	   6.8:	   Relative	   fitness	   and	   conjugation	   rate	   of	   evolved	   and	   ancestral	   pCT	  
plasmid	  carrying	  lineages.	  The	  relative	  fitness	  (A)	  of	  plasmid	  carriers	  is	  a	  significantly	  different	  between	  3a6	  and	  the	  blue	  ancestor.	  	  The	  number	  of	  transconjugants	  per	  donor	  
(B)	  is	  significantly	  lower	  for	  1a3	  compared	  to	  the	  white	  ancestor,	  significantly	  higher	  for	  3b6	  compared	  to	  the	  blue	  ancestor.	  
p	  =	  2.93	  x	  10	  -­‐3	  
	  	  	  p	  =	  0.021	  
A	  	  
B	  	  
p	  =	  0.01	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6.3.4 Plasmid	  maintenance	  is	  frequency	  dependent	  In	   the	   first	   serial	   transfer	   experiment	   (Figure	   6.3)	   the	   proportion	   of	   plasmid	  carriers	  decreases	  from	  a	  starting	  proportion	  of	  approximately	  0.01	  in	  all	  cases,	  with	   one	   exception	   (one	   replicate	   using	   the	   conjugative	   plasmid	   in	   the	   low	  intensity	   bottleneck).	   In	   the	   subsequent	   serial	   transfer	   (Figure	   6.5),	   the	  proportion	   of	   plasmid	   carriers	   increases	   from	   very	   rare	   (0.00001-­‐0.001)	   to	  around	  0.01-­‐0.1.	  Conjugation	  may	  explain	  the	  maintenance	  of	  the	  plasmid	  in	  the	  pCT	   mixes	   by	   counteracting	   the	   effects	   of	   segregation	   and	   cost	   of	   carriage,	  indeed	  a	  large	  proportion	  of	  plasmid	  carriage	  is	  by	  transconjugants	  in	  all	  but	  one	  of	  the	  pCT	  mixes	  (Figure	  6.6).	  A	  lack	  of	  conjugation	  could	  also	  explain	  the	  decline	  in	  plasmid	   carriage	   in	  pCT	  ΔtrbA	  mixes	  between	  day	  19	  and	  day	  32.	  However,	  conjugation	  cannot	  explain	  the	  increase	  in	  plasmid	  carriage	  seen	  between	  day	  0	  and	   day	   19	   in	   the	   pCT	   ΔtrbA	  mixes,	   nor	   can	   it	   explain	   the	   steeper	   decline	   in	  plasmid	   carriage	   in	   the	   pCT	   mixed	   from	   day	   19.	   The	   discrepancy	   in	   outcome	  between	   the	   first	   and	   second	   serial	   transfer	   experiments	   indicated	   that	   some	  critical	   change	   in	  plasmid	   fate	  was	  occurring	  when	  plasmid	  carriage	   reached	  a	  proportion	  between	  0.01-­‐0.1,	   suggesting	   that	  plasmid	  maintenance	  may	  have	  a	  frequency	   dependent	   aspect.	   In	   order	   to	   assess	  whether	   this	   apparent	   pattern	  held	  true,	  competitions	  were	  set	  up	  over	  a	  range	  of	  initial	  proportions	  of	  plasmid	  carriage,	   using	   the	   non-­‐conjugative	   plasmid	   in	   both	   host	   backgrounds	   (Figure	  6.9).	   This	   assay	   showed	   no	   significant	   effect	   of	   host	   background	   on	   relative	  fitness	   of	   plasmid	   carriers	   (F	   (3,	   68)	   =	   2.724,	   p	   =	   0.103),	   but	   in	   fact	   a	   highly	  significant	  effect	  of	  initial	  proportion	  of	  plasmid	  carriers	  (F	  (1,	  70)	  =	  36.92,	  p	  =	  5.75	  x	  10-­‐8):	  plasmid	  carriers	  do	  better	  at	  low	  initial	  proportions.	  Plasmid	  carriage	  has	  strong	   negative	   frequency	   dependent	   fitness	   effects,	   being	   beneficial	   at	   low	  frequencies	  but	  costly	  at	  high	  frequencies.	  	  It	  appears	  that	  the	  plasmid-­‐	  blue	  background	  combination	  is	  significantly	  less	  fit	  than	   the	   plasmid-­‐	   white	   background	   pairing	   at	   initial	   proportions	   of	   0.3	   and	  above	  (Figure	  6.9).	  Initial	  analysis	  suggested	  no	  interaction	  effect	  between	  host	  and	   initial	   proportion	   of	   plasmid	   (F	   (3,	  68)	   =	   1.933,	   p	   =	   0.169).	   However,	   if	   the	  initial	  proportions	  are	  grouped	  into	  ‘low’	  (0.01	  &	  0.1)	  and	  ‘high’	  (0.3	  –	  0.9),	  there	  is	  a	  highly	  significant	  interaction	  effect	  (F	  (3,	  68)	  =	  12.348,	  p	  =	  7.9	  x	  10-­‐4)	  as	  well	  as	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highly	  significant	  individual	  effects	  of	  host	  background	  (F	  (3,	  68)	  =	  8.838,	  p	  =	  4.08	  x	  10-­‐3)	  and	  initial	  proportion	  plasmid	  carriers	  (F	  (3,	  68)	   	  =	  270.82,	  p	  =	  2	  x	  10-­‐16).	  At	  low	   frequencies	   of	   plasmid	   carriers	   the	   host	   background	   is	   not	   important:	  plasmid	   carriers	   do	   better	   regardless,	   but	   at	   high	   frequencies	   there	   is	   some	  epistatic	  effect	  between	  the	  plasmid	  and	  the	  host:	  without	  the	  plasmid	  the	  blue	  strain	  is	  fitter	  (or	  no	  different,	  see	  Section	  6.3.3	  above),	  but	  with	  the	  plasmid	  the	  white	  strain	  is	  fitter.	  An	  epistatic	  interaction	  like	  this	  would	  completely	  confound	  the	   hitchhiking	   hypothesis,	   as	   the	   supposedly	   fitter	   blue	   strain	  would	   become	  less	  fit	  once	  it	  obtained	  the	  plasmid.	  	  
Figure	   6.9:	   Plasmid	  maintenance	   is	   frequency	   dependent.	  Mean	  relative	   fitness	  of	  blue	  MG1655	   (n)	   or	  white	  MG1655	  ΔlacZYA	  (o)	   non-­‐conjugative	   plasmid	   carriers,	   in	  competition	  with	   the	   opposite	   plasmid-­‐free	   strain,	   over	   a	   range	   of	   initial	   proportions.	  Plasmid	   carriers	   show	   higher	   relative	   fitness	   when	   the	   initial	   proportion	   is	   low,	   but	  lower	  fitness	  at	  proportions	  of	  0.3	  and	  above.	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6.4 Discussion	  
6.4.1 Bottleneck	  intensity	  increases	  rate	  of	  plasmid	  decline	  The	   importance	   of	   population	   dynamics	   can	   be	   seen	   clearly	   in	   the	   first	   serial	  transfer	  experiment,	  with	  varying	  bottleneck	  intensity,	  and	  from	  the	  effect	  of	  the	  initial	   proportion	   of	   plasmid	   carriers	   (see	   Section	   6.4.4	   below).	   The	   lower	   the	  bottleneck	   intensity,	   the	   slower	   the	   rate	   of	   plasmid	   decline,	   regardless	   of	  conjugation.	   Faster	   plasmid	   carrier	   decline	   will	   occur	   with	   more	   intense	  bottlenecks	   as	   the	   number	   of	   plasmid	   carriers	   surviving	   to	   found	   the	   next	  population	   will	   be	   small.	   Small	   founding	   populations	   in	   the	   high	   intensity	  bottleneck	  will	  lead	  to	  more	  bacterial	  generations	  per	  day	  (Figure	  6.3)	  and	  this,	  coupled	  with	  the	  fitness	  cost	  imposed	  by	  the	  plasmid	  (Chapter	  3,	  Section	  3.3.2),	  will	  lead	  to	  a	  greater	  reduction	  in	  plasmid	  frequency	  in	  the	  absence	  of	  selection.	  More	   intense	   bottlenecks	   also	   increase	   the	   impact	   of	   genetic	   drift	   on	   the	  population,	   meaning	   that	   rare	   plasmid	   carriers	   will	   tend	   to	   be	   lost	   from	   the	  population	  at	  higher	  bottleneck	  intensities.	  	  It	  is	  surprising	  conjugation	  has	  so	  little	  impact	  on	  plasmid	  decline:	  rapid	  decline	  of	  the	  conjugative	  plasmid	  is	  seen	  in	  all	  bottleneck	  regimes,	  although	  the	  rate	  of	  decline	  is	  slightly	  lower	  than	  for	  the	  non-­‐conjugative	  plasmid.	  It	  could	  be	  argued	  that	  the	  high	  proportion	  of	  plasmid-­‐free	  recipients	  at	  high	  intensity	  bottlenecks	  could	   facilitate	   conjugation	   and	   somewhat	   mitigate	   the	   effects	   of	   population	  bottlenecking,	   however,	   this	   was	   not	   seen	   here.	   This	   result	   corroborates	  previous	   experiments	   in	   liquid	   culture,	   and	   suggests	   that	   conjugation	   cannot	  maintain	  a	  plasmid	  in	  the	  face	  of	  significant	  segregational	  loss	  but	  can,	  to	  some	  extent,	  ameliorate	   the	  effect	  of	   segregation	   in	  comparison	   to	  a	  non-­‐conjugative	  plasmid	  (Bahl	  et	  al.	  2007).	  	  	  	  This	  result	  highlights	  the	  complexity	  of	  parasitic	  plasmid	  survival:	  pCT	  appears	  to	   confer	   no	  benefit,	   and	   is	   therefore	   lost	   from	   the	  population.	  We	   anticipated	  that	   parasitic	   survival	   of	   this	   large	   ~90	   Kb	   plasmid	   would	   be	   unlikely,	   as	   it	  appeared	   to	   confer	   no	   selective	   advantage	   (Cottell	   et	   al.	   2011),	   and	   it	   has	   had	  little	   opportunity	   for	   host-­‐plasmid	   (co-­‐)	   evolution,	   as	   the	   plasmid	   was	   newly	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transformed	  into	  the	  host.	  Although	  segregation	  does	  not	  appear	  to	  play	  a	  major	  role	  in	  plasmid	  decline	  in	  this	  case,	  the	  cost	  of	  carriage,	  in	  the	  face	  of	  competition	  with	  a	  plasmid-­‐free	  strain	  and	  significant	  population	  bottlenecks,	  is	  too	  great	  for	  conjugation	  to	  counteract	  plasmid	  decline.	  The	  long	  term	  coexistence	  of	  plasmid-­‐free	   and	   plasmid-­‐carrying	   strains	   may	   largely	   be	   due	   to	   the	   cost	   of	   carriage	  rather	   than	   conjugation	   or	   segregational	   loss	   (Freter	   et	   al.	   1983).	   In	   addition,	  mechanistic	  factors	  have	  been	  shown	  to	  affect	  the	  contribution	  of	  conjugation	  to	  plasmid	   survival,	   such	   as	   the	   ability	   to	   form	   mating	   pairs	   in	   broth,	   and	   the	  likelihood	  of	  donor-­‐recipient	  meetings	  at	   low	  cell	  density	   (Bahl	  et	  al.	  2007).	   In	  this	   case,	   low	   cell	   numbers	   after	   high	   intensity	   bottlenecks	   could	   inhibit	  conjugation,	   which	   is	   already	   limited	   by	   the	   sub-­‐optimal	   conditions	   of	   shaken	  broth	  culture.	  	  
6.4.2 The	  importance	  of	  conjugation	  &	  hitchhiking	  One	  of	   the	   key	   arguments	   surrounding	   the	  parasitic	   persistence	  of	   plasmids	   is	  the	   rate	   and	   impact	   of	   conjugation:	   are	   rates	   of	   conjugation	   high	   enough	   to	  maintain	   parasitic	   plasmids?	   And	   is	   this	   generally	   true,	   or	   are	   complex,	  fluctuating	  environments	  a	  prerequisite	  (Stewart	  &	  Levin	  1977;	  Bergstrom	  et	  al.	  2000;	  Lili	  et	  al.	  2007;	  Ponciano	  et	  al.	  2007)?	  Serial	  transfer	  2	  shows	  that	  pCT	  can	  increase	   from	   extremely	   rare,	   suggesting	   some	   benefit	   to	   plasmid	   carriage.	  Transitory	   derepression	   of	   the	   conjugative	   apparatus	   has	   been	   proposed	   as	   a	  mechanism	  of	  parasitic	  plasmid	  persistence	  (Lundquist	  &	  Levin	  1986;	  Simonsen	  1990).	  Here,	  the	  conjugation	  apparatus	  of	  recent	  transconjugants	  is	  temporarily	  derepressed,	  facilitating	  transfer,	  whilst	  conjugation	  is	  otherwise	  depressed.	  The	  important	   contribution	   of	   transconjugants	   to	   plasmid-­‐carrier	   survival	   in	   these	  experiments	  could	  be	  indicative	  of	  this	  phenomenon,	  however,	  the	  fact	  that	  both	  conjugative	  and	  non-­‐conjugative	  plasmids	   increased	   in	   frequency	  suggests	   that	  there	  must	  be	  other	  factors	  in	  play,	  and	  it	  should	  also	  be	  noted	  that	  conjugation	  rates	   may	   be	   too	   low	   for	   transitory	   derepression	   to	   maintain	   plasmids	  (Simonsen	  1991;	  Gordon	  1992).	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The	   results	   of	   serial	   transfer	   2	   indicate	   that	   host	   background	   does	   not	   have	   a	  significant	  effect	  on	  plasmid	  persistence.	  In	  contrast	  to	  my	  hypothesis,	  the	  fitness	  of	   the	   incoming	   plasmid-­‐free	   competitor,	   relative	   to	   the	   current	   plasmid	   host,	  has	   no	   impact	   on	   the	   final	   proportion	   of	   plasmid	   carrying	   cells.	   Plasmids	  transferring	  to	  a	  fitter	  strain	  do	  not	  rise	  disproportionately	  to	  success.	  In	  fact,	  the	  increase	  in	  plasmid	  carriers	   is	  seen	  regardless	  of	  host	  background	  and	  plasmid	  conjugational	   ability,	   suggesting	   that	   neither	   conjugation	   nor	   hitchhiking	   are	  contributing	  to	  plasmid	  persistence	  (Bergstrom	  et	  al.	  2000).	  	  	  
6.4.3 The	  contribution	  of	  plasmid	  and	  host	  (co-­‐)	  evolution	  One	   possible	   explanation	   for	   the	   increase	   in	   plasmid	   carriers	   seen	   in	   serial	  transfer	  2	   is	   evolution	  of	   the	  plasmid,	   the	  host	   strain	  or	   coevolution	  of	   the	   two	  (Dionisio	   et	   al.	   2005;	   Bouma	   &	   Lenski	   1988;	   Dahlberg	   &	   Chao	   2003;	   Modi	   &	  Adams	  1991).	  Evolution	  may	  act	  to	  facilitate	  plasmid	  persistence	  by	  altering	  one	  or	   more	   of	   the	   three	   major	   parameters	   affecting	   plasmid	   maintenance:	  conjugation	  rate,	  segregation	  rate	  and	  cost	  of	  carriage.	  Preliminary	  investigations	  conducted	   with	   a	   selection	   of	   evolved	   strains	   suggest	   that,	   perhaps	  unsurprisingly,	   different	   lineages	   may	   have	   evolved	   different	   strategies.	  However,	  there	  is	  no	  evidence	  for	  strong	  evolutionary	  effects	  in	  the	  clones	  tested.	  It	   is	  of	  course	  possible	  that	  this	  is	  an	  artifact	  of	  the	  strains	  selected,	  and	  further	  testing	  might	  reveal	  stronger	  effects.	  Alternatively,	  it	  could	  be	  that	  comparison	  of	  relative	   fitness	   is	   not	   the	   most	   appropriate	   way	   to	   test	   plasmid	   and	   host	  evolution:	   re-­‐isolation	   of	   evolved	   plasmids	   and	   transformation	   into	   ancestral	  hosts	  (and	  vice	  versa	  with	  ancestral	  plasmids	  and	  evolved	  hosts)	  would	  facilitate	  examination	  of	  any	  host-­‐plasmid	  coevolution,	  and	  assess	  the	  contribution	  of	  the	  plasmid	  and	   the	  host	   to	  any	  changes.	  This	  would	  also	  allow	  examination	  of	   the	  potential	  epistatic	  host	  -­‐	  plasmid	  fitness	  interactions	  observed.	  It	  is	  not	  possible	  to	   draw	   conclusions	   about	   the	   extent	   or	   contribution	   of	   evolution	   and/or	  coevolution	   to	   plasmid	   persistence	   from	   this	   preliminary	   data.	   Further	  phenotypic	  analyses	  (as	  discussed	  above),	  and	  sequencing	  of	  plasmids	  and	  hosts	  would	  allow	  any	  changes	  to	  be	  confirmed.	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The	   relative	   fitness	   of	   plasmid	   carriers	   in	   these	   experiments	   is	   not	   only	  dependent	  on	  the	  evolution	  of	  the	  plasmid	  carrying	  strain,	  but	  also	  on	  its	  plasmid	  free	  competitor.	  In	  order	  to	  test	  for	  evolutionary	  changes	  in	  the	  plasmid	  and	  host,	  an	   experiment	   in	   which	   single	   strain	   populations	   of	   one	   host	   carrying	   one	  plasmid,	   without	   a	   competitor,	   would	   be	   more	   appropriate.	   The	   fitness	   of	   the	  evolved	  strains	   could	  be	   compared	   to	   the	  ancestor	  by	  competition	  experiments	  using	  a	  standard	  competitor,	  as	  described	  above.	  In	  addition,	  host	  strains	  without	  the	  plasmid	  could	  also	  be	  evolved,	  and	  their	  fitness	  assessed	  alone	  and	  with	  the	  addition	   of	   an	   evolved	   and	   ancestral	   plasmid	   (Table	   6.4).	   This	  would	   allow	   all	  combinations	   of	   evolved	   and	   ancestral	   plasmids	   and	   hosts	   to	   be	   combined,	  allowing	  evolution	  of	  the	  host	  strain,	  the	  plasmid	  and	  coevolution	  of	  the	  two	  to	  be	  identified	   (see	   Table	   6.4).	   However,	   in	   this	   experiment	   the	   increase	   in	   plasmid	  carrier	   frequency	   occurs	   at	   the	   very	   beginning,	   suggesting	   that	   although	  evolution	   may	   contribute	   to	   plasmid	   maintenance	   over	   time,	   there	   is	   some	  unknown	  advantage	  of	  plasmid	  carriage	  from	  the	  start	  of	  the	  experiment,	  which	  cannot	  be	  explained	  by	  subsequent	  adaptation.	  	  	  	  	  	  	  	  	  	  	  	  
Table	   6.4:	   Combinations	   of	   evolved	   and	   ancestral	   hosts	   and	   plasmids	   to	   allow	  evolutionary	  changes	  to	  be	  attributed	  to	  host,	  plasmid	  or	  coevolution.	  All	  combinations	  of	  host	  and	  plasmid	  would	  be	  competed	  against	  a	  standard	  competitor	  strain.	  	  	  
Host	  strain	   Plasmid	  Ancestor	   -­‐	  Ancestor	   Ancestor	  Ancestor	   Evolved	  Evolved	  (no	  plasmid)	   -­‐	  Evolved	  (cured)	   -­‐	  Evolved	   Evolved	  Evolved	  (no	  plasmid)	  Evolved	  (no	  plasmid)	  Evolved	  (cured)	  Evolved	  (cured)	  
Ancestor	  Evolved	  Ancestor	  Evolved	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6.4.4 Frequency	  dependent	  plasmid	  persistence	  Neither	   conjugation	   nor	   coevolution	   satisfactorily	   explains	   the	   rise	   in	   the	  proportion	  of	  plasmid	  carriers	  seen	  in	  serial	  transfer	  2.	  I	  propose	  two	  alternative	  hypotheses:	  i)	  a	  transient	  fitness	  benefit	  for	  new	  transconjugants,	  or	  ii)	  a	  generic	  benefit	   of	   plasmid	   carriage.	   Lundquist	   and	   Levin	   (Lundquist	   &	   Levin	   1986)	  concede	  that	  their	  data	  could	  be	  explained	  by	  a	  “transitory	  fitness	  increase”,	  but	  suggest	  that	  this	  is	  biologically	  unlikely.	  I	  propose	  that	  this	  fitness	  increase	  could	  be	   in	   the	   form	  of	   increased	   adaptability	   to	   new	   environment	   conferred	   by	   the	  plasmid.	  This	  would	  be	  a	  transitory	  benefit,	  as	  it	  would	  give	  the	  plasmid	  carriers	  an	   advantage	   over	   their	   competitors	   in	   the	   first	   instance,	   but	   over	   time	   the	  plasmid	   free	   strains	   would	   also	   adapt,	   and	   the	   cost	   of	   plasmid	   carriage	   may	  counter	  the	  initial	  benefit	  of	  rapid	  adaptation,	  leading	  to	  the	  decline	  we	  see	  after	  day	   19.	   Helling	   et	   al.	   (1981)	   suggest	   that	   beneficial	   mutations	   occurring	   in	  selectively	   disadvantaged	   strains	   could	   lead	   to	   fluctuating	   dynamics	   in	  competitions,	   with	   plasmid	   carriers	   gaining	   a	   brief	   advantage,	   and	   then	   being	  overtaken	  again	  by	  plasmid	  free	  competitors.	  Although	  in	  their	  work	  the	  plasmid	  carriers	   were	   in	   the	   majority,	   this	   could	   perhaps	   be	   compensated	   for	   if	   the	  plasmid	   itself	   were	   facilitating	   faster	   adaptation.	   While	   this	   could	   explain	   the	  decline	  in	  plasmid	  carriers	  after	  day	  19,	  as	  the	  brief	  advantage	  was	  lost,	  it	  does	  not	  explain	  the	  striking	  frequency	  dependent	  pattern.	  	  	  Two	   possible	   mechanisms	   could	   explain	   the	   observed	   frequency	   dependent	  fitness	  of	  plasmid	  carriers:	  i)	  pCT	  carries	  a	  spiteful	  trait,	  which	  negatively	  affects	  the	   plasmid-­‐free	   cells;	   ii)	   pCT	   carries	   some	   unknown	   beneficial	   trait.	   One	  example	   of	   a	   negative	   trait	   could	   be	   a	   bacteriocin.	   These	   are	   known	   to	   be	  plasmid	  carried,	  and	   in	   fact	   the	  colicins	  of	  E.	  coli	  are	  exclusively	  plasmid	  based	  (Riley	   &	   Wertz	   2002).	   In	   addition,	   bacteriocins	   are	   known	   to	   be	   involved	   in	  spiteful	   interactions	   (Gardner	   et	   al.	   2004)	   and	   have	   a	   frequency	   dependent	  aspect	  (Chao	  &	  Levin	  1981).	  However,	  Chao	  &	  Levin	  (1981)	  suggest	  that	  colicin-­‐carrying	  strains	  only	  do	  better	  when	  they	  are	  common	  in	  broth	  culture,	  which	  is	  the	   converse	  of	  what	   I	  have	  observed	  with	  pCT.	   Similarly,	  Adams	  et	   al	   (1979),	  showed	   frequency	   dependent	   patterns	   with	   colicin-­‐carrying	   plasmids,	   where	  plasmid	  carriers	  do	  better	  when	  their	   initial	   frequency	  is	  >0.5.	  Although	  Cottell	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et	  al.	   (2011)	  do	  not	   identify	  any	  bacteriocin	  genes	   in	   their	   sequence	  analysis,	   I	  also	  looked	  for	  bacteriocin	  genes	  in	  pCT	  with	  the	  specialized	  BAGEL3	  bacteriocin	  mining	   software	  with	  no	   success	   (de	   Jong	   et	   al.	   2006;	   van	  Heel	   et	   al.	   2013).	   It	  therefore	   seems	   unlikely	   that	   this	   is	   the	   cause	   of	   the	   frequency	   dependent	  pattern.	  It	  could	  be	  that	  there	  is	  some	  undetected	  novel	  colicin	  present,	  but	  even	  if	   that	  were	  true,	   the	  patterns	  of	   frequency	  dependence	  suggest	   that	   this	   is	  not	  the	  cause.	  	  	  Negative	   frequency	   dependence	   has	   been	   observed	   for	   beneficial	   plasmids	  (Levin	   1988).	   Curiously	   for	   this	   thesis,	   the	   beneficial	   traits	   carried	   are	   often	  cooperative,	   public	   goods-­‐type	   traits	   such	   as	   mercury	   resistance	   or	   toxin	  production,	   and	   it	   is	   these	   cooperative	   traits	   which	   are	   subject	   to	   frequency	  dependent	  selection	  (Ellis	  et	  al.	  2007;	  Raymond	  et	  al.	  2012).	  Considering	  the	  lack	  of	   evidence	   to	   indicate	   a	   spiteful	   trait,	   and	   the	   clear	   support	   for	   frequency	  dependence,	  it	  seems	  that	  pCT	  must	  carry	  some	  unknown	  frequency	  dependent	  benefit.	  This	  could	  be	  in	  the	  form	  of	  increased	  adaptability	  (as	  suggested	  above),	  perhaps	  through	  increased	  mutation	  rate,	  or	  some	  other	  (possibly	  cooperative?)	  trait.	  	  	  
6.4.5 Conclusions	  and	  outlook	  This	  work	  highlights	  how	  little	  we	  know	  about	  not	  only	  plasmid	  persistence,	  but	  also	   plasmid	   carried	   genes	   and	   the	   advantages	   they	   may	   confer	   (Enne	   et	   al.	  2004;	   Bennett	   &	   Linton	   1986),	   bringing	   back	   into	   question	   the	   existence	   of	  cryptic	  plasmids:	  as	  Bergstrom	  et	  al.	  (2000)	  ask,	  are	  they	  truly	  cryptic,	  or	  are	  we	  just	  yet	  to	  discover	  their	  advantage?	  In	  the	  case	  of	  pCT,	  these	  questions	  might	  be	  addressed	  in	  future	  through	  the	  production	  of	  a	  knockout	  library,	  allowing	  genes	  involved	  in	  frequency	  dependence	  to	  be	  identified	  and	  studied	  further.	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Chapter	  7: General	  Conclusion	  
	  
7.1 Recapitulation	  of	  thesis	  aims	  This	  thesis	  set	  out	  to	  explore	  a	  novel	  strategy	  for	  limiting	  the	  spread	  of	  antibiotic	  resistance	   by	   exploiting	   plasmids	   and	  bacterial	   cooperation,	   and	   to	   investigate	  the	   evolutionary	   ecology	   of	   plasmids	   and	   antibiotic	   resistance	   in	   natural	  bacterial	  communities.	  Four	  aims	  were	  set	  out	   in	  Chapter	  1,	  Section	  1.5.2:	   i)	   to	  examine	   the	   conditions	   under	   which	   β-­‐lactam	   resistance	   is	   cooperative;	   ii)	   to	  identify	   and	   sequence	   ‘cheat’	   plasmids	   from	   natural	   zoonotic	   bacterial	  populations;	   iii)	   to	   investigate	   the	   manipulation	   of	   cooperative	   resistance	  population	   dynamics	   using	   ‘cheat’	   plasmids;	   iv)	   to	   investigate	   mechanisms	   of	  plasmid	  persistence,	   in	  particular	  the	  role	  of	  conjugation	  in	  the	  maintenance	  of	  large	  naturally	  occurring	  plasmids.	  This	  concluding	  chapter	  brings	  together	  the	  key	   results	   stemming	   from	   each	   aim,	   and	   highlights	   the	   implications	   of	   these	  results	  for	  future	  research.	  	  
7.2 Cooperative	  resistance	  and	  cheat	  plasmids	  One	  major	  hypothesis	  was	  the	  existence	  of	  ‘cheat’	  plasmids;	  plasmids	  of	  the	  same	  incompatibility	  group	  as	  a	   resistance	  plasmid,	  which	   could	  block	   the	   spread	  of	  resistance	   genes	   by	   horizontal	   transfer,	   and	   invade	   resistant	   populations	   by	  social	   cheating,	   facilitating	   the	   clearance	   of	   an	   infection	   with	   antibiotics	   (see	  Chapter	  1,	  Section	  1.3.2	  and	  Chapter	  4	  Section	  4.1.1).	  The	  results	  of	  Chapter	  3,	  and	   the	   failure	   to	   identify	   ‘cheat’	   plasmids	   in	   Chapters	   4	   or	   6,	   lead	   me	   to	  conclude	   that	   ‘cheat’	   plasmids	   may	   not	   be	   the	   panacea	   I	   had	   envisaged.	  With	  social	   resistance	  occurring	  only	  under	  very	  specific	   conditions,	   the	  presence	  of	  susceptible	   persister	   cells,	   there	   is	   likely	   to	   be	   limited	   application	   for	   cheat	  plasmids	  in	  a	  clinical	  context.	  Despite	  this,	  cross-­‐species	  antibiotic	  protection	  has	  been	  seen	  in	  vivo	  (Brook	  et	  al.	  1983;	  Brook	  2004),	  and	  the	  complexity	  of	  the	  host	  environment	  and	  dose	  variations	  within	  tissues	  may	  mean	  that	  all	  is	  not	  lost	  for	  this	  idea.	  It	  is	  also	  interesting	  to	  note	  that	  persistence	  has	  been	  cited	  as	  a	  social	  trait	   (Gardner	   et	   al.	   2007).	   This	   opens	   up	   the	   possibility	   of	   some	   mutually	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beneficial	   resistance-­‐persistence	   interactions,	   particularly	   in	   the	   context	   of	  biofilms	  where	  both	  traits	  are	  common.	  	  	  
7.3 Plasmid	  persistence,	  frequency-­‐dependence	  and	  public	  goods	  Plasmid	   persistence	   in	   competition	   with	   plasmid-­‐free	   strains	   was	   explored	   in	  Chapter	   6,	   and	   a	   strong	   negative	   frequency-­‐dependent	   benefit	   of	   pCT	   carriage	  was	  observed,	   indicating	  some	  unknown	  benefit	  of	  plasmid	  carriage.	  Beneficial	  traits	  carried	  on	  plasmids	  are	  often	  cooperative,	  public	  goods-­‐type	  traits,	  as	  seen	  on	  the	  plasmids	  sequenced	  in	  Chapter	  4:	  both	  pCow52/24456	  and	  pCow23	  carry	  siderophore	   operons,	  which	   are	   commonly	   associated	  with	  both	   virulence	   and	  social	   traits	   (West	   &	   Buckling	   2003),	   and	   pCow23	   also	   carries	   the	   secreted	  enterotoxin	  espC	  (Mellies	  et	  al.	  2001).	  Cooperative	  traits	  may	  also	  be	  subject	  to	  frequency	   dependent	   selection,	   as	   has	   been	   demonstrated	   for	   mercury	  resistance	  and	  toxin	  production	  (Ellis	  et	  al.	  2007;	  Raymond	  et	  al.	  2012).	  The	  fact	  that	  public	  goods	  genes	  are	  more	  commonly	  found	  on	  plasmids	  (Nogueira	  et	  al.	  2009),	  and	  that	  these	  genes	  are	  often	  subject	  to	  frequency	  dependent	  selection,	  suggests	   that	   frequency	   dependent	   cooperative	   traits	   may	   drive	   plasmid	  persistence	   in	  some	  cases:	  plasmid	  carrying	  strains	  may	  persist	   in	  competition	  with	   plasmid	   free	   strains	   if	   plasmid	   carriage	   is	   beneficial	   when	   rare.	   The	  unknown	   cause	   of	   the	   frequency	   dependent	   pattern	   observed	   in	   Chapter	   6	  highlights	  how	   little	  we	  know	  about	  plasmid	  carried	  genes	  and	   the	  advantages	  (or	  costs)	  they	  may	  confer	  (Bergstrom	  et	  al.	  2000).	  	  	  
7.4 Plasmid	  populations	  Naturally	   occurring	   plasmids	   and	   plasmid	   populations	   are	   still	   poorly	  understood	  as	  many	  studies	  have	  focussed	  on	  clinically	  or	  economically	  relevant	  plasmids,	  such	  as	  those	  conferring	  antibiotic	  resistance	  or	  heavy	  metal	  tolerance.	  The	  diversity	  of	  natural	  plasmids	  is	  highlighted	  by	  those	  sequenced	  in	  Chapter	  4,	  which	   included	   one	   completely	   unique	   plasmid,	   pCow63.	   In	   addition,	   the	   field	  study	   in	   Chapter	   5	   demonstrated	   the	   link	   between	   host	   E.	   coli	   diversity	   and	  plasmid	  diversity,	  and	  found	  that	  E.	  coli	  populations	  are	  highly	  structured.	  This	  work	  found	  that	   the	  E.	  coli	  population	  within	  one	  pat	  was	   likely	  to	  contain	   just	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one	   H-­‐antigen	   type,	   and	   that	   specific	   plasmids	   are	   associated	   with	   specific	   H-­‐antigens.	  This	   clonal	   host	   and	  plasmid	  population	   structure	  within	   a	  pat	   could	  have	  implications	  for	  cooperative	  traits	  (such	  as	  the	  siderophore	  and	  toxin	  genes	  found	  on	  plasmids	  pCow52/24456	  and	  pCow23),	  as	  Hamilton’s	  rule	  states	  that	  cooperation	   should	   be	   directed	   towards	   close	   relatives	   (Hamilton	   1964).	  Populations	   carrying	   the	   same	   cooperative	   plasmid	   are	   highly	   related	   at	   the	  cooperative	   locus,	   therefore	   limiting	   the	   potential	   for	   exploitation	   of	   public	  goods	   by	   cheats	   (Raymond	   &	   Bonsall	   2013;	   Raymond	   et	   al.	   2012).	   If	   plasmid	  replicon	   diversity	   is	   explained	   by	   E.	   coli	   diversity,	   and	   E.	   coli	   diversity	   is	  explained	   by	   animal	   host	   (pat),	   then	   it	   follows	   that	   the	   plasmid	   population	   is	  highly	  related	  within	  animal	  hosts,	  and	  that	  there	  will	  be	  limited	  exploitation	  of	  any	   plasmid	   carried	   cooperative	   traits	   by	   cheats.	   Unfortunately,	   this	   high	  relatedness	   and	   increased	   cooperation	   may	   lead	   to	   increased	   virulence,	   as	  cooperative	  genes	  are	  also	  often	  virulence	  genes	  (West	  &	  Buckling	  2003).	  	  
7.5 Conclusions	  and	  recommendations	  Ten	  years	  ago,	  Thomas	  (2004)	  identified	  three	  directions	  for	  future	  research	  into	  plasmid	   biology:	   i)	   to	   gain	   a	   fuller	   picture	   of	   the	   plasmid-­‐borne	   gene	   pool	   by	  focussed	   sequencing	   of	   plasmids	   from	   specific	   species	   and	   genera;	   ii)	   to	  understand	  better	  how	  plasmids	  interact	  within	  microbial	  communities;	  and	  iii)	  to	   assess	   the	   costs	   and	   advantages	   of	   plasmid	   carriage	   that	   cause	   plasmids	   to	  persist,	   or	   not.	   This	   thesis	   has	   addressed	   all	   of	   these	   points:	   firstly,	   plasmid	  sequencing	  (Chapter	  4)	  and	  replicon	  typing	  (Chapter	  5)	  have	  contributed	  to	  our	  knowledge	   of	   the	   plasmid	   gene	   pool	   of	   bovine	   enteric	   E.	   coli.	   Secondly,	   the	  question	   of	   understanding	   plasmids	   within	   microbial	   communities	   has	   been	  addressed	  at	  both	  a	  population	  level,	  with	  a	  non-­‐selective	  field	  study	  of	  natural	  plasmids	   (Chapter	   5),	   and	   at	   a	   smaller-­‐scale,	   through	   the	   investigation	   of	  cooperative	   antibiotic	   resistance	   (Chapter	   3).	   And	   thirdly,	   the	   unknown	  advantages	  of	  plasmid	  carriage	  have	  been	  exemplified	  by	  the	  curious	  frequency-­‐dependent	   benefit	   of	   pCT	   carriage	   observed	   in	   the	   serial	   transfer	   experiments	  (Chapter	  6).	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To	  maximise	  the	  impact	  of	  this	  work,	  I	  propose	  a	  number	  of	  lines	  of	  enquiry:	  i)	  the	   production	   of	   a	   knockout	   library	   to	   identify	   the	   genes	   involved	   in	   the	  frequency	  dependent	  benefit	  of	  pCT	  carriage;	  ii)	  further	  sequencing	  of	  plasmids	  isolated	   in	   the	   field	   study	   would	   generate	   a	   fuller	   picture	   of	   the	   plasmid	  population,	   and	   a	   focus	   on	   IncF	   plasmids	   would	   complement	   the	   other	  sequencing	  work.	  	  	  Plasmids	   are	   major	   carriers	   of	   antibiotic	   resistance	   genes,	   and	   the	   spread	   of	  ESBLs,	   in	   particular	   CTX-­‐M	   β-­‐lactamases,	   has	   been	   largely	   plasmid	   mediated	  (Canton	   et	   al.	   2008).	   Although	   the	   hypothesised	   ‘cheat’	   plasmids	   have	   been	  elusive,	  this	  thesis	  nonetheless	  provides	  insights	  into	  the	  evolutionary	  ecology	  of	  antibiotic	  resistance	  plasmids,	  and	  also	  enhances	  our	  understanding	  of	  plasmid	  persistence	  and	  population	  structure.	  I	  hope	  that	  this	  contribution	  to	  knowledge	  will	   inform	   future	   strategies	   for	   the	  management	   of	   plasmid	   carried	   antibiotic	  resistance.	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Appendix	  1:	  RAST	  annotations	  of	  sequenced	  plasmids	  	  
pCow52/24456	  	  
Contig	   Start	   Stop	   Strand	   Function	  1	   689	   820	   +	   hypothetical	  protein	  1	   2303	   1041	   -­‐	   Putative	  membrane	  spanning	  export	  protein	  1	   4495	   2348	   -­‐	   ABC	  transporter,	  transmembrane	  region:ABC	  transporter:Peptidase	  C39,	  bacteriocin	  processing	  1	   5676	   4492	   -­‐	   hypothetical	  protein	  1	   5976	   5818	   -­‐	   hypothetical	  protein	  1	   6664	   6792	   +	   Transposase	  insE	  for	  insertion	  sequence	  IS3A/B/C/D/E/fA/fB	  1	   6960	   7397	   +	   Transposase	  1	   7436	   7837	   +	   putative	  integrase	  1	   8584	   8435	   -­‐	   hypothetical	  protein	  1	   8685	   9752	   +	   Glycosyltransferase	  IroB	  1	   9892	   13551	   +	   ABC	  transporter	  protein	  IroC	  1	   13655	   14884	   +	   Trilactone	  hydrolase	  IroD	  1	   14969	   15925	   +	   Periplasmic	  esterase	  IroE	  1	   18147	   15970	   -­‐	   Outer	  Membrane	  Siderophore	  Receptor	  IroN	  1	   19952	   18918	   -­‐	   2-­‐keto-­‐3-­‐deoxy-­‐D-­‐arabino-­‐heptulosonate-­‐7-­‐phosphate	  synthase	  I	  alpha	  (EC	  2.5.1.54)	  1	   20151	   20297	   +	   hypothetical	  protein	  1	   20820	   20512	   -­‐	   ORF2	  1	   21942	   21661	   -­‐	   stability	  (stb)	  locus	  of	  IncFII	  plasmid	  NR1;	  similar	  to	  SwissProt	  accession	  number	  P11907	  1	   22170	   22048	   -­‐	   hypothetical	  protein	  1	   22202	   22357	   +	   FIG01070796:	  hypothetical	  protein	  1	   22544	   22323	   -­‐	   hypothetical	  protein	  1	   23368	   23511	   +	   hypothetical	  protein	  1	   24392	   23523	   -­‐	   RepA1	  1	   24494	   24640	   +	   FIG00642162:	  hypothetical	  protein	  1	   24938	   24681	   -­‐	   Replication	  regulatory	  protein	  repA2	  (Protein	  copB)	  1	   25408	   25178	   -­‐	   hypothetical	  protein	  1	   25768	   25421	   -­‐	   hypothetical	  protein	  1	   25795	   25941	   +	   hypothetical	  protein	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1	   26582	   26061	   -­‐	   putative	  nuclease	  1	   26976	   26764	   -­‐	   hypothetical	  protein	  1	   27672	   27112	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  fertility	  inhibition	  protein	  FinO	  1	   28473	   27727	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilin	  acetylase	  TraX	  1	   33763	   28493	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  DNA-­‐nicking	  and	  unwinding	  protein	  TraI	  1	   35979	   33763	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TraD	  1	   37008	   36232	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  surface	  exclusion	  protein	  TraT	  1	   40330	   37508	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TraG	  1	   41700	   40327	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraH	  1	   42080	   41700	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbF	  1	   42348	   42067	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbJ	  1	   42883	   42338	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbB	  1	   43151	   42870	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TraQ	  1	   43234	   43569	   +	   hypothetical	  protein	  1	   43769	   43530	   -­‐	   hypothetical	  protein	  1	   43768	   43899	   +	   hypothetical	  protein	  1	   44652	   43909	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraF	  1	   44902	   44645	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbE	  1	   46737	   44929	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TraN	  1	   47372	   46734	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbC	  1	   48373	   47381	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraU	  1	   49002	   48370	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraW	  1	   49385	   48999	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbI	  1	   52009	   49382	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraC	  1	   52215	   52072	   -­‐	   FIG00641101:	  hypothetical	  protein	  1	   52390	   52169	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TraR	  1	   53040	   52525	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraV	  
	  165	  
1	   53288	   53037	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbG	  1	   53497	   53300	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbD	  1	   54074	   53484	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TraP	  1	   55491	   54064	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraB	  1	   56219	   55491	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraK	  1	   56772	   56206	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraE	  1	   57105	   56794	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraL	  1	   57485	   57120	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilin	  protein	  TraA	  1	   57701	   57519	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  regulator	  TraY	  1	   58526	   57840	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  regulator	  TraJ	  1	   59099	   58716	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  mating	  signal	  transduction	  protein	  TraM	  1	   59430	   60023	   +	   X	  polypeptide	  1	   60183	   60049	   -­‐	   putative	  ORF	  1	   61215	   60319	   -­‐	   unnamed	  protein	  product	  1	   61546	   61259	   -­‐	   hypothetical	  protein	  1	   61656	   61543	   -­‐	   Single-­‐stranded	  DNA-­‐binding	  protein	  1	   62146	   61946	   -­‐	   hypothetical	  protein	  1	   62276	   62112	   -­‐	   unknown	  function	  1	   63521	   62802	   -­‐	   PsiA	  protein	  1	   63952	   63518	   -­‐	   PsiB	  protein	  1	   64408	   64007	   -­‐	   hypothetical	  protein	  1	   65943	   64405	   -­‐	   hypothetical	  protein	  1	   66248	   66009	   -­‐	   Putative	  cytoplasmic	  protein	  1	   66751	   66299	   -­‐	   Single-­‐stranded	  DNA-­‐binding	  protein	  1	   66938	   66777	   -­‐	   Single-­‐stranded	  DNA-­‐binding	  protein	  1	   67234	   67479	   +	   hypothetical	  protein	  1	   68128	   67565	   -­‐	   Plasmid	  pO157	  DNA,	  complete	  sequence	  1	   69536	   68175	   -­‐	   hypothetical	  plasmid	  protein	  1	   69818	   69588	   -­‐	   YdaB	  1	   69840	   69989	   +	   hypothetical	  protein	  1	   70170	   70042	   -­‐	   Single-­‐stranded	  DNA-­‐binding	  protein	  1	   70235	   70363	   +	   FIG00639891:	  hypothetical	  protein	  1	   70667	   70491	   -­‐	   hypothetical	  protein	  1	   71014	   70823	   -­‐	   hypothetical	  protein	  1	   71433	   71011	   -­‐	   Orf52	  protein	  1	   71905	   71480	   -­‐	   Putative	  antirestriction	  protein	  1	   72319	   72155	   -­‐	   FIG01049476:	  hypothetical	  protein	  1	   73095	   72319	   -­‐	   FIG00638373:	  hypothetical	  protein	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1	   73575	   73141	   -­‐	   YcgB	  1	   73810	   73589	   -­‐	   putative	  cytoplasmic	  protein	  1	   74493	   73807	   -­‐	   Adenine-­‐specific	  methyltransferase	  (EC	  2.1.1.72)	  1	   74601	   74726	   +	   hypothetical	  protein	  1	   74740	   74928	   +	   FIG00639560:	  hypothetical	  protein	  1	   75805	   74879	   -­‐	   Plasmid	  PO157	  DNA,	  complete	  sequence	  1	   77404	   76433	   -­‐	   Chromosome	  (plasmid)	  partitioning	  protein	  ParB	  1	   78579	   77404	   -­‐	   Chromosome	  (plasmid)	  partitioning	  protein	  ParA	  1	   79913	   79158	   -­‐	   Replication	  initiation	  protein	  RepE	  1	   80473	   80354	   -­‐	   FIG00638134:	  hypothetical	  protein	  1	   81472	   80666	   -­‐	   Resolvase	  1	   81778	   81473	   -­‐	   CcdB	  toxin	  protein	  1	   81998	   81780	   -­‐	   CcdA	  protein	  (antitoxin	  to	  CcdB)	  1	   82288	   82175	   -­‐	   hypothetical	  protein	  1	   82446	   82562	   +	   hypothetical	  protein	  1	   85668	   82549	   -­‐	   hypothetical	  protein	  1	   85722	   86087	   +	   Transposase	  insC	  for	  insertion	  element	  IS2A/D/F/H/I/K	  1	   86045	   86950	   +	   insertion	  sequence	  2	  OrfB	  protein	  1	   88160	   88591	   +	   Transposase	  1	   88659	   88805	   +	   Transposase	  1	   89758	   90735	   +	   RepFIB	  replication	  protein	  A	  1	   90930	   90811	   -­‐	   FIG00243898:	  hypothetical	  protein	  1	   91760	   91020	   -­‐	   RepFIB	  associated	  resolvase	  1	   91901	   92053	   +	   hypothetical	  protein	  1	   92589	   93599	   +	   hypothetical	  protein	  1	   93870	   93983	   +	   hypothetical	  protein	  1	   94459	   94307	   -­‐	   hypothetical	  protein	  1	   94638	   94504	   -­‐	   Transposase	  1	   94742	   94596	   -­‐	   hypothetical	  protein	  1	   95798	   95601	   -­‐	   hypothetical	  protein	  1	   97008	   98894	   +	   membrane;	  Transport	  of	  small	  molecules:	  Cations	  1	   98913	   99704	   +	   hypothetical	  protein	  1	   100235	   100378	   +	   hypothetical	  protein	  1	   102574	   100706	   -­‐	   outer	  membrane	  secretion	  protein	  1	   103643	   102633	   -­‐	   hypothetical	  protein	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Contig	   Start	   Stop	   Strand	   Function	  1	   1881	   1435	   -­‐	   gpR	  1	   2821	   1976	   -­‐	   hypothetical	  protein	  1	   4262	   2832	   -­‐	   Phage	  baseplate	  wedge	  1	   4633	   4259	   -­‐	   PmgA	  1	   8421	   4639	   -­‐	   Structural	  protein	  P5	  1	   9257	   8436	   -­‐	   PmgB	  1	   9331	   9450	   +	   hypothetical	  protein	  1	   9646	   10401	   +	   Replication	  initiation	  protein	  RepE	  1	   11490	   10783	   -­‐	   Tub	  1	   12057	   11506	   -­‐	   PmgC	  1	   12603	   12112	   -­‐	   BplB	  1	   13160	   12612	   -­‐	   PmgG	  1	   13992	   13252	   -­‐	   hypothetical	  protein	  1	   15688	   14030	   -­‐	   hypothetical	  protein	  1	   16035	   15757	   -­‐	   hypothetical	  protein	  1	   17880	   16183	   -­‐	   hypothetical	  protein	  1	   18039	   18431	   +	   hypothetical	  protein	  1	   18448	   18906	   +	   hypothetical	  protein	  1	   19025	   18894	   -­‐	   hypothetical	  protein	  1	   19329	   19060	   -­‐	   hypothetical	  protein	  1	   19549	   19409	   -­‐	   hypothetical	  protein	  1	   20395	   19589	   -­‐	   UpfB	  1	   20679	   20395	   -­‐	   UpfC	  1	   20946	   21902	   +	   Putative	  stability/partitioning	  protein	  encoded	  within	  prophage	  CP-­‐933T	  1	   21916	   22254	   +	   ParB	  1	   22542	   23183	   +	   Chromosome	  partitioning	  protein	  ParA	  1	   23176	   23463	   +	   hypothetical	  protein	  1	   23732	   25393	   +	   Glutaminyl-­‐tRNA	  synthetase	  (EC	  6.1.1.18)	  1	   26347	   25442	   -­‐	   putative	  DNA	  methylase	  1	   27020	   26340	   -­‐	   hypothetical	  protein	  1	   27909	   27004	   -­‐	   DNA	  recombination-­‐dependent	  growth	  factor	  C	  1	   28622	   27969	   -­‐	   gp5	  1	   29599	   28619	   -­‐	   gp6	  1	   30370	   29603	   -­‐	   hypothetical	  protein	  1	   31158	   30367	   -­‐	   gp7	  1	   31321	   31623	   +	   HigB	  toxin	  protein	  1	   31694	   32032	   +	   HigA	  protein	  (antitoxin	  to	  HigB)	  1	   32089	   32289	   +	   Helix-­‐turn-­‐helix	  motif	  1	   32311	   33039	   +	   hypothetical	  protein	  1	   34266	   33073	   -­‐	   hypothetical	  protein	  1	   34588	   34259	   -­‐	   hypothetical	  protein	  1	   35570	   34917	   -­‐	   hypothetical	  protein	  1	   35839	   36462	   +	   hypothetical	  protein	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1	   36483	   36875	   +	   hypothetical	  protein	  1	   37183	   36872	   -­‐	   hypothetical	  protein	  1	   38169	   37243	   -­‐	   Putative	  DNA-­‐binding	  protein	  Roi	  of	  bacteriophage	  BP-­‐933W	  1	   38384	   38169	   -­‐	   Icd	  1	   38865	   38698	   -­‐	   hypothetical	  protein	  1	   39775	   39197	   -­‐	   Recombination	  enhancement	  function	  protein	  1	   39896	   40048	   +	   hypothetical	  protein	  1	   40048	   40671	   +	   hypothetical	  protein	  1	   40668	   40985	   +	   hypothetical	  protein	  1	   40975	   41484	   +	   Eae	  protein	  1	   41481	   42149	   +	   putative	  phage-­‐related	  protein	  1	   42149	   42472	   +	   ATP-­‐dependent	  Clp	  protease	  ATP-­‐binding	  subunit	  ClpX	  1	   42469	   43254	   +	   Phage	  EaE	  protein	  1	   43251	   43526	   +	   Phage	  protein	  1	   43523	   43747	   +	   hypothetical	  protein	  1	   43744	   44055	   +	   hypothetical	  protein	  1	   44052	   44744	   +	   Ppp	  1	   44842	   45837	   +	   Putative	  cytoplasmic	  protein	  1	   45854	   46534	   +	   Phage-­‐related	  protein	  1	   46618	   46821	   +	   hypothetical	  protein	  1	   46814	   47053	   +	   hypothetical	  protein	  1	   47050	   47775	   +	   enterohemolysin	  2	  1	   47777	   47971	   +	   Phage	  protein	  1	   47973	   48182	   +	   Phage	  protein	  1	   48179	   49345	   +	   hypothetical	  protein	  1	   49329	   49613	   +	   hypothetical	  protein	  1	   49948	   49598	   -­‐	   hypothetical	  protein	  1	   49981	   50127	   +	   DNA	  polymerase	  III	  theta	  subunit	  (EC	  2.7.7.7)	  1	   50139	   50528	   +	   Error-­‐prone	  repair	  protein	  UmuD	  1	   50663	   51085	   +	   hypothetical	  protein	  1	   51194	   51415	   +	   Prevent	  host	  death	  protein,	  Phd	  antitoxin	  1	   51415	   51795	   +	   Death	  on	  curing	  protein,	  Doc	  toxin	  1	   51800	   51997	   +	   PdcA	  1	   52806	   52030	   -­‐	   IsaA	  1	   53490	   52813	   -­‐	   conserved	  hypothetical	  protein	  protein	  1	   53999	   53505	   -­‐	   Deoxyuridine	  5'-­‐triphosphate	  nucleotidohydrolase	  (EC	  3.6.1.23)	  1	   54472	   53996	   -­‐	   hypothetical	  protein	  1	   54813	   54469	   -­‐	   hypothetical	  protein	  1	   55915	   54887	   -­‐	   GST-­‐loxP-­‐cre	  recombinase	  fusion	  protein	  1	   56311	   57348	   +	   hypothetical	  protein	  1	   58884	   57376	   -­‐	   Terminase	  B	  protein	  1	   60248	   58884	   -­‐	   DNA	  pacase	  A	  subunit	  1	   60637	   60245	   -­‐	   hypothetical	  protein	  1	   61138	   60746	   -­‐	   hypothetical	  protein	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1	   61707	   61138	   -­‐	   hypothetical	  protein	  1	   62381	   62253	   -­‐	   hypothetical	  protein	  1	   63225	   62398	   -­‐	   Putative	  SPFH	  domain	  protein	  1	   64167	   63994	   -­‐	   hypothetical	  protein	  1	   66886	   65678	   -­‐	   hypothetical	  protein	  1	   67299	   67000	   -­‐	   hypothetical	  protein	  1	   67496	   67296	   -­‐	   hypothetical	  protein	  1	   67663	   67511	   -­‐	   hypothetical	  protein	  1	   68401	   68141	   -­‐	   hypothetical	  protein	  1	   68838	   68404	   -­‐	   Ulx	  1	   75711	   68875	   -­‐	   N-­‐6	  DNA	  methylase	  1	   75863	   76348	   +	   FIG00641051:	  hypothetical	  protein	  1	   76578	   76381	   -­‐	   Putative	  DNA-­‐binding	  protein	  Roi	  of	  bacteriophage	  BP-­‐933W	  1	   77285	   76578	   -­‐	   Putative	  DNA-­‐binding	  protein	  Roi	  of	  bacteriophage	  BP-­‐933W	  1	   77509	   77285	   -­‐	   Icd	  1	   78885	   77923	   -­‐	   RepL	  protein	  1	   80084	   79086	   -­‐	   Pro	  1	   81780	   80098	   -­‐	   Prt	  1	   82197	   81865	   -­‐	   hypothetical	  protein	  1	   82799	   82242	   -­‐	   hypothetical	  protein	  1	   84289	   82925	   -­‐	   FIG00350536:	  hypothetical	  protein	  1	   84752	   84384	   -­‐	   hypothetical	  protein	  1	   86671	   84752	   -­‐	   DarA	  1	   87284	   86664	   -­‐	   Hdf	  1	   87720	   87274	   -­‐	   LydB	  1	   88046	   87720	   -­‐	   LydA	  2	   101	   892	   +	   Phage	  tail	  fiber	  protein	  2	   895	   1428	   +	   Phage	  tail	  fibers	  2	   1983	   1456	   -­‐	   hypothetical	  protein	  2	   3118	   1985	   -­‐	   Phage	  tail	  fibers	  3	   348	   199	   -­‐	   hypothetical	  protein	  3	   576	   746	   +	   hypothetical	  protein	  3	   1249	   773	   -­‐	   RepA	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Contig	   Start	   Stop	   Strand	   Function	  1	   568	   29	   -­‐	   putative	  transposase	  1	   1000	   689	   -­‐	   putative	  transposase	  1	   1164	   1730	   +	   Resolvase/integrase	  Bin	  1	   1938	   2468	   +	   hypothetical	  protein	  1	   3289	   4056	   +	   hypothetical	  protein	  1	   4318	   4193	   -­‐	   stability	  (stb)	  locus	  of	  IncFII	  plasmid	  NR1	  1	   4699	   4424	   -­‐	   COG3668:	  Plasmid	  stabilization	  system	  protein	  1	   4920	   4699	   -­‐	   hypothetical	  protein	  1	   5948	   6100	   +	   hypothetical	  protein	  1	   6939	   6070	   -­‐	   RepA1	  1	   7043	   7168	   +	   hypothetical	  protein	  1	   7489	   7241	   -­‐	   Replication	  regulatory	  protein	  repA2	  (Protein	  copB)	  1	   7669	   7791	   +	   hypothetical	  protein	  1	   7922	   7773	   -­‐	   post-­‐segregation	  killing	  protein	  1	   8336	   8202	   -­‐	   hypothetical	  protein	  1	   9148	   8687	   -­‐	   putative	  nuclease	  1	   9576	   9460	   -­‐	   hypothetical	  protein	  1	   9731	   9558	   -­‐	   hypothetical	  protein	  1	   10094	   9891	   -­‐	   hypothetical	  protein	  1	   10806	   10249	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  fertility	  inhibition	  protein	  FinO	  1	   11769	   10909	   -­‐	   Dienelactone	  hydrolase	  and	  related	  enzymes	  1	   12574	   11828	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilin	  acetylase	  TraX	  1	   17864	   12594	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  DNA-­‐nicking	  and	  unwinding	  protein	  TraI	  1	   18151	   17861	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbH	  1	   18173	   18571	   +	   VapC	  toxin	  protein	  1	   20733	   18580	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TraD	  1	   20776	   20898	   +	   hypothetical	  protein	  1	   21648	   20986	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  surface	  exclusion	  protein	  TraT	  1	   21632	   21763	   +	   hypothetical	  protein	  1	   22239	   21748	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  surface	  exclusion	  protein	  TraS	  1	   25083	   22261	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TraG	  1	   26456	   25080	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraH	  1	   26833	   26453	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbF	  1	   27101	   26820	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbJ	  1	   27636	   27091	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbB	  1	   27907	   27623	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TraQ	  1	   27988	   28302	   +	   ArtA	  1	   28651	   28304	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbA	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1	   29410	   28667	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraF	  1	   29660	   29403	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbE	  1	   29983	   29687	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TraN	  2	   23	   163	   +	   stable	  plasmid	  inheritance	  protein	  2	   554	   165	   -­‐	   Error-­‐prone,	  lesion	  bypass	  DNA	  polymerase	  V	  (UmuC)	  2	   1168	   812	   -­‐	   Transposase	  2	   1598	   1371	   -­‐	   hypothetical	  protein	  2	   1748	   1918	   +	   hypothetical	  protein	  2	   1935	   2888	   +	   RepFIB	  replication	  protein	  A	  2	   3083	   2964	   -­‐	   hypothetical	  protein	  2	   3913	   3173	   -­‐	   RepFIB	  associated	  resolvase	  2	   4589	   5758	   +	   hypothetical	  protein	  2	   5974	   6087	   +	   hypothetical	  protein	  2	   7573	   7007	   -­‐	   Transposase	  2	   8619	   7570	   -­‐	   Transposase	  2	   9000	   8650	   -­‐	   Insertion	  Sequence	  Associated	  2	   9431	   8997	   -­‐	   hypothetical	  protein	  2	   9762	   11732	   +	   Colicin	  I	  receptor	  precursor	  2	   11739	   12530	   +	   hypothetical	  protein	  2	   13111	   12593	   -­‐	   Transposase	  2	   13106	   13222	   +	   hypothetical	  protein	  2	   13246	   13458	   +	   COG2801:	  Transposase	  and	  inactivated	  derivatives	  2	   13755	   13868	   +	   hypothetical	  protein	  2	   14050	   15573	   +	   reverse	  transcriptase-­‐like	  protein	  2	   15690	   16136	   +	   COG2801:	  Transposase	  and	  inactivated	  derivatives	  2	   17495	   16671	   -­‐	   IS2	  ORF2	  2	   17899	   17534	   -­‐	   Transposase	  insC	  for	  insertion	  element	  IS2A/D/F/H/I/K	  2	   18211	   17975	   -­‐	   Per-­‐activated	  serine	  protease	  autotransporter	  enterotoxin	  EspC	  2	   18582	   18385	   -­‐	   Transposase	  insE	  for	  insertion	  sequence	  IS3A/B/C/D/E/fA/fB	  2	   21124	   18716	   -­‐	   putative	  F1	  capsule	  anchoring	  protein	  2	   21861	   21142	   -­‐	   Periplasmic	  fimbrial	  chaperone	  protein	  3	   1132	   278	   -­‐	   Chromosome	  (plasmid)	  partitioning	  protein	  ParB	  3	   2406	   1249	   -­‐	   Chromosome	  (plasmid)	  partitioning	  protein	  ParA	  3	   2371	   2523	   +	   hypothetical	  protein	  3	   3758	   3003	   -­‐	   Replication	  initiation	  protein	  RepE	  3	   4338	   4219	   -­‐	   hypothetical	  protein	  3	   5338	   4532	   -­‐	   Resolvase	  3	   5644	   5339	   -­‐	   CcdB	  toxin	  protein	  3	   5864	   5646	   -­‐	   CcdA	  protein	  (antitoxin	  to	  CcdB)	  3	   6190	   6041	   -­‐	   hypothetical	  protein	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3	   6432	   6944	   +	   putative	  periplasmic	  protein	  3	   7796	   6978	   -­‐	   unknown	  3	   7836	   7988	   +	   hypothetical	  protein	  3	   9051	   8278	   -­‐	   hypothetical	  protein	  3	   9564	   9064	   -­‐	   hypothetical	  protein	  3	   9753	   9640	   -­‐	   hypothetical	  protein	  3	   9829	   10059	   +	   Virulence-­‐associated	  protein	  vagC	  3	   10056	   10472	   +	   VagD	  3	   13852	   10517	   -­‐	   DNA-­‐binding	  protein	  3	   14340	   13870	   -­‐	   hypothetical	  protein	  3	   14523	   14921	   +	   Virulence-­‐associated	  protein	  vagC	  3	   14918	   15334	   +	   VagD	  3	   15409	   16974	   +	   Predicted	  ATP-­‐dependent	  endonuclease	  of	  the	  OLD	  family	  3	   16959	   17981	   +	   hypothetical	  protein	  3	   18201	   18037	   -­‐	   hypothetical	  protein	  4	   2009	   1371	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbC	  4	   3010	   2018	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraU	  4	   3639	   3007	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraW	  4	   4022	   3636	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbI	  4	   5725	   4019	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraC	  4	   6645	   5737	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraC	  4	   6851	   6708	   -­‐	   hypothetical	  protein	  4	   7026	   6805	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TraR	  4	   7676	   7161	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraV	  4	   7993	   7673	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TrbD	  4	   8567	   7980	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  protein	  TraP	  4	   9984	   8557	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraB	  4	   10712	   9984	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraK	  4	   11265	   10699	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraE	  4	   11598	   11287	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilus	  assembly	  protein	  TraL	  4	   11965	   11603	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  pilin	  protein	  TraA	  4	   12393	   11998	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  regulator	  TraY	  4	   13181	   12492	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  regulator	  TraJ	  4	   13499	   13368	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  mating	  signal	  transduction	  protein	  TraM	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4	   13750	   13526	   -­‐	   IncF	  plasmid	  conjugative	  transfer	  mating	  signal	  transduction	  protein	  TraM	  5	   418	   933	   +	   Plasmid	  PO157	  DNA,	  complete	  sequence	  5	   930	   1319	   +	   Plasmid	  PO157	  DNA,	  complete	  sequence	  5	   1458	   1270	   -­‐	   FIG00639560:	  hypothetical	  protein	  5	   1597	   1472	   -­‐	   hypothetical	  protein	  5	   1705	   2388	   +	   Adenine-­‐specific	  methyltransferase	  (EC	  2.1.1.72)	  5	   2389	   2610	   +	   putative	  cytoplasmic	  protein	  5	   2624	   3058	   +	   YcgB	  5	   3103	   3873	   +	   FIG00638373:	  hypothetical	  protein	  5	   4159	   3989	   -­‐	   hypothetical	  protein	  5	   4290	   4715	   +	   Putative	  antirestriction	  protein	  5	   4762	   5184	   +	   Orf52	  protein	  5	   5181	   5372	   +	   hypothetical	  protein	  5	   5859	   5578	   -­‐	   hypothetical	  protein	  5	   6057	   6185	   +	   Single-­‐stranded	  DNA-­‐binding	  protein	  5	   6175	   6312	   +	   hypothetical	  protein	  5	   6407	   6637	   +	   YdaB	  5	   6689	   8050	   +	   hypothetical	  plasmid	  protein	  5	   8098	   8661	   +	   hypothetical	  protein	  5	   8661	   8825	   +	   hypothetical	  protein	  6	   449	   174	   -­‐	   Insertion	  element	  protein	  6	   491	   643	   +	   FIG00642294:	  hypothetical	  protein	  6	   983	   2299	   +	   Transposase	  6	   2314	   3060	   +	   Transposase	  6	   3569	   7324	   +	   Per-­‐activated	  serine	  protease	  autotransporter	  enterotoxin	  EspC	  6	   7302	   7469	   +	   Per-­‐activated	  serine	  protease	  autotransporter	  enterotoxin	  EspC	  7	   242	   120	   -­‐	   hypothetical	  protein	  7	   2831	   738	   -­‐	   Colicin-­‐D	  7	   3089	   3526	   +	   entry	  exclusion	  protein	  1	  7	   3610	   4029	   +	   entry	  exclusion	  protein	  2	  7	   4376	   4155	   -­‐	   hypothetical	  protein	  7	   6002	   4404	   -­‐	   hypothetical	  protein	  7	   6339	   5992	   -­‐	   mobilization	  protein	  MobC	  7	   6382	   6573	   +	   RNAI	  modulator	  protein	  Rom	  7	   6997	   6884	   -­‐	   hypothetical	  protein	  8	   665	   471	   -­‐	   putative	  replication	  regulatory	  protein	  8	   918	   799	   -­‐	   hypothetical	  protein	  8	   1545	   3410	   +	   Type	  III	  restriction-­‐modification	  system	  methylation	  subunit	  (EC	  2.1.1.72)	  8	   3415	   6051	   +	   Type	  III	  restriction-­‐modification	  system	  DNA	  endonuclease	  res	  (EC	  3.1.21.5)	  9	   42	   689	   +	   hypothetical	  protein	  9	   1449	   1069	   -­‐	   CrcB	  protein	  9	   2224	   1790	   -­‐	   Enolase	  (EC	  4.2.1.11)	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9	   3549	   2692	   -­‐	   Manganese	  ABC	  transporter,	  inner	  membrane	  permease	  protein	  SitD	  9	   4403	   3546	   -­‐	   Manganese	  ABC	  transporter,	  inner	  membrane	  permease	  protein	  SitC	  9	   5227	   4400	   -­‐	   Manganese	  ABC	  transporter,	  ATP-­‐binding	  protein	  SitB	  9	   6141	   5227	   -­‐	   Manganese	  ABC	  transporter,	  periplasmic-­‐binding	  protein	  SitA	  10	   86	   1303	   +	   Citrate:6-­‐N-­‐acetyl-­‐6-­‐N-­‐hydroxy-­‐L-­‐lysine	  ligase,	  alpha	  subunit	  (EC	  6.3.2.27),	  aerobactin	  biosynthesis	  protein	  IucA	  	  10	   1300	   2577	   +	   L-­‐lysine	  6-­‐monooxygenase	  [NADPH]	  (EC	  1.14.13.59),	  aerobactin	  biosynthesis	  protein	  IucD	  	  10	   2659	   4860	   +	   Aerobactin	  siderophore	  receptor	  IutA	  	  11	   77	   895	   +	   IS600	  ORF2	  11	   1234	   1362	   +	   hypothetical	  protein	  11	   1363	   1662	   +	   F1845	  adhesin	  operon	  regulatory	  protein	  11	   1670	   2212	   +	   hypothetical	  protein	  11	   2227	   4671	   +	   Hypothetical	  outer	  membrane	  usher	  protein	  yraJ	  precursor	  12	   85	   510	   +	   unknown	  in	  ISEc8	  12	   507	   857	   +	   unknown	  in	  ISEc8	  12	   1244	   840	   -­‐	   hypothetical	  protein	  12	   3741	   2170	   -­‐	   Transposase	  12	   4108	   3761	   -­‐	   orf,	  conserved	  hypothetical	  protein	  12	   4758	   4108	   -­‐	   Insertion	  Sequence	  Associated	  12	   4854	   5009	   +	   Transposase	  13	   18	   296	   +	   Putative	  fimbrial	  chaperone	  protein	  13	   331	   822	   +	   K88	  minor	  fimbrial	  subunit	  faeF	  precursor	  13	   1060	   1896	   +	   fimbrial	  antigen	  FaeG	  precursor	  13	   2050	   2850	   +	   K88	  minor	  fimbrial	  subunit	  faeH	  precursor	  13	   2882	   3646	   +	   K88	  minor	  fimbrial	  subunit	  faeI	  precursor	  13	   3663	   4436	   +	   K88	  minor	  fimbrial	  subunit	  faeJ	  precursor	  14	   20	   1438	   +	   putative	  transposase	  14	   2258	   1482	   -­‐	   Transposase	  14	   3283	   2261	   -­‐	   hypothetical	  protein	  14	   3383	   3967	   +	   putative	  transposase	  15	   1960	   2	   -­‐	   FIG00638906:	  hypothetical	  protein	  15	   2259	   2026	   -­‐	   Putative	  cytoplasmic	  protein	  15	   2861	   2322	   -­‐	   Single-­‐stranded	  DNA-­‐binding	  protein	  15	   3093	   2887	   -­‐	   Single-­‐stranded	  DNA-­‐binding	  protein	  16	   878	   48	   -­‐	   possible	  AraC-­‐family	  transcriptional	  regulator	  16	   1523	   1281	   -­‐	   putative	  arylsulfatase	  regulatory	  protein	  16	   1786	   1661	   -­‐	   hypothetical	  protein	  16	   1775	   2302	   +	   Transposase	  16	   2271	   2621	   +	   Transposase	  17	   129	   344	   +	   Single-­‐stranded	  DNA-­‐binding	  protein	  17	   1493	   438	   -­‐	   invertase	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17	   1693	   1980	   +	   hypothetical	  protein	  17	   2024	   2920	   +	   unnamed	  protein	  product	  18	   46	   675	   +	   Transposase	  18	   823	   701	   -­‐	   hypothetical	  protein	  18	   891	   778	   -­‐	   hypothetical	  protein	  18	   1349	   1140	   -­‐	   Dr	  hemagglutinin	  AFA-­‐III	  operon	  regulatory	  protein	  afaF	  18	   1579	   1851	   +	   IS,	  phage,	  Tn;	  Transposon-­‐related	  functions	  18	   1900	   2118	   +	   Insertion	  element	  iso-­‐IS1n	  protein	  insB	  19	   823	   617	   -­‐	   FIG00511078:	  hypothetical	  protein	  20	   389	   273	   -­‐	   post-­‐segregation	  killing	  protein	  20	   511	   699	   +	   Protein	  sok	  20	   1429	   668	   -­‐	   PsiA	  protein	  20	   1860	   1426	   -­‐	   PsiB	  protein	  21	   12	   446	   +	   Citrate:6-­‐N-­‐acetyl-­‐6-­‐N-­‐hydroxy-­‐L-­‐lysine	  ligase,	  alpha	  subunit	  (EC	  6.3.2.27),	  aerobactin	  biosynthesis	  protein	  IucA	  	  21	   447	   1394	   +	   N6-­‐hydroxylysine	  O-­‐acetyltransferase	  (EC	  2.3.1.102),	  aerobactin	  biosynthesis	  protein	  IucB	  	  23	   223	   816	   +	   X	  polypeptide	  23	   976	   842	   -­‐	   putative	  ORF	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Appendix	  2:	  Raw	  plasmid	  and	  E.	  coli	  field	  data	  	  
Total	  E.	  coli	  collected	  per	  site	  	  
Plot	   A	   CC	   D	   OC	   R	   RH	   TM	   W	   WC	   SUM	  
E.	  coli	   140	   52	   4130	   6392	   6101	   2408	   484	   488	   4288	   24483	  	  
E.	  coli	  H-­‐antigen	  types	  by	  site	  	  	   A	   CC	   D	   OC	   R	   RH	   TM	   W	   WC	   SUM	  
H2	   0	   0	   0	   0	   4	   1	   0	   2	   0	   7	  
H4	   0	   7	   0	   40	   0	   0	   0	   0	   0	   47	  
H5	   4	   0	   1	   0	   12	   0	   0	   0	   0	   17	  
H6	   0	   0	   0	   0	   0	   0	   0	   0	   2	   2	  
H7	   1	   0	   7	   0	   1	   0	   0	   0	   1	   10	  
H8	   4	   10	   4	   0	   0	   0	   0	   0	   0	   18	  
H10	   1	   0	   0	   8	   19	   0	   0	   0	   0	   28	  
H11	   0	   0	   1	   1	   4	   0	   0	   0	   0	   6	  
H12	   0	   0	   1	   31	   0	   19	   47	   0	   20	   118	  
H14	   0	   0	   0	   4	   0	   0	   0	   0	   1	   5	  
H15	   0	   0	   8	   0	   0	   0	   0	   0	   0	   8	  
H16	   1	   0	   2	   0	   7	   0	   1	   4	   0	   15	  
H18	   0	   0	   0	   2	   0	   0	   0	   0	   2	   4	  
H19	   1	   0	   0	   3	   1	   0	   0	   0	   0	   5	  
H20	   0	   0	   0	   2	   0	   0	   0	   0	   0	   2	  
H21	   6	   0	   10	   1	   1	   1	   0	   0	   27	   46	  
H27	   0	   0	   0	   0	   0	   0	   1	   0	   20	   21	  
H28	   0	   0	   4	   0	   0	   30	   0	   0	   0	   34	  
H31	   3	   0	   0	   0	   1	   0	   0	   7	   0	   11	  
H32	   0	   0	   0	   0	   0	   0	   0	   0	   1	   1	  
H33	   0	   0	   0	   0	   0	   9	   0	   0	   0	   9	  
H37	   10	   0	   2	   0	   1	   0	   0	   1	   0	   14	  
H38	   7	   0	   2	   0	   9	   0	   0	   2	   0	   20	  
H39	   8	   0	   0	   0	   8	   0	   0	   0	   0	   16	  
H41	   0	   0	   0	   1	   0	   0	   0	   0	   0	   1	  
H42	   0	   0	   2	   0	   0	   0	   0	   0	   0	   2	  
H48	   0	   0	   0	   0	   12	   0	   0	   17	   0	   29	  
H49	   0	   1	   0	   0	   14	   0	   0	   5	   0	   20	  
H56	   1	   0	   9	   1	   0	   0	   0	   0	   0	   11	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Plasmids	  by	  site	  	  
Site	   A	   CC	   D	   OC	   R	   RH	   TM	   W	   WC	   SUM	  
KBBO	   0	   2	   0	   5	   0	   0	   0	   0	   0	   7	  
FIC	   0	   0	   8	   0	   23	   0	   0	   0	   1	   32	  
P	   0	   14	   8	   1	   0	   26	   33	   0	   21	   103	  
FIA	   16	   0	   7	   0	   60	   0	   0	   21	   14	   118	  
FIB	   38	   17	   41	   36	   79	   27	   42	   23	   49	   352	  
Y	   1	   0	   0	   1	   0	   0	   0	   0	   7	   9	  
I1	   0	   0	   10	   0	   27	   0	   0	   0	   0	   37	  
None	   8	   0	   10	   53	   10	   30	   1	   10	   17	   139	  	  
	  
	  
